Professional Documents
Culture Documents
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the norm
20 to 30 Marginal
> 30 Unacceptable Check = 30
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.300 0.040 0.260 0.214
0EX65002519030592T00026
0.060 0.090 0.140 0.214
0EX6500251903059320006E
0.110 0.020 0.010 0.214
0EX65002519030593200073
0.050 0.010 0.050 0.214
0EX65002519030593200076
0.080 0.080 0.110 0.214
0EX650025190305932000A2
0.110 0.020 0.050 0.214
0EX650025190305932000CD
0.040 0.100 0.140 0.214
0EX65002519030593200166
0.120 0.020 0.020 0.214
0EX6500251903059320018F
0.070 0.040 0.010 0.214
0EX6500251903059320019A
0.130 0.110 0.100 0.214
FX-2 FX-3
Trial 2 Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.43 22.43 0.040 22.23 22.49 22.43 0.260 UCL Range Violation - A
22.4 22.31 0.090 22.32 22.46 22.45 0.140
22.62 22.62 0.020 22.65 22.64 22.65 0.010
22.57 22.56 0.010 22.62 22.57 22.61 0.050
22.29 22.32 0.080 22.25 22.36 22.27 0.110
22.58 22.6 0.020 22.59 22.61 22.64 0.050
22.31 22.41 0.100 22.41 22.5 22.36 0.140
22.51 22.49 0.020 22.5 22.48 22.48 0.020
22.6 22.56 0.040 22.55 22.55 22.54 0.010
22.51 22.41 0.110 22.42 22.42 22.52 0.100
Average = 22.471 0.053 Average = 22.486 0.089
Average by Part
22.700
22.600
Average
22.500
22.400
22.300
22.200
22.100
8 9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.290 22.417 22.383
0EX65002519030592T00026
22.463 22.357 22.410
0EX6500251903059320006E
22.577 22.627 22.647
0EX65002519030593200073
22.537 22.567 22.600
0EX65002519030593200076
22.290 22.283 22.293
0EX650025190305932000A2
22.560 22.590 22.613
0EX650025190305932000CD
22.373 22.357 22.423
0EX65002519030593200166
22.450 22.497 22.487
0EX6500251903059320018F
22.520 22.577 22.547
0EX6500251903059320019A
22.410 22.440 22.453
CL Range Violation - A
heck
0.083
0.214
0.039
any of the individual
re above this control limit
K2
3.65
2.7
8 9 10
Part Name: 613376 USL = 24.5
Dimension: 2412 DSSS-1 BW-20 TX2 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.030 0.070 0.030 0.223
0EX65002519030592T00026
0.110 0.110 0.100 0.223
0EX6500251903059320006E
0.110 0.080 0.170 0.223
0EX65002519030593200073
0.230 0.090 0.120 0.223
0EX65002519030593200076
0.080 0.050 0.130 0.223
0EX650025190305932000A2
0.010 0.050 0.030 0.223
0EX650025190305932000CD
0.090 0.080 0.020 0.223
0EX65002519030593200166
0.110 0.060 0.040 0.223
0EX6500251903059320018F
0.090 0.010 0.040 0.223
0EX6500251903059320019A
0.300 0.080 0.070 0.223
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.67 0.070 21.69 21.66 21.68 0.030
21.63 0.110 21.59 21.69 21.63 0.100
21.88 0.080 21.88 21.94 21.77 0.170
21.79 0.090 21.82 21.94 21.89 0.120 UCL Range Violation - A
21.6 0.050 21.73 21.6 21.69 0.130
22.06 0.050 22.14 22.11 22.11 0.030
21.55 0.080 21.55 21.55 21.53 0.020
21.93 0.060 21.93 21.89 21.89 0.040
22.1 0.010 22.14 22.16 22.18 0.040
21.68 0.080 21.59 21.56 21.52 0.070 UCL Range Violation - A
21.789 0.068 Average = 21.802 0.075
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.400
22.200
Average
22.000
21.800
21.600
21.400
21.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.663 21.633 21.677
0EX65002519030592T00026
21.657 21.627 21.637
0EX6500251903059320006E
21.847 21.873 21.863
0EX65002519030593200073
21.863 21.830 21.883
0EX65002519030593200076
21.587 21.617 21.673
0EX650025190305932000A2
22.037 22.083 22.120
0EX650025190305932000CD
21.560 21.577 21.543
0EX65002519030593200166
21.847 21.910 21.903
0EX6500251903059320018F
22.087 22.107 22.160
0EX6500251903059320019A
21.613 21.633 21.557
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2442 DSSS-1 BW-20 TX1 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.080 0.070 0.080 0.169
0EX65002519030592T00026
0.050 0.050 0.070 0.169
0EX6500251903059320006E
0.090 0.030 0.040 0.169
0EX65002519030593200073
0.060 0.080 0.100 0.169
0EX65002519030593200076
0.050 0.060 0.090 0.169
0EX650025190305932000A2
0.150 0.040 0.060 0.169
0EX650025190305932000CD
0.030 0.010 0.020 0.169
0EX65002519030593200166
0.080 0.090 0.000 0.169
0EX6500251903059320018F
0.110 0.010 0.060 0.169
0EX6500251903059320019A
0.120 0.080 0.100 0.169
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.79 0.070 22.79 22.84 22.87 0.080
22.81 0.050 22.77 22.84 22.84 0.070
22.63 0.030 22.6 22.56 22.6 0.040
22.77 0.080 22.83 22.88 22.78 0.100
22.64 0.060 22.65 22.56 22.62 0.090
22.81 0.040 22.82 22.76 22.78 0.060
22.68 0.010 22.68 22.66 22.67 0.020
22.89 0.090 22.89 22.89 22.89 0.000
22.78 0.010 22.79 22.85 22.85 0.060
22.64 0.080 22.7 22.61 22.71 0.100
22.745 0.052 Average = 22.753 0.062
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.000
22.900
Average
22.800
22.700
22.600
22.500
22.400
22.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.770 22.833 22.833
0EX65002519030592T00026
22.817 22.787 22.817
0EX6500251903059320006E
22.530 22.613 22.587
0EX65002519030593200073
22.773 22.797 22.830
0EX65002519030593200076
22.603 22.653 22.610
0EX650025190305932000A2
22.747 22.787 22.787
0EX650025190305932000CD
22.643 22.677 22.670
0EX65002519030593200166
22.873 22.833 22.890
0EX6500251903059320018F
22.763 22.787 22.830
0EX6500251903059320019A
22.683 22.680 22.673
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2442 DSSS-1 BW-20 TX2 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.060 0.100 0.080 0.222
0EX65002519030592T00026
0.180 0.070 0.120 0.222
0EX6500251903059320006E
0.120 0.110 0.020 0.222
0EX65002519030593200073
0.040 0.040 0.130 0.222
0EX65002519030593200076
0.070 0.060 0.090 0.222
0EX650025190305932000A2
0.050 0.060 0.110 0.222
0EX650025190305932000CD
0.080 0.110 0.120 0.222
0EX65002519030593200166
0.040 0.050 0.010 0.222
0EX6500251903059320018F
0.160 0.140 0.090 0.222
0EX6500251903059320019A
0.090 0.020 0.160 0.222
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.07 0.100 22.18 22.1 22.17 0.080
22.17 0.070 22.24 22.13 22.12 0.120
22.25 0.110 22.32 22.31 22.3 0.020
22.24 0.040 22.31 22.18 22.21 0.130
21.99 0.060 22.08 22.04 22.13 0.090
22.52 0.060 22.44 22.55 22.48 0.110
22.17 0.110 22.17 22.08 22.05 0.120
22.2 0.050 22.2 22.2 22.19 0.010
22.37 0.140 22.42 22.38 22.33 0.090
22.14 0.020 22.02 22.18 22.02 0.160
22.207 0.076 Average = 22.218 0.093
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.600
22.500
Average
22.400
22.300
22.200
22.100
22.000
21.900
21.800
21.700
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.090 22.070 22.150
0EX65002519030592T00026
22.150 22.180 22.163
0EX6500251903059320006E
22.273 22.303 22.310
0EX65002519030593200073
22.237 22.223 22.233
0EX65002519030593200076
22.063 22.010 22.083
0EX650025190305932000A2
22.377 22.493 22.490
0EX650025190305932000CD
21.997 22.100 22.100
0EX65002519030593200166
22.097 22.197 22.197
0EX6500251903059320018F
22.277 22.363 22.377
0EX6500251903059320019A
22.040 22.133 22.073
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2472 DSSS-1 BW-20 TX1 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.030 0.120 0.020 0.139
0EX65002519030592T00026
0.060 0.050 0.030 0.139
0EX6500251903059320006E
0.100 0.100 0.010 0.139
0EX65002519030593200073
0.070 0.080 0.060 0.139
0EX65002519030593200076
0.040 0.050 0.030 0.139
0EX650025190305932000A2
0.100 0.010 0.030 0.139
0EX650025190305932000CD
0.080 0.010 0.130 0.139
0EX65002519030593200166
0.120 0.020 0.030 0.139
0EX6500251903059320018F
0.070 0.020 0.100 0.139
0EX6500251903059320019A
0.010 0.030 0.010 0.139
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.06 0.120 22.09 22.09 22.07 0.020
22.12 0.050 22.13 22.15 22.12 0.030
22.08 0.100 22.09 22.1 22.1 0.010
22.07 0.080 22.09 22.03 22.03 0.060
21.93 0.050 21.89 21.92 21.92 0.030
22.45 0.010 22.47 22.45 22.48 0.030
22.03 0.010 22.07 22.06 21.94 0.130
22.08 0.020 22.09 22.12 22.09 0.030
22.37 0.020 22.41 22.36 22.31 0.100
22.02 0.030 22.02 22.03 22.03 0.010
22.127 0.049 Average = 22.125 0.045
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.600
22.500
Average
22.400
22.300
22.200
22.100
22.000
21.900
21.800
21.700
21.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.000 22.047 22.083
0EX65002519030592T00026
22.123 22.143 22.133
0EX6500251903059320006E
22.057 22.113 22.097
0EX65002519030593200073
22.013 22.090 22.050
0EX65002519030593200076
21.933 21.920 21.910
0EX650025190305932000A2
22.393 22.447 22.467
0EX650025190305932000CD
22.040 22.027 22.023
0EX65002519030593200166
22.057 22.080 22.100
0EX6500251903059320018F
22.297 22.377 22.360
0EX6500251903059320019A
21.997 22.030 22.027
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2472 DSSS-1 BW-20 TX2 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.180 0.110 0.070 0.258
0EX65002519030592T00026
0.120 0.150 0.110 0.258
0EX6500251903059320006E
0.100 0.200 0.180 0.258
0EX65002519030593200073
0.080 0.110 0.130 0.258
0EX65002519030593200076
0.040 0.210 0.010 0.258
0EX650025190305932000A2
0.070 0.040 0.050 0.258
0EX650025190305932000CD
0.030 0.040 0.110 0.258
0EX65002519030593200166
0.040 0.110 0.080 0.258
0EX6500251903059320018F
0.140 0.150 0.100 0.258
0EX6500251903059320019A
0.070 0.080 0.090 0.258
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.07 0.110 22.14 22.18 22.11 0.070
22.02 0.150 22.06 21.97 22.08 0.110
21.93 0.200 21.8 21.98 21.81 0.180
22.07 0.110 21.91 22.04 22.03 0.130
22 0.210 21.94 21.93 21.94 0.010
22.31 0.040 22.33 22.35 22.3 0.050
21.7 0.040 21.67 21.67 21.78 0.110
22.06 0.110 22.03 22.1 22.11 0.080
22.12 0.150 22.02 22.12 22.05 0.100
22.03 0.080 22.06 21.97 22 0.090
22.015 0.120 Average = 22.016 0.093
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.400
22.200
Average
22.000
21.800
21.600
21.400
21.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.077 22.080 22.143
0EX65002519030592T00026
22.027 22.043 22.037
0EX6500251903059320006E
21.803 21.910 21.863
0EX65002519030593200073
21.950 22.047 21.993
0EX65002519030593200076
21.873 21.920 21.937
0EX650025190305932000A2
22.280 22.317 22.327
0EX650025190305932000CD
21.633 21.720 21.707
0EX65002519030593200166
21.980 21.990 22.080
0EX6500251903059320018F
22.137 22.083 22.063
0EX6500251903059320019A
21.960 22.043 22.010
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2412 CCK-11 BW-20 TX1 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.050 0.130 0.030 0.177
0EX65002519030592T00026
0.060 0.050 0.060 0.177
0EX6500251903059320006E
0.100 0.040 0.050 0.177
0EX65002519030593200073
0.050 0.040 0.070 0.177
0EX65002519030593200076
0.090 0.010 0.050 0.177
0EX650025190305932000A2
0.110 0.130 0.020 0.177
0EX650025190305932000CD
0.040 0.050 0.120 0.177
0EX65002519030593200166
0.020 0.090 0.090 0.177
0EX6500251903059320018F
0.070 0.100 0.100 0.177
0EX6500251903059320019A
0.050 0.100 0.090 0.177
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.69 0.130 22.63 22.62 22.65 0.030
22.6 0.050 22.6 22.54 22.6 0.060
22.83 0.040 22.89 22.9 22.85 0.050
22.82 0.040 22.83 22.9 22.85 0.070
22.55 0.010 22.56 22.58 22.53 0.050
22.92 0.130 22.92 22.93 22.91 0.020
22.64 0.050 22.68 22.56 22.64 0.120
22.82 0.090 22.81 22.72 22.76 0.090
22.74 0.100 22.83 22.77 22.73 0.100
22.6 0.100 22.66 22.62 22.71 0.090
22.717 0.074 Average = 22.726 0.068
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.000
22.900
Average
22.800
22.700
22.600
22.500
22.400
22.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.620 22.630 22.633
0EX65002519030592T00026
22.597 22.617 22.580
0EX6500251903059320006E
22.847 22.850 22.880
0EX65002519030593200073
22.813 22.820 22.860
0EX65002519030593200076
22.567 22.547 22.557
0EX650025190305932000A2
22.883 22.860 22.920
0EX650025190305932000CD
22.567 22.630 22.627
0EX65002519030593200166
22.713 22.777 22.763
0EX6500251903059320018F
22.773 22.777 22.777
0EX6500251903059320019A
22.597 22.663 22.663
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2412 CCK-11 BW-20 TX2 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.040 0.150 0.070 0.239
0EX65002519030592T00026
0.130 0.060 0.140 0.239
0EX6500251903059320006E
0.010 0.050 0.090 0.239
0EX65002519030593200073
0.160 0.080 0.060 0.239
0EX65002519030593200076
0.120 0.080 0.080 0.239
0EX650025190305932000A2
0.100 0.050 0.100 0.239
0EX650025190305932000CD
0.160 0.070 0.060 0.239
0EX65002519030593200166
0.120 0.110 0.030 0.239
0EX6500251903059320018F
0.160 0.040 0.090 0.239
0EX6500251903059320019A
0.070 0.180 0.120 0.239
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.9 0.150 21.88 21.84 21.91 0.070
21.81 0.060 21.88 21.74 21.81 0.140
22.09 0.050 22.07 22.13 22.16 0.090
22.07 0.080 22.07 22.09 22.13 0.060
21.82 0.080 21.84 21.78 21.86 0.080
22.3 0.050 22.37 22.33 22.27 0.100
21.74 0.070 21.68 21.74 21.73 0.060
22.06 0.110 22 22 22.03 0.030
22.31 0.040 22.38 22.3 22.29 0.090
21.79 0.180 21.78 21.88 21.76 0.120
21.984 0.087 Average = 21.991 0.084
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.400
22.200
Average
22.000
21.800
21.600
21.400
21.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.830 21.827 21.877
0EX65002519030592T00026
21.827 21.810 21.810
0EX6500251903059320006E
22.053 22.093 22.120
0EX65002519030593200073
22.000 22.110 22.097
0EX65002519030593200076
21.813 21.770 21.827
0EX650025190305932000A2
22.280 22.303 22.323
0EX650025190305932000CD
21.667 21.757 21.717
0EX65002519030593200166
22.060 22.020 22.010
0EX6500251903059320018F
22.260 22.317 22.323
0EX6500251903059320019A
21.803 21.837 21.807
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2442 CCK-11 BW-20 TX1 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.090 0.060 0.030 0.150
0EX65002519030592T00026
0.090 0.020 0.030 0.150
0EX6500251903059320006E
0.050 0.020 0.090 0.150
0EX65002519030593200073
0.120 0.010 0.020 0.150
0EX65002519030593200076
0.040 0.070 0.070 0.150
0EX650025190305932000A2
0.090 0.100 0.060 0.150
0EX650025190305932000CD
0.060 0.060 0.040 0.150
0EX65002519030593200166
0.080 0.090 0.040 0.150
0EX6500251903059320018F
0.030 0.060 0.050 0.150
0EX6500251903059320019A
0.130 0.010 0.030 0.150
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
23.03 0.060 23.09 23.09 23.06 0.030
23.02 0.020 23.03 23 23.02 0.030
22.79 0.020 22.9 22.86 22.81 0.090
23.1 0.010 23.1 23.12 23.11 0.020
22.88 0.070 22.89 22.94 22.87 0.070
23.03 0.100 23.07 23.03 23.01 0.060
22.82 0.060 22.9 22.88 22.86 0.040
23.09 0.090 23.05 23.09 23.08 0.040
23.07 0.060 23.11 23.06 23.06 0.050
22.93 0.010 22.94 22.91 22.91 0.030
22.970 0.050 Average = 22.995 0.046
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.200
23.100
Average
23.000
22.900
22.800
22.700
22.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
23.027 23.037 23.080
0EX65002519030592T00026
23.053 23.030 23.017
0EX6500251903059320006E
22.780 22.800 22.857
0EX65002519030593200073
23.047 23.103 23.110
0EX65002519030593200076
22.883 22.870 22.900
0EX650025190305932000A2
22.973 23.023 23.037
0EX650025190305932000CD
22.863 22.850 22.880
0EX65002519030593200166
23.053 23.030 23.073
0EX6500251903059320018F
23.003 23.033 23.077
0EX6500251903059320019A
22.887 22.927 22.920
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2442 CCK-11 BW-20 TX2 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.060 0.120 0.010 0.249
0EX65002519030592T00026
0.070 0.110 0.060 0.249
0EX6500251903059320006E
0.030 0.010 0.120 0.249
0EX65002519030593200073
0.090 0.080 0.180 0.249
0EX65002519030593200076
0.070 0.050 0.070 0.249
0EX650025190305932000A2
0.170 0.080 0.030 0.249
0EX650025190305932000CD
0.130 0.090 0.120 0.249
0EX65002519030593200166
0.120 0.160 0.120 0.249
0EX6500251903059320018F
0.110 0.110 0.160 0.249
0EX6500251903059320019A
0.130 0.090 0.150 0.249
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.3 0.120 22.32 22.33 22.32 0.010
22.41 0.110 22.33 22.3 22.36 0.060
22.45 0.010 22.36 22.48 22.48 0.120
22.35 0.080 22.52 22.49 22.34 0.180
22.24 0.050 22.24 22.2 22.27 0.070
22.63 0.080 22.67 22.68 22.65 0.030
22.32 0.090 22.32 22.37 22.25 0.120
22.43 0.160 22.4 22.33 22.28 0.120
22.58 0.110 22.6 22.48 22.64 0.160
22.25 0.090 22.26 22.36 22.41 0.150
22.395 0.090 Average = 22.401 0.102
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.800
22.700
Average
22.600
22.500
22.400
22.300
22.200
22.100
22.000
21.900
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.317 22.300 22.323
0EX65002519030592T00026
22.380 22.427 22.330
0EX6500251903059320006E
22.457 22.453 22.440
0EX65002519030593200073
22.397 22.397 22.450
0EX65002519030593200076
22.210 22.250 22.237
0EX650025190305932000A2
22.627 22.677 22.667
0EX650025190305932000CD
22.260 22.310 22.313
0EX65002519030593200166
22.320 22.333 22.337
0EX6500251903059320018F
22.530 22.537 22.573
0EX6500251903059320019A
22.257 22.267 22.343
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2472 CCK-11 BW-20 TX1 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.060 0.060 0.050 0.160
0EX65002519030592T00026
0.050 0.050 0.050 0.160
0EX6500251903059320006E
0.120 0.040 0.080 0.160
0EX65002519030593200073
0.020 0.110 0.120 0.160
0EX65002519030593200076
0.050 0.060 0.050 0.160
0EX650025190305932000A2
0.040 0.070 0.090 0.160
0EX650025190305932000CD
0.140 0.050 0.010 0.160
0EX65002519030593200166
0.130 0.010 0.010 0.160
0EX6500251903059320018F
0.100 0.090 0.010 0.160
0EX6500251903059320019A
0.070 0.020 0.050 0.160
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.29 0.060 22.26 22.27 22.31 0.050
22.39 0.050 22.38 22.33 22.37 0.050
22.31 0.040 22.38 22.34 22.3 0.080
22.28 0.110 22.33 22.27 22.39 0.120
22.18 0.060 22.13 22.17 22.12 0.050
22.59 0.070 22.59 22.63 22.68 0.090
22.18 0.050 22.2 22.21 22.21 0.010
22.34 0.010 22.35 22.35 22.34 0.010
22.62 0.090 22.6 22.6 22.59 0.010
22.23 0.020 22.26 22.21 22.23 0.050
22.339 0.056 Average = 22.347 0.052
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.700
22.600
Average
22.500
22.400
22.300
22.200
22.100
22.000
21.900
21.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.257 22.270 22.280
0EX65002519030592T00026
22.357 22.370 22.360
0EX6500251903059320006E
22.333 22.327 22.340
0EX65002519030593200073
22.233 22.290 22.330
0EX65002519030593200076
22.157 22.153 22.140
0EX650025190305932000A2
22.600 22.613 22.633
0EX650025190305932000CD
22.217 22.200 22.207
0EX65002519030593200166
22.280 22.343 22.347
0EX6500251903059320018F
22.567 22.587 22.597
0EX6500251903059320019A
22.243 22.240 22.233
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2472 CCK-11 BW-20 TX2 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.080 0.000 0.228
0EX65002519030592T00026
0.080 0.120 0.050 0.228
0EX6500251903059320006E
0.190 0.060 0.170 0.228
0EX65002519030593200073
0.170 0.090 0.140 0.228
0EX65002519030593200076
0.010 0.110 0.050 0.228
0EX650025190305932000A2
0.190 0.090 0.090 0.228
0EX650025190305932000CD
0.050 0.060 0.090 0.228
0EX65002519030593200166
0.060 0.070 0.050 0.228
0EX6500251903059320018F
0.080 0.040 0.060 0.228
0EX6500251903059320019A
0.120 0.090 0.060 0.228
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.35 0.080 22.31 22.31 22.31 0.000
22.24 0.120 22.21 22.22 22.17 0.050
22.07 0.060 22.17 22.12 22 0.170
22.17 0.090 22.24 22.1 22.13 0.140
22.05 0.110 22.09 22.04 22.09 0.050
22.47 0.090 22.51 22.43 22.52 0.090
21.94 0.060 21.79 21.84 21.88 0.090
22.09 0.070 22.23 22.19 22.18 0.050
22.24 0.040 22.34 22.28 22.29 0.060
22.2 0.090 22.23 22.19 22.25 0.060
22.182 0.081 Average = 22.189 0.076
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.600
22.400
Average
22.200
22.000
21.800
21.600
21.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.353 22.303 22.310
0EX65002519030592T00026
22.173 22.240 22.200
0EX6500251903059320006E
22.013 22.090 22.097
0EX65002519030593200073
22.150 22.167 22.157
0EX65002519030593200076
22.087 22.033 22.073
0EX650025190305932000A2
22.470 22.473 22.487
0EX650025190305932000CD
21.860 21.907 21.837
0EX65002519030593200166
22.147 22.133 22.200
0EX6500251903059320018F
22.240 22.247 22.303
0EX6500251903059320019A
22.193 22.230 22.223
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2412 OFDM-6 BW-20 TX1 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.080 0.030 0.060 0.180
0EX65002519030592T00026
0.070 0.010 0.060 0.180
0EX6500251903059320006E
0.100 0.110 0.000 0.180
0EX65002519030593200073
0.120 0.130 0.010 0.180
0EX65002519030593200076
0.060 0.080 0.010 0.180
0EX650025190305932000A2
0.060 0.100 0.080 0.180
0EX650025190305932000CD
0.080 0.040 0.060 0.180
0EX65002519030593200166
0.170 0.090 0.130 0.180
0EX6500251903059320018F
0.070 0.020 0.030 0.180
0EX6500251903059320019A
0.060 0.090 0.080 0.180
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.88 0.030 22.9 22.95 22.89 0.060
22.91 0.010 22.91 22.89 22.95 0.060
23.19 0.110 23.14 23.14 23.14 0.000
23.11 0.130 23.08 23.09 23.08 0.010
22.85 0.080 22.77 22.77 22.76 0.010
23.08 0.100 23.17 23.09 23.1 0.080
22.85 0.040 22.95 22.89 22.92 0.060
23.04 0.090 22.91 23.04 22.98 0.130
23.05 0.020 23.01 23.04 23.04 0.030
22.91 0.090 22.9 22.94 22.86 0.080
22.974 0.070 Average = 22.977 0.052
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.200
23.100
Average
23.000
22.900
22.800
22.700
22.600
22.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.850 22.897 22.913
0EX65002519030592T00026
22.913 22.907 22.917
0EX6500251903059320006E
23.103 23.143 23.140
0EX65002519030593200073
23.017 23.060 23.083
0EX65002519030593200076
22.853 22.797 22.767
0EX650025190305932000A2
23.083 23.123 23.120
0EX650025190305932000CD
22.870 22.867 22.920
0EX65002519030593200166
22.940 23.017 22.977
0EX6500251903059320018F
22.987 23.057 23.030
0EX6500251903059320019A
22.873 22.873 22.900
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2412 OFDM-6 BW-20 TX2 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.120 0.060 0.050 0.244
0EX65002519030592T00026
0.050 0.100 0.150 0.244
0EX6500251903059320006E
0.040 0.040 0.030 0.244
0EX65002519030593200073
0.120 0.160 0.020 0.244
0EX65002519030593200076
0.170 0.070 0.080 0.244
0EX650025190305932000A2
0.140 0.080 0.110 0.244
0EX650025190305932000CD
0.130 0.070 0.160 0.244
0EX65002519030593200166
0.140 0.100 0.140 0.244
0EX6500251903059320018F
0.190 0.080 0.040 0.244
0EX6500251903059320019A
0.080 0.050 0.070 0.244
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.09 0.060 22.16 22.11 22.16 0.050
22.12 0.100 22.19 22.08 22.04 0.150
22.31 0.040 22.31 22.34 22.33 0.030
22.23 0.160 22.34 22.32 22.32 0.020
22.04 0.070 22.1 22.08 22.02 0.080
22.56 0.080 22.52 22.58 22.63 0.110
22.02 0.070 22.06 21.93 21.9 0.160
22.35 0.100 22.4 22.26 22.35 0.140
22.54 0.080 22.58 22.57 22.54 0.040
22.04 0.050 22.13 22.06 22.06 0.070
22.212 0.081 Average = 22.249 0.085
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.800
22.600
Average
22.400
22.200
22.000
21.800
21.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.113 22.077 22.143
0EX65002519030592T00026
22.100 22.067 22.103
0EX6500251903059320006E
22.290 22.327 22.327
0EX65002519030593200073
22.230 22.163 22.327
0EX65002519030593200076
22.060 22.043 22.067
0EX650025190305932000A2
22.513 22.587 22.577
0EX650025190305932000CD
21.993 21.980 21.963
0EX65002519030593200166
22.313 22.300 22.337
0EX6500251903059320018F
22.567 22.553 22.563
0EX6500251903059320019A
22.060 22.023 22.083
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2442 OFDM-6 BW-20 TX1 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.080 0.030 0.165
0EX65002519030592T00026
0.030 0.020 0.030 0.165
0EX6500251903059320006E
0.050 0.080 0.080 0.165
0EX65002519030593200073
0.060 0.050 0.120 0.165
0EX65002519030593200076
0.120 0.080 0.060 0.165
0EX650025190305932000A2
0.080 0.060 0.050 0.165
0EX650025190305932000CD
0.020 0.030 0.080 0.165
0EX65002519030593200166
0.030 0.060 0.000 0.165
0EX6500251903059320018F
0.180 0.030 0.060 0.165
0EX6500251903059320019A
0.050 0.080 0.080 0.165
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
23.38 0.080 23.36 23.35 23.33 0.030
23.32 0.020 23.28 23.31 23.31 0.030
23.17 0.080 23.07 23.1 23.15 0.080
23.36 0.050 23.32 23.37 23.44 0.120
23.18 0.080 23.2 23.18 23.14 0.060
23.35 0.060 23.31 23.36 23.33 0.050
23.17 0.030 23.1 23.12 23.18 0.080
23.36 0.060 23.37 23.37 23.37 0.000
23.34 0.030 23.41 23.37 23.35 0.060 UCL Range Violation - A
23.13 0.080 23.14 23.21 23.22 0.080
23.263 0.057 Average = 23.271 0.059
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.500
23.400
Average
23.300
23.200
23.100
23.000
22.900
22.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
23.323 23.337 23.347
0EX65002519030592T00026
23.313 23.320 23.300
0EX6500251903059320006E
23.050 23.123 23.107
0EX65002519030593200073
23.300 23.327 23.377
0EX65002519030593200076
23.167 23.167 23.173
0EX650025190305932000A2
23.287 23.317 23.333
0EX650025190305932000CD
23.163 23.167 23.133
0EX65002519030593200166
23.357 23.380 23.370
0EX6500251903059320018F
23.307 23.330 23.377
0EX6500251903059320019A
23.147 23.163 23.190
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2442 OFDM-6 BW-20 TX2 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.170 0.030 0.040 0.229
0EX65002519030592T00026
0.180 0.040 0.030 0.229
0EX6500251903059320006E
0.140 0.080 0.030 0.229
0EX65002519030593200073
0.140 0.030 0.070 0.229
0EX65002519030593200076
0.080 0.080 0.090 0.229
0EX650025190305932000A2
0.050 0.060 0.070 0.229
0EX650025190305932000CD
0.100 0.100 0.040 0.229
0EX65002519030593200166
0.150 0.020 0.080 0.229
0EX6500251903059320018F
0.200 0.120 0.120 0.229
0EX6500251903059320019A
0.160 0.050 0.110 0.229
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.54 0.030 22.53 22.57 22.57 0.040
22.62 0.040 22.6 22.57 22.57 0.030
22.73 0.080 22.73 22.76 22.74 0.030
22.61 0.030 22.63 22.63 22.7 0.070
22.43 0.080 22.45 22.36 22.4 0.090
22.89 0.060 22.92 22.93 22.86 0.070
22.56 0.100 22.53 22.49 22.51 0.040
22.57 0.020 22.58 22.57 22.5 0.080
22.79 0.120 22.87 22.78 22.75 0.120
22.54 0.050 22.58 22.47 22.55 0.110
22.628 0.061 Average = 22.623 0.068
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.000
22.900
Average
22.800
22.700
22.600
22.500
22.400
22.300
22.200
22.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.533 22.523 22.557
0EX65002519030592T00026
22.657 22.613 22.580
0EX6500251903059320006E
22.690 22.757 22.743
0EX65002519030593200073
22.580 22.620 22.653
0EX65002519030593200076
22.470 22.410 22.403
0EX650025190305932000A2
22.830 22.923 22.903
0EX650025190305932000CD
22.463 22.560 22.510
0EX65002519030593200166
22.480 22.570 22.550
0EX6500251903059320018F
22.753 22.757 22.800
0EX6500251903059320019A
22.517 22.543 22.533
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2472 OFDM-6 BW-20 TX1 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.100
Range
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.050 0.020 0.060 0.117
0EX65002519030592T00026
0.040 0.020 0.030 0.117
0EX6500251903059320006E
0.010 0.040 0.040 0.117
0EX65002519030593200073
0.030 0.020 0.020 0.117
0EX65002519030593200076
0.020 0.100 0.030 0.117
0EX650025190305932000A2
0.090 0.010 0.010 0.117
0EX650025190305932000CD
0.060 0.010 0.090 0.117
0EX65002519030593200166
0.100 0.010 0.020 0.117
0EX6500251903059320018F
0.070 0.100 0.070 0.117
0EX6500251903059320019A
0.090 0.060 0.040 0.117
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.56 0.020 22.58 22.62 22.56 0.060
22.6 0.020 22.61 22.61 22.64 0.030
22.61 0.040 22.63 22.59 22.6 0.040
22.56 0.020 22.58 22.57 22.56 0.020
22.46 0.100 22.42 22.42 22.45 0.030
22.9 0.010 22.92 22.91 22.92 0.010
22.54 0.010 22.49 22.58 22.53 0.090
22.61 0.010 22.61 22.62 22.63 0.020
22.85 0.100 22.82 22.89 22.89 0.070
22.55 0.060 22.56 22.52 22.53 0.040
22.618 0.039 Average = 22.629 0.041
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.000
22.900
Average
22.800
22.700
22.600
22.500
22.400
22.300
22.200
22.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.513 22.547 22.587
0EX65002519030592T00026
22.633 22.600 22.620
0EX6500251903059320006E
22.583 22.597 22.607
0EX65002519030593200073
22.540 22.550 22.570
0EX65002519030593200076
22.443 22.460 22.430
0EX650025190305932000A2
22.910 22.893 22.917
0EX650025190305932000CD
22.497 22.533 22.533
0EX65002519030593200166
22.577 22.613 22.620
0EX6500251903059320018F
22.843 22.857 22.867
0EX6500251903059320019A
22.567 22.527 22.537
control limit
9 10
Part Name: 613376 USL = 24.5
Dimension: 2472 OFDM-6 BW-20 TX2 LSL = 20.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.180 0.080 0.090 0.210
0EX65002519030592T00026
0.130 0.110 0.010 0.210
0EX6500251903059320006E
0.020 0.080 0.140 0.210
0EX65002519030593200073
0.090 0.020 0.070 0.210
0EX65002519030593200076
0.030 0.070 0.160 0.210
0EX650025190305932000A2
0.090 0.050 0.040 0.210
0EX650025190305932000CD
0.080 0.090 0.050 0.210
0EX65002519030593200166
0.090 0.110 0.010 0.210
0EX6500251903059320018F
0.040 0.190 0.060 0.210
0EX6500251903059320019A
0.050 0.100 0.110 0.210
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.69 0.080 22.6 22.65 22.69 0.090
22.54 0.110 22.59 22.58 22.58 0.010
22.36 0.080 22.32 22.46 22.45 0.140
22.5 0.020 22.48 22.48 22.55 0.070
22.46 0.070 22.42 22.42 22.58 0.160
22.79 0.050 22.83 22.84 22.87 0.040
22.27 0.090 22.23 22.27 22.22 0.050
22.42 0.110 22.54 22.54 22.55 0.010
22.57 0.190 22.71 22.65 22.67 0.060
22.62 0.100 22.6 22.63 22.52 0.110
22.538 0.090 Average = 22.551 0.074
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.000
22.800
Average
22.600
22.400
22.200
22.000
21.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.650 22.643 22.647
0EX65002519030592T00026
22.533 22.607 22.583
0EX6500251903059320006E
22.393 22.400 22.410
0EX65002519030593200073
22.507 22.500 22.503
0EX65002519030593200076
22.403 22.413 22.473
0EX650025190305932000A2
22.853 22.813 22.847
0EX650025190305932000CD
22.223 22.247 22.240
0EX65002519030593200166
22.470 22.470 22.543
0EX6500251903059320018F
22.630 22.657 22.677
0EX6500251903059320019A
22.517 22.633 22.583
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 2412 OFDM-54 BW-20 TX1 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.090 0.100 0.150 0.218
0EX65002519030592T00026
0.210 0.070 0.070 0.218
0EX6500251903059320006E
0.020 0.150 0.070 0.218
0EX65002519030593200073
0.120 0.030 0.100 0.218
0EX65002519030593200076
0.120 0.050 0.080 0.218
0EX650025190305932000A2
0.110 0.100 0.030 0.218
0EX650025190305932000CD
0.070 0.080 0.090 0.218
0EX65002519030593200166
0.070 0.130 0.100 0.218
0EX6500251903059320018F
0.010 0.010 0.110 0.218
0EX6500251903059320019A
0.020 0.090 0.090 0.218
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.98 0.100 20.92 20.92 21.07 0.150
20.89 0.070 20.98 20.97 20.91 0.070
21.27 0.150 21.13 21.15 21.2 0.070
21.14 0.030 21.14 21.09 21.04 0.100
20.9 0.050 20.92 20.86 20.84 0.080
21.31 0.100 21.23 21.24 21.21 0.030
20.88 0.080 20.87 20.96 20.96 0.090
21.05 0.130 21.06 20.99 20.96 0.100
21.08 0.010 21.11 21.14 21.03 0.110
20.91 0.090 21.06 20.99 20.97 0.090
21.020 0.081 Average = 21.031 0.089
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.300
21.200
Average
21.100
21.000
20.900
20.800
20.700
20.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.953 20.973 20.970
0EX65002519030592T00026
20.873 20.850 20.953
0EX6500251903059320006E
21.093 21.173 21.160
0EX65002519030593200073
21.030 21.120 21.090
0EX65002519030593200076
20.880 20.877 20.873
0EX650025190305932000A2
21.117 21.247 21.227
0EX650025190305932000CD
20.880 20.887 20.930
0EX65002519030593200166
20.983 21.033 21.003
0EX6500251903059320018F
21.093 21.077 21.093
0EX6500251903059320019A
20.933 20.960 21.007
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 2412 OFDM-54 BW-20 TX2 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.120 0.090 0.090 0.230
0EX65002519030592T00026
0.040 0.110 0.100 0.230
0EX6500251903059320006E
0.000 0.080 0.130 0.230
0EX65002519030593200073
0.190 0.070 0.110 0.230
0EX65002519030593200076
0.130 0.160 0.020 0.230
0EX650025190305932000A2
0.140 0.020 0.060 0.230
0EX650025190305932000CD
0.020 0.020 0.060 0.230
0EX65002519030593200166
0.150 0.100 0.170 0.230
0EX6500251903059320018F
0.050 0.050 0.070 0.230
0EX6500251903059320019A
0.080 0.140 0.110 0.230
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.09 0.090 20.08 20.01 20.1 0.090
20.07 0.110 19.93 20.03 19.96 0.100
20.31 0.080 20.35 20.37 20.24 0.130
20.29 0.070 20.28 20.39 20.34 0.110
20.17 0.160 20.08 20.08 20.06 0.020
20.55 0.020 20.59 20.63 20.57 0.060
20.04 0.020 20.04 20.1 20.04 0.060
20.42 0.100 20.21 20.38 20.34 0.170
20.64 0.050 20.51 20.58 20.57 0.070
20.07 0.140 20.12 20.2 20.23 0.110
20.260 0.084 Average = 20.247 0.092
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.800
20.600
Average
20.400
20.200
20.000
19.800
19.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.093 20.030 20.063
0EX65002519030592T00026
20.047 20.017 19.973
0EX6500251903059320006E
20.270 20.340 20.320
0EX65002519030593200073
20.217 20.307 20.337
0EX65002519030593200076
20.077 20.137 20.073
0EX650025190305932000A2
20.543 20.560 20.597
0EX650025190305932000CD
20.043 20.047 20.060
0EX65002519030593200166
20.213 20.373 20.310
0EX6500251903059320018F
20.517 20.650 20.553
0EX6500251903059320019A
20.040 20.143 20.183
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 2442 OFDM-54 BW-20 TX1 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.050 0.090 0.060 0.230
0EX65002519030592T00026
0.140 0.160 0.060 0.230
0EX6500251903059320006E
0.120 0.080 0.040 0.230
0EX65002519030593200073
0.080 0.030 0.040 0.230
0EX65002519030593200076
0.130 0.060 0.060 0.230
0EX650025190305932000A2
0.080 0.110 0.030 0.230
0EX650025190305932000CD
0.050 0.100 0.100 0.230
0EX65002519030593200166
0.210 0.030 0.050 0.230
0EX6500251903059320018F
0.170 0.180 0.120 0.230
0EX6500251903059320019A
0.010 0.130 0.100 0.230
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.29 0.090 21.33 21.32 21.27 0.060
21.27 0.160 21.17 21.14 21.2 0.060
21.09 0.080 21.1 21.06 21.06 0.040
21.41 0.030 21.33 21.37 21.33 0.040
21.1 0.060 21.1 21.16 21.1 0.060
21.2 0.110 21.3 21.32 21.29 0.030
21.1 0.100 21.19 21.09 21.15 0.100
21.31 0.030 21.35 21.4 21.37 0.050
21.25 0.180 21.4 21.28 21.3 0.120
21.13 0.130 21.12 21.1 21.2 0.100
21.216 0.097 Average = 21.230 0.066
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.500
21.400
Average
21.300
21.200
21.100
21.000
20.900
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.260 21.240 21.307
0EX65002519030592T00026
21.217 21.207 21.170
0EX6500251903059320006E
21.083 21.083 21.073
0EX65002519030593200073
21.287 21.393 21.343
0EX65002519030593200076
21.127 21.140 21.120
0EX650025190305932000A2
21.203 21.247 21.303
0EX650025190305932000CD
21.130 21.080 21.143
0EX65002519030593200166
21.330 21.300 21.373
0EX6500251903059320018F
21.267 21.320 21.327
0EX6500251903059320019A
21.117 21.153 21.140
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 2442 OFDM-54 BW-20 TX2 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.090 0.090 0.090 0.280
0EX65002519030592T00026
0.110 0.070 0.160 0.280
0EX6500251903059320006E
0.150 0.210 0.160 0.280
0EX65002519030593200073
0.060 0.080 0.080 0.280
0EX65002519030593200076
0.060 0.110 0.050 0.280
0EX650025190305932000A2
0.060 0.090 0.180 0.280
0EX650025190305932000CD
0.070 0.120 0.070 0.280
0EX65002519030593200166
0.250 0.130 0.050 0.280
0EX6500251903059320018F
0.080 0.070 0.160 0.280
0EX6500251903059320019A
0.090 0.080 0.180 0.280
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.64 0.090 20.67 20.61 20.7 0.090
20.59 0.070 20.67 20.51 20.67 0.160
20.92 0.210 20.63 20.79 20.72 0.160
20.68 0.080 20.7 20.75 20.78 0.080
20.55 0.110 20.56 20.55 20.51 0.050
20.97 0.090 21.08 20.92 20.9 0.180
20.55 0.120 20.62 20.63 20.56 0.070
20.47 0.130 20.47 20.5 20.45 0.050
20.86 0.070 20.82 20.98 20.83 0.160
20.62 0.080 20.62 20.54 20.72 0.180
20.680 0.105 Average = 20.682 0.118
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.100
21.000
Average
20.900
20.800
20.700
20.600
20.500
20.400
20.300
20.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.637 20.637 20.660
0EX65002519030592T00026
20.620 20.630 20.617
0EX6500251903059320006E
20.750 20.797 20.713
0EX65002519030593200073
20.703 20.650 20.743
0EX65002519030593200076
20.507 20.500 20.540
0EX650025190305932000A2
20.907 20.930 20.967
0EX650025190305932000CD
20.543 20.620 20.603
0EX65002519030593200166
20.573 20.533 20.473
0EX6500251903059320018F
20.810 20.850 20.877
0EX6500251903059320019A
20.663 20.657 20.627
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 2472 OFDM-54 BW-20 TX1 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.020 0.070 0.120 0.200
0EX65002519030592T00026
0.120 0.050 0.040 0.200
0EX6500251903059320006E
0.120 0.080 0.120 0.200
0EX65002519030593200073
0.060 0.080 0.090 0.200
0EX65002519030593200076
0.020 0.100 0.020 0.200
0EX650025190305932000A2
0.090 0.030 0.090 0.200
0EX650025190305932000CD
0.080 0.080 0.120 0.200
0EX65002519030593200166
0.090 0.110 0.080 0.200
0EX6500251903059320018F
0.100 0.090 0.060 0.200
0EX6500251903059320019A
0.010 0.100 0.090 0.200
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.83 0.070 20.76 20.84 20.88 0.120
20.84 0.050 20.86 20.82 20.82 0.040
20.83 0.080 20.94 20.83 20.95 0.120
20.85 0.080 20.86 20.9 20.81 0.090
20.7 0.100 20.71 20.71 20.69 0.020
21.23 0.030 21.31 21.22 21.26 0.090
20.75 0.080 20.77 20.88 20.76 0.120
20.96 0.110 20.9 20.82 20.87 0.080
21.1 0.090 21.13 21.07 21.1 0.060
20.77 0.100 20.74 20.79 20.83 0.090
20.889 0.079 Average = 20.894 0.083
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.400
21.200
Average
21.000
20.800
20.600
20.400
20.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.790 20.797 20.827
0EX65002519030592T00026
20.857 20.857 20.833
0EX6500251903059320006E
20.823 20.880 20.907
0EX65002519030593200073
20.770 20.807 20.857
0EX65002519030593200076
20.680 20.707 20.703
0EX650025190305932000A2
21.123 21.227 21.263
0EX650025190305932000CD
20.767 20.793 20.803
0EX65002519030593200166
20.847 20.923 20.863
0EX6500251903059320018F
21.110 21.110 21.100
0EX6500251903059320019A
20.823 20.790 20.787
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 2472 OFDM-54 BW-20 TX2 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.170 0.010 0.110 0.254
0EX65002519030592T00026
0.030 0.140 0.070 0.254
0EX6500251903059320006E
0.230 0.150 0.110 0.254
0EX65002519030593200073
0.100 0.100 0.110 0.254
0EX65002519030593200076
0.040 0.100 0.150 0.254
0EX650025190305932000A2
0.070 0.090 0.090 0.254
0EX650025190305932000CD
0.140 0.100 0.120 0.254
0EX65002519030593200166
0.140 0.110 0.070 0.254
0EX6500251903059320018F
0.070 0.070 0.080 0.254
0EX6500251903059320019A
0.070 0.030 0.080 0.254
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.53 0.010 20.62 20.51 20.59 0.110
20.47 0.140 20.45 20.49 20.52 0.070
20.35 0.150 20.32 20.39 20.28 0.110
20.34 0.100 20.33 20.44 20.35 0.110
20.28 0.100 20.3 20.45 20.39 0.150
20.71 0.090 20.72 20.72 20.63 0.090
20.09 0.100 20.14 20.25 20.13 0.120
20.36 0.110 20.48 20.52 20.45 0.070
20.56 0.070 20.59 20.54 20.51 0.080
20.57 0.030 20.37 20.43 20.45 0.080
20.428 0.090 Average = 20.445 0.099
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.800
20.700
Average
20.600
20.500
20.400
20.300
20.200
20.100
20.000
19.900
19.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.530 20.523 20.573
0EX65002519030592T00026
20.457 20.477 20.487
0EX6500251903059320006E
20.303 20.260 20.330
0EX65002519030593200073
20.353 20.397 20.373
0EX65002519030593200076
20.343 20.307 20.380
0EX650025190305932000A2
20.673 20.673 20.690
0EX650025190305932000CD
20.110 20.147 20.173
0EX65002519030593200166
20.407 20.400 20.483
0EX6500251903059320018F
20.570 20.537 20.547
0EX6500251903059320019A
20.447 20.557 20.417
control limit
9 10
Part Name: 613376 USL = 25.5
Dimension: 2412 MCS0 BW-20 TX1 LSL = 21.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.080 0.150 0.020 0.159
0EX65002519030592T00026
0.030 0.040 0.050 0.159
0EX6500251903059320006E
0.030 0.020 0.080 0.159
0EX65002519030593200073
0.130 0.120 0.070 0.159
0EX65002519030593200076
0.020 0.080 0.040 0.159
0EX650025190305932000A2
0.110 0.090 0.020 0.159
0EX650025190305932000CD
0.130 0.040 0.040 0.159
0EX65002519030593200166
0.090 0.050 0.030 0.159
0EX6500251903059320018F
0.030 0.060 0.070 0.159
0EX6500251903059320019A
0.030 0.080 0.020 0.159
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
23.82 0.150 23.79 23.8 23.78 0.020
23.74 0.040 23.81 23.76 23.8 0.050
23.97 0.020 24.04 23.98 23.96 0.080
23.95 0.120 23.93 23.95 23.88 0.070
23.7 0.080 23.62 23.61 23.65 0.040
23.96 0.090 23.94 23.95 23.96 0.020
23.74 0.040 23.7 23.74 23.73 0.040
23.84 0.050 23.88 23.88 23.85 0.030
23.88 0.060 23.84 23.91 23.87 0.070
23.67 0.080 23.79 23.79 23.77 0.020
23.820 0.073 Average = 23.832 0.044
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
24.100
24.000
Average
23.900
23.800
23.700
23.600
23.500
23.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
23.710 23.753 23.790
0EX65002519030592T00026
23.773 23.757 23.790
0EX6500251903059320006E
23.923 23.977 23.993
0EX65002519030593200073
23.857 23.907 23.920
0EX65002519030593200076
23.633 23.650 23.627
0EX650025190305932000A2
23.957 23.963 23.950
0EX650025190305932000CD
23.713 23.740 23.723
0EX65002519030593200166
23.820 23.863 23.870
0EX6500251903059320018F
23.867 23.867 23.873
0EX6500251903059320019A
23.737 23.720 23.783
control limit
9 10
Part Name: 613376 USL = 25.5
Dimension: 2412 MCS0 BW-20 TX2 LSL = 21.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.090 0.030 0.150 0.255
0EX65002519030592T00026
0.180 0.080 0.110 0.255
0EX6500251903059320006E
0.160 0.060 0.080 0.255
0EX65002519030593200073
0.190 0.150 0.070 0.255
0EX65002519030593200076
0.120 0.010 0.020 0.255
0EX650025190305932000A2
0.070 0.110 0.110 0.255
0EX650025190305932000CD
0.140 0.070 0.110 0.255
0EX65002519030593200166
0.090 0.160 0.070 0.255
0EX6500251903059320018F
0.130 0.050 0.050 0.255
0EX6500251903059320019A
0.100 0.080 0.120 0.255
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.88 0.030 23.09 22.94 22.95 0.150
22.86 0.080 23 22.89 22.93 0.110
23.21 0.060 23.14 23.18 23.22 0.080
23.04 0.150 23.1 23.12 23.17 0.070
22.86 0.010 22.92 22.91 22.9 0.020
23.4 0.110 23.34 23.37 23.45 0.110
22.9 0.070 22.96 22.87 22.85 0.110
22.98 0.160 23.18 23.17 23.11 0.070
23.42 0.050 23.4 23.42 23.37 0.050
22.85 0.080 22.83 22.95 22.92 0.120
23.067 0.080 Average = 23.088 0.089
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.600
23.400
Average
23.200
23.000
22.800
22.600
22.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.957 22.883 22.993
0EX65002519030592T00026
22.890 22.900 22.940
0EX6500251903059320006E
23.167 23.240 23.180
0EX65002519030593200073
23.067 23.123 23.130
0EX65002519030593200076
22.850 22.867 22.910
0EX650025190305932000A2
23.357 23.403 23.387
0EX650025190305932000CD
22.773 22.863 22.893
0EX65002519030593200166
23.133 23.073 23.153
0EX6500251903059320018F
23.360 23.423 23.397
0EX6500251903059320019A
22.860 22.890 22.900
control limit
9 10
Part Name: 613376 USL = 25.5
Dimension: 2442 MCS0 BW-20 TX1 LSL = 21.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.040 0.060 0.040 0.157
0EX65002519030592T00026
0.040 0.070 0.080 0.157
0EX6500251903059320006E
0.170 0.040 0.040 0.157
0EX65002519030593200073
0.080 0.080 0.040 0.157
0EX65002519030593200076
0.020 0.020 0.020 0.157
0EX650025190305932000A2
0.050 0.050 0.130 0.157
0EX650025190305932000CD
0.030 0.090 0.010 0.157
0EX65002519030593200166
0.070 0.050 0.080 0.157
0EX6500251903059320018F
0.060 0.070 0.030 0.157
0EX6500251903059320019A
0.110 0.050 0.110 0.157
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
24.18 0.060 24.21 24.23 24.19 0.040
24.14 0.070 24.16 24.16 24.24 0.080
23.98 0.040 23.93 23.96 23.97 0.040 UCL Range Violation - A
24.24 0.080 24.25 24.28 24.29 0.040
24.03 0.020 23.98 23.99 24 0.020
24.21 0.050 24.18 24.11 24.24 0.130
24.04 0.090 24.01 24.02 24.02 0.010
24.27 0.050 24.25 24.2 24.28 0.080
24.19 0.070 24.23 24.21 24.2 0.030
24.06 0.050 24.04 23.95 24.06 0.110
24.131 0.058 Average = 24.128 0.058
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
24.400
24.300
Average
24.200
24.100
24.000
23.900
23.800
23.700
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
24.127 24.217 24.210
0EX65002519030592T00026
24.217 24.170 24.187
0EX6500251903059320006E
23.953 23.963 23.953
0EX65002519030593200073
24.180 24.207 24.273
0EX65002519030593200076
24.033 24.037 23.990
0EX650025190305932000A2
24.150 24.180 24.177
0EX650025190305932000CD
23.920 24.000 24.017
0EX65002519030593200166
24.213 24.267 24.243
0EX6500251903059320018F
24.177 24.227 24.213
0EX6500251903059320019A
23.990 24.040 24.017
control limit
9 10
Part Name: 613376 USL = 25.5
Dimension: 2442 MCS0 BW-20 TX2 LSL = 21.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.080 0.070 0.080 0.254
0EX65002519030592T00026
0.120 0.080 0.150 0.254
0EX6500251903059320006E
0.060 0.130 0.200 0.254
0EX65002519030593200073
0.170 0.070 0.050 0.254
0EX65002519030593200076
0.060 0.120 0.130 0.254
0EX650025190305932000A2
0.110 0.060 0.030 0.254
0EX650025190305932000CD
0.100 0.120 0.010 0.254
0EX65002519030593200166
0.270 0.100 0.060 0.254
0EX6500251903059320018F
0.160 0.120 0.020 0.254
0EX6500251903059320019A
0.110 0.070 0.040 0.254
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
23.41 0.070 23.43 23.35 23.39 0.080
23.5 0.080 23.41 23.34 23.49 0.150
23.5 0.130 23.49 23.69 23.58 0.200
23.44 0.070 23.51 23.46 23.47 0.050
23.21 0.120 23.27 23.34 23.21 0.130
23.77 0.060 23.74 23.71 23.71 0.030
23.41 0.120 23.34 23.34 23.33 0.010
23.38 0.100 23.37 23.43 23.4 0.060 UCL Range Violation - A
23.66 0.120 23.62 23.6 23.62 0.020
23.44 0.070 23.37 23.37 23.41 0.040
23.474 0.094 Average = 23.460 0.077
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.800
23.700
Average
23.600
23.500
23.400
23.300
23.200
23.100
23.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
23.410 23.380 23.390
0EX65002519030592T00026
23.450 23.447 23.413
0EX6500251903059320006E
23.573 23.580 23.587
0EX65002519030593200073
23.423 23.477 23.480
0EX65002519030593200076
23.303 23.257 23.273
0EX650025190305932000A2
23.650 23.737 23.720
0EX650025190305932000CD
23.313 23.403 23.337
0EX65002519030593200166
23.390 23.373 23.400
0EX6500251903059320018F
23.617 23.680 23.613
0EX6500251903059320019A
23.343 23.407 23.383
control limit
9 10
Part Name: 613376 USL = 25.5
Dimension: 2472 MCS0 BW-20 TX1 LSL = 21.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.100 0.050 0.070 0.141
0EX65002519030592T00026
0.090 0.060 0.020 0.141
0EX6500251903059320006E
0.160 0.070 0.090 0.141
0EX65002519030593200073
0.120 0.010 0.000 0.141
0EX65002519030593200076
0.020 0.040 0.000 0.141
0EX650025190305932000A2
0.060 0.010 0.020 0.141
0EX650025190305932000CD
0.030 0.030 0.090 0.141
0EX65002519030593200166
0.050 0.040 0.120 0.141
0EX6500251903059320018F
0.020 0.030 0.020 0.141
0EX6500251903059320019A
0.090 0.060 0.070 0.141
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
23.48 0.050 23.42 23.49 23.48 0.070
23.55 0.060 23.55 23.53 23.54 0.020
23.52 0.070 23.55 23.53 23.46 0.090 UCL Range Violation - A
23.44 0.010 23.45 23.45 23.45 0.000
23.38 0.040 23.3 23.3 23.3 0.000
23.78 0.010 23.8 23.81 23.82 0.020
23.4 0.030 23.36 23.36 23.45 0.090
23.51 0.040 23.59 23.55 23.47 0.120
23.77 0.030 23.76 23.75 23.74 0.020
23.39 0.060 23.47 23.45 23.4 0.070
23.514 0.040 Average = 23.519 0.050
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.900
23.800
Average
23.700
23.600
23.500
23.400
23.300
23.200
23.100
23.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
23.390 23.453 23.463
0EX65002519030592T00026
23.523 23.510 23.540
0EX6500251903059320006E
23.423 23.547 23.513
0EX65002519030593200073
23.370 23.437 23.450
0EX65002519030593200076
23.337 23.357 23.300
0EX650025190305932000A2
23.757 23.773 23.810
0EX650025190305932000CD
23.380 23.410 23.390
0EX65002519030593200166
23.463 23.487 23.537
0EX6500251903059320018F
23.670 23.760 23.750
0EX6500251903059320019A
23.393 23.403 23.440
control limit
9 10
Part Name: 613376 USL = 25.5
Dimension: 2472 MCS0 BW-20 TX2 LSL = 21.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.110 0.070 0.060 0.200
0EX65002519030592T00026
0.120 0.060 0.060 0.200
0EX6500251903059320006E
0.050 0.140 0.040 0.200
0EX65002519030593200073
0.120 0.050 0.080 0.200
0EX65002519030593200076
0.010 0.110 0.080 0.200
0EX650025190305932000A2
0.080 0.060 0.010 0.200
0EX650025190305932000CD
0.030 0.000 0.110 0.200
0EX65002519030593200166
0.150 0.110 0.040 0.200
0EX6500251903059320018F
0.190 0.150 0.060 0.200
0EX6500251903059320019A
0.040 0.100 0.040 0.200
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
23.46 0.070 23.55 23.55 23.49 0.060
23.39 0.060 23.43 23.37 23.41 0.060
23.17 0.140 23.24 23.2 23.22 0.040
23.29 0.050 23.4 23.32 23.34 0.080
23.19 0.110 23.26 23.26 23.18 0.080
23.67 0.060 23.67 23.68 23.68 0.010
23.1 0.000 22.99 23.06 23.1 0.110
23.38 0.110 23.3 23.3 23.34 0.040
23.46 0.150 23.47 23.41 23.42 0.060
23.42 0.100 23.37 23.38 23.41 0.040
23.359 0.085 Average = 23.360 0.058
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.800
23.600
Average
23.400
23.200
23.000
22.800
22.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
23.510 23.470 23.530
0EX65002519030592T00026
23.383 23.383 23.403
0EX6500251903059320006E
23.220 23.227 23.220
0EX65002519030593200073
23.300 23.320 23.353
0EX65002519030593200076
23.267 23.200 23.233
0EX650025190305932000A2
23.593 23.677 23.677
0EX650025190305932000CD
23.047 23.100 23.050
0EX65002519030593200166
23.323 23.323 23.313
0EX6500251903059320018F
23.407 23.513 23.433
0EX6500251903059320019A
23.330 23.377 23.387
control limit
9 10
Part Name: 613376 USL = 22.5
Dimension: 2412 MCS7 BW-20 TX1 LSL = 18.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.020 0.090 0.070 0.187
0EX65002519030592T00026
0.090 0.070 0.100 0.187
0EX6500251903059320006E
0.160 0.060 0.050 0.187
0EX65002519030593200073
0.090 0.090 0.080 0.187
0EX65002519030593200076
0.130 0.110 0.030 0.187
0EX650025190305932000A2
0.070 0.070 0.070 0.187
0EX650025190305932000CD
0.120 0.030 0.060 0.187
0EX65002519030593200166
0.040 0.060 0.060 0.187
0EX6500251903059320018F
0.060 0.020 0.100 0.187
0EX6500251903059320019A
0.010 0.050 0.110 0.187
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.67 0.090 20.68 20.73 20.66 0.070
20.54 0.070 20.53 20.61 20.51 0.100
20.8 0.060 20.87 20.85 20.82 0.050
20.8 0.090 20.9 20.82 20.83 0.080
20.57 0.110 20.63 20.66 20.63 0.030
20.88 0.070 20.92 20.85 20.89 0.070
20.61 0.030 20.64 20.58 20.63 0.060
20.7 0.060 20.76 20.73 20.7 0.060
20.79 0.020 20.72 20.8 20.82 0.100
20.63 0.050 20.62 20.58 20.69 0.110
20.714 0.065 Average = 20.722 0.073
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.000
20.900
Average
20.800
20.700
20.600
20.500
20.400
20.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.627 20.653 20.690
0EX65002519030592T00026
20.537 20.537 20.550
0EX6500251903059320006E
20.820 20.837 20.847
0EX65002519030593200073
20.777 20.797 20.850
0EX65002519030593200076
20.650 20.630 20.640
0EX650025190305932000A2
20.860 20.917 20.887
0EX650025190305932000CD
20.657 20.593 20.617
0EX65002519030593200166
20.697 20.733 20.730
0EX6500251903059320018F
20.767 20.797 20.780
0EX6500251903059320019A
20.593 20.650 20.630
control limit
9 10
Part Name: 613376 USL = 22.5
Dimension: 2412 MCS7 BW-20 TX2 LSL = 18.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.060 0.050 0.120 0.212
0EX65002519030592T00026
0.070 0.130 0.120 0.212
0EX6500251903059320006E
0.040 0.090 0.020 0.212
0EX65002519030593200073
0.180 0.050 0.100 0.212
0EX65002519030593200076
0.060 0.090 0.080 0.212
0EX650025190305932000A2
0.160 0.080 0.030 0.212
0EX650025190305932000CD
0.080 0.100 0.040 0.212
0EX65002519030593200166
0.100 0.110 0.070 0.212
0EX6500251903059320018F
0.080 0.040 0.070 0.212
0EX6500251903059320019A
0.090 0.010 0.140 0.212
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.79 0.050 19.82 19.88 19.76 0.120
19.81 0.130 19.69 19.76 19.81 0.120
20.03 0.090 20.09 20.09 20.07 0.020
20.06 0.050 20.09 20.02 19.99 0.100
19.9 0.090 19.9 19.88 19.82 0.080
20.25 0.080 20.26 20.23 20.23 0.030
19.83 0.100 19.82 19.78 19.79 0.040
20.04 0.110 20.09 20.02 20.09 0.070
20.31 0.040 20.22 20.29 20.28 0.070
19.81 0.010 19.87 19.73 19.77 0.140
19.976 0.075 Average = 19.971 0.079
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.400
20.300
Average
20.200
20.100
20.000
19.900
19.800
19.700
19.600
19.500
19.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.823 19.760 19.820
0EX65002519030592T00026
19.737 19.747 19.753
0EX6500251903059320006E
20.017 20.087 20.083
0EX65002519030593200073
19.973 20.040 20.033
0EX65002519030593200076
19.803 19.857 19.867
0EX650025190305932000A2
20.200 20.290 20.240
0EX650025190305932000CD
19.830 19.797 19.797
0EX65002519030593200166
20.017 20.080 20.067
0EX6500251903059320018F
20.270 20.297 20.263
0EX6500251903059320019A
19.763 19.807 19.790
control limit
9 10
Part Name: 613376 USL = 22.5
Dimension: 2442 MCS7 BW-20 TX1 LSL = 18.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.120 0.060 0.140 0.177
0EX65002519030592T00026
0.100 0.040 0.010 0.177
0EX6500251903059320006E
0.110 0.140 0.040 0.177
0EX65002519030593200073
0.100 0.030 0.070 0.177
0EX65002519030593200076
0.110 0.030 0.070 0.177
0EX650025190305932000A2
0.050 0.050 0.010 0.177
0EX650025190305932000CD
0.090 0.000 0.020 0.177
0EX65002519030593200166
0.050 0.110 0.040 0.177
0EX6500251903059320018F
0.060 0.100 0.110 0.177
0EX6500251903059320019A
0.060 0.050 0.090 0.177
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.11 0.060 21.11 21.17 21.03 0.140
20.94 0.040 20.91 20.92 20.92 0.010
20.87 0.140 20.87 20.83 20.83 0.040
21.09 0.030 21.1 21.16 21.17 0.070
20.94 0.030 20.94 20.95 21.01 0.070
21.02 0.050 21.06 21.05 21.05 0.010
20.94 0.000 20.93 20.92 20.94 0.020
21.03 0.110 21.11 21.1 21.14 0.040
21.08 0.100 21.07 21.17 21.06 0.110
20.87 0.050 20.83 20.92 20.9 0.090
21.002 0.061 Average = 21.006 0.060
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.200
21.100
Average
21.000
20.900
20.800
20.700
20.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.067 21.103 21.103
0EX65002519030592T00026
20.977 20.960 20.917
0EX6500251903059320006E
20.877 20.910 20.843
0EX65002519030593200073
21.027 21.080 21.143
0EX65002519030593200076
20.937 20.937 20.967
0EX650025190305932000A2
20.990 21.017 21.053
0EX650025190305932000CD
20.873 20.940 20.930
0EX65002519030593200166
21.087 21.097 21.117
0EX6500251903059320018F
21.090 21.100 21.100
0EX6500251903059320019A
20.867 20.880 20.883
control limit
9 10
Part Name: 613376 USL = 22.5
Dimension: 2442 MCS7 BW-20 TX2 LSL = 18.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.100 0.090 0.030 0.202
0EX65002519030592T00026
0.070 0.070 0.070 0.202
0EX6500251903059320006E
0.030 0.130 0.080 0.202
0EX65002519030593200073
0.120 0.050 0.070 0.202
0EX65002519030593200076
0.150 0.110 0.120 0.202
0EX650025190305932000A2
0.050 0.000 0.090 0.202
0EX650025190305932000CD
0.050 0.050 0.070 0.202
0EX65002519030593200166
0.100 0.090 0.070 0.202
0EX6500251903059320018F
0.060 0.070 0.140 0.202
0EX6500251903059320019A
0.080 0.120 0.020 0.202
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.19 0.090 20.25 20.25 20.22 0.030
20.22 0.070 20.27 20.2 20.23 0.070
20.47 0.130 20.41 20.47 20.39 0.080
20.3 0.050 20.42 20.38 20.35 0.070
20.18 0.110 20.27 20.2 20.15 0.120
20.61 0.000 20.52 20.61 20.58 0.090
20.29 0.050 20.26 20.33 20.26 0.070
20.35 0.090 20.39 20.33 20.32 0.070
20.58 0.070 20.44 20.58 20.48 0.140
20.36 0.120 20.32 20.31 20.3 0.020
20.347 0.078 Average = 20.350 0.076
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.700
20.600
Average
20.500
20.400
20.300
20.200
20.100
20.000
19.900
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.217 20.223 20.240
0EX65002519030592T00026
20.197 20.223 20.233
0EX6500251903059320006E
20.370 20.407 20.423
0EX65002519030593200073
20.293 20.330 20.383
0EX65002519030593200076
20.187 20.197 20.207
0EX650025190305932000A2
20.557 20.610 20.570
0EX650025190305932000CD
20.240 20.320 20.283
0EX65002519030593200166
20.277 20.303 20.347
0EX6500251903059320018F
20.533 20.553 20.500
0EX6500251903059320019A
20.250 20.303 20.310
control limit
9 10
Part Name: 613376 USL = 22.5
Dimension: 2472 MCS7 BW-20 TX1 LSL = 18.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.040 0.090 0.040 0.171
0EX65002519030592T00026
0.080 0.040 0.060 0.171
0EX6500251903059320006E
0.060 0.090 0.100 0.171
0EX65002519030593200073
0.000 0.030 0.070 0.171
0EX65002519030593200076
0.090 0.070 0.080 0.171
0EX650025190305932000A2
0.080 0.050 0.010 0.171
0EX650025190305932000CD
0.110 0.040 0.150 0.171
0EX65002519030593200166
0.030 0.060 0.090 0.171
0EX6500251903059320018F
0.080 0.030 0.100 0.171
0EX6500251903059320019A
0.030 0.130 0.060 0.171
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.22 0.090 20.24 20.26 20.22 0.040
20.32 0.040 20.38 20.32 20.35 0.060
20.45 0.090 20.45 20.35 20.4 0.100
20.29 0.030 20.37 20.32 20.3 0.070
20.15 0.070 20.17 20.09 20.17 0.080
20.65 0.050 20.68 20.69 20.68 0.010
20.39 0.040 20.22 20.36 20.37 0.150
20.3 0.060 20.44 20.35 20.38 0.090
20.6 0.030 20.58 20.54 20.64 0.100
20.31 0.130 20.24 20.3 20.27 0.060
20.370 0.063 Average = 20.371 0.076
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.800
20.700
Average
20.600
20.500
20.400
20.300
20.200
20.100
20.000
19.900
19.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.280 20.257 20.240
0EX65002519030592T00026
20.337 20.300 20.350
0EX6500251903059320006E
20.357 20.393 20.400
0EX65002519030593200073
20.250 20.280 20.330
0EX65002519030593200076
20.193 20.183 20.143
0EX650025190305932000A2
20.613 20.670 20.683
0EX650025190305932000CD
20.337 20.370 20.317
0EX65002519030593200166
20.313 20.340 20.390
0EX6500251903059320018F
20.533 20.610 20.587
0EX6500251903059320019A
20.320 20.300 20.270
control limit
9 10
Part Name: 613376 USL = 22.5
Dimension: 2472 MCS7 BW-20 TX2 LSL = 18.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.070 0.010 0.225
0EX65002519030592T00026
0.070 0.050 0.080 0.225
0EX6500251903059320006E
0.160 0.180 0.120 0.225
0EX65002519030593200073
0.060 0.060 0.090 0.225
0EX65002519030593200076
0.080 0.170 0.070 0.225
0EX650025190305932000A2
0.170 0.030 0.060 0.225
0EX650025190305932000CD
0.110 0.070 0.080 0.225
0EX65002519030593200166
0.050 0.060 0.080 0.225
0EX6500251903059320018F
0.040 0.040 0.050 0.225
0EX6500251903059320019A
0.170 0.060 0.150 0.225
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.24 0.070 20.35 20.34 20.34 0.010
20.21 0.050 20.21 20.13 20.19 0.080
20.1 0.180 19.99 20.07 19.95 0.120
20.24 0.060 20.11 20.2 20.18 0.090
20.12 0.170 20.1 20.03 20.03 0.070
20.49 0.030 20.53 20.48 20.54 0.060
19.95 0.070 19.9 19.86 19.94 0.080
20.12 0.060 20.15 20.23 20.19 0.080
20.34 0.040 20.38 20.33 20.37 0.050
20.22 0.060 20.28 20.21 20.36 0.150
20.190 0.079 Average = 20.199 0.079
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.600
20.400
Average
20.200
20.000
19.800
19.600
19.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.263 20.283 20.343
0EX65002519030592T00026
20.147 20.200 20.177
0EX6500251903059320006E
20.013 20.020 20.003
0EX65002519030593200073
20.170 20.213 20.163
0EX65002519030593200076
20.107 20.083 20.053
0EX650025190305932000A2
20.470 20.500 20.517
0EX650025190305932000CD
19.903 19.913 19.900
0EX65002519030593200166
20.163 20.107 20.190
0EX6500251903059320018F
20.333 20.347 20.360
0EX6500251903059320019A
20.213 20.233 20.283
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 2432 MCS9 BW-40 TX1 LSL = 17
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.040 0.020 0.030 0.182
0EX65002519030592T00026
0.060 0.020 0.130 0.182
0EX6500251903059320006E
0.130 0.070 0.040 0.182
0EX65002519030593200073
0.110 0.060 0.050 0.182
0EX65002519030593200076
0.090 0.100 0.040 0.182
0EX650025190305932000A2
0.150 0.060 0.090 0.182
0EX650025190305932000CD
0.090 0.060 0.120 0.182
0EX65002519030593200166
0.020 0.050 0.140 0.182
0EX6500251903059320018F
0.020 0.080 0.090 0.182
0EX6500251903059320019A
0.090 0.050 0.020 0.182
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.29 0.020 19.27 19.26 19.24 0.030
19.17 0.020 19.2 19.07 19.19 0.130
19.25 0.070 19.27 19.24 19.23 0.040
19.39 0.060 19.35 19.35 19.4 0.050
19.08 0.100 19.12 19.12 19.08 0.040
19.22 0.060 19.22 19.13 19.2 0.090
19.19 0.060 19.29 19.17 19.28 0.120
19.25 0.050 19.37 19.25 19.23 0.140
19.36 0.080 19.31 19.37 19.4 0.090
19.06 0.050 19.07 19.05 19.06 0.020
19.243 0.057 Average = 19.226 0.075
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.500
19.400
Average
19.300
19.200
19.100
19.000
18.900
18.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.243 19.303 19.257
0EX65002519030592T00026
19.170 19.160 19.153
0EX6500251903059320006E
19.237 19.290 19.247
0EX65002519030593200073
19.290 19.363 19.367
0EX65002519030593200076
19.107 19.137 19.107
0EX650025190305932000A2
19.130 19.193 19.183
0EX650025190305932000CD
19.217 19.223 19.247
0EX65002519030593200166
19.200 19.260 19.283
0EX6500251903059320018F
19.333 19.410 19.360
0EX6500251903059320019A
19.023 19.087 19.060
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 2432 MCS9 BW-40 TX2 LSL = 17
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.100 0.090 0.110 0.239
0EX65002519030592T00026
0.150 0.050 0.100 0.239
0EX6500251903059320006E
0.200 0.080 0.160 0.239
0EX65002519030593200073
0.130 0.110 0.130 0.239
0EX65002519030593200076
0.120 0.060 0.110 0.239
0EX650025190305932000A2
0.070 0.050 0.070 0.239
0EX650025190305932000CD
0.040 0.050 0.070 0.239
0EX65002519030593200166
0.100 0.080 0.130 0.239
0EX6500251903059320018F
0.010 0.060 0.070 0.239
0EX6500251903059320019A
0.160 0.060 0.060 0.239
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.43 0.090 18.54 18.51 18.62 0.110
18.2 0.050 18.22 18.32 18.23 0.100
18.37 0.080 18.41 18.38 18.54 0.160
18.35 0.110 18.41 18.44 18.31 0.130
18.36 0.060 18.18 18.19 18.29 0.110
18.65 0.050 18.62 18.67 18.6 0.070
18.46 0.050 18.47 18.43 18.5 0.070
18.42 0.080 18.37 18.5 18.39 0.130
18.72 0.060 18.7 18.73 18.66 0.070
18.61 0.060 18.57 18.62 18.56 0.060
18.465 0.069 Average = 18.466 0.101
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.800
18.700
Average
18.600
18.500
18.400
18.300
18.200
18.100
18.000
17.900
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.507 18.467 18.557
0EX65002519030592T00026
18.210 18.210 18.257
0EX6500251903059320006E
18.473 18.407 18.443
0EX65002519030593200073
18.347 18.400 18.387
0EX65002519030593200076
18.253 18.323 18.220
0EX650025190305932000A2
18.600 18.633 18.630
0EX650025190305932000CD
18.433 18.490 18.467
0EX65002519030593200166
18.387 18.393 18.420
0EX6500251903059320018F
18.663 18.720 18.697
0EX6500251903059320019A
18.567 18.610 18.583
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 2452 MCS9 BW-40 TX1 LSL = 17
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.100 0.040 0.030 0.149
0EX65002519030592T00026
0.030 0.100 0.060 0.149
0EX6500251903059320006E
0.110 0.040 0.040 0.149
0EX65002519030593200073
0.060 0.080 0.090 0.149
0EX65002519030593200076
0.030 0.040 0.050 0.149
0EX650025190305932000A2
0.090 0.060 0.060 0.149
0EX650025190305932000CD
0.030 0.020 0.010 0.149
0EX65002519030593200166
0.130 0.030 0.080 0.149
0EX6500251903059320018F
0.060 0.020 0.020 0.149
0EX6500251903059320019A
0.050 0.030 0.140 0.149
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.89 0.040 18.91 18.91 18.94 0.030
19.02 0.100 18.96 18.93 18.99 0.060
19.04 0.040 19.01 19.05 19.02 0.040
18.86 0.080 18.91 19 18.96 0.090
18.86 0.040 18.85 18.9 18.85 0.050
19.2 0.060 19.26 19.22 19.28 0.060
19.03 0.020 19.03 19.02 19.02 0.010
19.02 0.030 19.1 19.02 19.06 0.080
19.17 0.020 19.18 19.16 19.16 0.020
18.94 0.030 19.07 18.93 18.94 0.140
19.014 0.046 Average = 19.021 0.058
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.300
19.200
Average
19.100
19.000
18.900
18.800
18.700
18.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.870 18.917 18.920
0EX65002519030592T00026
18.947 19.033 18.960
0EX6500251903059320006E
18.943 19.040 19.027
0EX65002519030593200073
18.830 18.893 18.957
0EX65002519030593200076
18.900 18.853 18.867
0EX650025190305932000A2
19.177 19.233 19.253
0EX650025190305932000CD
18.997 19.017 19.023
0EX65002519030593200166
19.040 19.030 19.060
0EX6500251903059320018F
19.153 19.170 19.167
0EX6500251903059320019A
18.937 18.957 18.980
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 2452 MCS9 BW-40 TX2 LSL = 17
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.110 0.150 0.090 0.225
0EX65002519030592T00026
0.150 0.130 0.070 0.225
0EX6500251903059320006E
0.120 0.120 0.010 0.225
0EX65002519030593200073
0.060 0.100 0.080 0.225
0EX65002519030593200076
0.180 0.060 0.060 0.225
0EX650025190305932000A2
0.020 0.040 0.030 0.225
0EX650025190305932000CD
0.020 0.060 0.080 0.225
0EX65002519030593200166
0.030 0.070 0.040 0.225
0EX6500251903059320018F
0.230 0.130 0.110 0.225
0EX6500251903059320019A
0.070 0.070 0.130 0.225
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.85 0.150 18.7 18.77 18.79 0.090
18.7 0.130 18.65 18.69 18.72 0.070
18.68 0.120 18.63 18.64 18.63 0.010
18.76 0.100 18.61 18.66 18.69 0.080
18.68 0.060 18.54 18.6 18.6 0.060
18.97 0.040 18.97 19 18.98 0.030
18.47 0.060 18.55 18.47 18.49 0.080
18.81 0.070 18.76 18.8 18.76 0.040
18.79 0.130 18.91 18.8 18.87 0.110 UCL Range Violation - A
18.72 0.070 18.7 18.67 18.8 0.130
18.722 0.093 Average = 18.715 0.070
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.100
19.000
Average
18.900
18.800
18.700
18.600
18.500
18.400
18.300
18.200
18.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.733 18.787 18.753
0EX65002519030592T00026
18.693 18.650 18.687
0EX6500251903059320006E
18.550 18.660 18.633
0EX65002519030593200073
18.610 18.723 18.653
0EX65002519030593200076
18.650 18.650 18.580
0EX650025190305932000A2
18.857 18.947 18.983
0EX650025190305932000CD
18.433 18.450 18.503
0EX65002519030593200166
18.707 18.767 18.773
0EX6500251903059320018F
18.797 18.843 18.860
0EX6500251903059320019A
18.727 18.747 18.723
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2402 1DH1 LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.060 0.070 0.090
0EX65002519030592T00026
0.040 0.030 0.090 0.090
0EX6500251903059320006E
0.010 0.030 0.080 0.090
0EX65002519030593200073
0.010 0.030 0.010 0.090
0EX65002519030593200076
0.030 0.020 0.020 0.090
0EX650025190305932000A2
0.020 0.030 0.030 0.090
0EX650025190305932000CD
0.020 0.020 0.080 0.090
0EX65002519030593200166
0.020 0.020 0.010 0.090
0EX6500251903059320018F
0.030 0.010 0.010 0.090
0EX6500251903059320019A
0.030 0.030 0.020 0.090
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
15.26 0.060 15.24 15.24 15.17 0.070 UCL Range Violation - A
14.67 0.030 14.68 14.76 14.67 0.090
15.16 0.030 15.18 15.17 15.25 0.080
15.25 0.030 15.24 15.25 15.24 0.010
15.65 0.020 15.66 15.65 15.67 0.020
15.71 0.030 15.7 15.71 15.73 0.030
14.74 0.020 14.75 14.74 14.82 0.080
14.62 0.020 14.63 14.63 14.62 0.010
14.98 0.010 14.97 14.97 14.96 0.010
14.52 0.030 14.5 14.52 14.51 0.020
15.049 0.028 Average = 15.061 0.042
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
16.000
Average
15.500
15.000
14.500
14.000
13.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
15.320 15.247 15.217
0EX65002519030592T00026
14.670 14.667 14.703
0EX6500251903059320006E
15.153 15.163 15.200
0EX65002519030593200073
15.217 15.233 15.243
0EX65002519030593200076
15.673 15.660 15.660
0EX650025190305932000A2
15.693 15.693 15.713
0EX650025190305932000CD
14.730 14.727 14.770
0EX65002519030593200166
14.620 14.627 14.627
0EX6500251903059320018F
14.983 14.973 14.967
0EX6500251903059320019A
14.480 14.503 14.510
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2440 1DH1 LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.060 0.090 0.081
0EX65002519030592T00026
0.020 0.030 0.100 0.081
0EX6500251903059320006E
0.020 0.030 0.080 0.081
0EX65002519030593200073
0.020 0.020 0.010 0.081
0EX65002519030593200076
0.020 0.020 0.000 0.081
0EX650025190305932000A2
0.010 0.020 0.030 0.081
0EX650025190305932000CD
0.030 0.000 0.070 0.081
0EX65002519030593200166
0.030 0.010 0.020 0.081
0EX6500251903059320018F
0.020 0.000 0.010 0.081
0EX6500251903059320019A
0.020 0.020 0.000 0.081
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
16.23 0.060 16.22 16.2 16.13 0.090 UCL Range Violation - A
15.55 0.030 15.55 15.63 15.53 0.100 UCL Range Violation - C
16.16 0.030 16.18 16.18 16.26 0.080
16.22 0.020 16.23 16.24 16.23 0.010
16.71 0.020 16.71 16.71 16.71 0.000
16.67 0.020 16.66 16.67 16.69 0.030
15.84 0.000 15.84 15.84 15.91 0.070
15.63 0.010 15.62 15.64 15.63 0.020
16.04 0.000 16.03 16.03 16.02 0.010
15.51 0.020 15.51 15.51 15.51 0.000
16.054 0.021 Average = 16.061 0.041
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
17.000
Average
16.500
16.000
15.500
15.000
14.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
16.297 16.223 16.183
0EX65002519030592T00026
15.530 15.540 15.570
0EX6500251903059320006E
16.170 16.173 16.207
0EX65002519030593200073
16.200 16.207 16.233
0EX65002519030593200076
16.730 16.720 16.710
0EX650025190305932000A2
16.657 16.660 16.673
0EX650025190305932000CD
15.840 15.840 15.863
0EX65002519030593200166
15.630 15.637 15.630
0EX6500251903059320018F
16.050 16.040 16.027
0EX6500251903059320019A
15.480 15.503 15.510
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 2480 1DH1 LSL = 10.5
Characteristic: #N/A 10
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.150 0.060 0.090 0.078
0EX65002519030592T00026
0.030 0.030 0.100 0.078
0EX6500251903059320006E
0.010 0.020 0.090 0.078
0EX65002519030593200073
0.010 0.030 0.000 0.078
0EX65002519030593200076
0.030 0.010 0.010 0.078
0EX650025190305932000A2
0.000 0.010 0.020 0.078
0EX650025190305932000CD
0.020 0.010 0.080 0.078
0EX65002519030593200166
0.010 0.000 0.010 0.078
0EX6500251903059320018F
0.020 0.010 0.010 0.078
0EX6500251903059320019A
0.010 0.020 0.010 0.078
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
16.94 0.060 16.93 16.93 16.84 0.090 UCL Range Violation - A
16.25 0.030 16.24 16.33 16.23 0.100 UCL Range Violation - C
17.07 0.020 17.1 17.07 17.16 0.090 UCL Range Violation - C
17.08 0.030 17.07 17.07 17.07 0.000
17.74 0.010 17.73 17.74 17.73 0.010
17.54 0.010 17.54 17.56 17.56 0.020
16.97 0.010 16.96 16.97 17.04 0.080 UCL Range Violation - C
16.53 0.000 16.53 16.54 16.54 0.010
17.08 0.010 17.07 17.07 17.06 0.010
16.42 0.020 16.43 16.42 16.43 0.010
16.957 0.020 Average = 16.965 0.042
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.000
17.500
Average
17.000
16.500
16.000
15.500
15.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.013 16.940 16.900
0EX65002519030592T00026
16.230 16.240 16.267
0EX6500251903059320006E
17.067 17.070 17.110
0EX65002519030593200073
17.043 17.060 17.070
0EX65002519030593200076
17.747 17.743 17.733
0EX650025190305932000A2
17.530 17.533 17.553
0EX650025190305932000CD
16.960 16.963 16.990
0EX65002519030593200166
16.527 16.530 16.537
0EX6500251903059320018F
17.100 17.083 17.067
0EX6500251903059320019A
16.383 16.410 16.427
control limit
9 10
Part Name: 613376 USL = 14
Dimension: 2402 3DH5 LSL = 6
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.040 0.060 0.106
0EX65002519030592T00026
0.020 0.010 0.090 0.106
0EX6500251903059320006E
0.030 0.030 0.070 0.106
0EX65002519030593200073
0.060 0.070 0.050 0.106
0EX65002519030593200076
0.020 0.020 0.000 0.106
0EX650025190305932000A2
0.040 0.020 0.020 0.106
0EX650025190305932000CD
0.050 0.010 0.100 0.106
0EX65002519030593200166
0.030 0.010 0.050 0.106
0EX6500251903059320018F
0.010 0.040 0.020 0.106
0EX6500251903059320019A
0.010 0.050 0.060 0.106
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
11.3 0.040 11.28 11.29 11.23 0.060 UCL Range Violation - A
10.76 0.010 10.77 10.85 10.76 0.090
11.25 0.030 11.29 11.27 11.34 0.070
11.35 0.070 11.3 11.35 11.3 0.050
11.71 0.020 11.71 11.71 11.71 0.000
11.79 0.020 11.78 11.79 11.8 0.020
10.87 0.010 10.87 10.86 10.96 0.100
10.78 0.010 10.72 10.77 10.77 0.050
11.1 0.040 11.06 11.07 11.05 0.020
10.65 0.050 10.67 10.61 10.62 0.060
11.143 0.030 Average = 11.152 0.052
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
12.000
Average
11.500
11.000
10.500
10.000
9.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
11.367 11.300 11.267
0EX65002519030592T00026
10.760 10.757 10.793
0EX6500251903059320006E
11.263 11.260 11.300
0EX65002519030593200073
11.277 11.303 11.317
0EX65002519030593200076
11.723 11.703 11.710
0EX650025190305932000A2
11.787 11.777 11.790
0EX650025190305932000CD
10.870 10.863 10.897
0EX65002519030593200166
10.757 10.773 10.753
0EX6500251903059320018F
11.073 11.073 11.060
0EX6500251903059320019A
10.577 10.620 10.633
control limit
9 10
Part Name: 613376 USL = 14
Dimension: 2440 3DH5 LSL = 6
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.150 0.040 0.070 0.117
0EX65002519030592T00026
0.020 0.020 0.090 0.117
0EX6500251903059320006E
0.020 0.030 0.060 0.117
0EX65002519030593200073
0.060 0.070 0.060 0.117
0EX65002519030593200076
0.020 0.030 0.010 0.117
0EX650025190305932000A2
0.050 0.020 0.020 0.117
0EX650025190305932000CD
0.060 0.010 0.090 0.117
0EX65002519030593200166
0.040 0.020 0.050 0.117
0EX6500251903059320018F
0.020 0.060 0.030 0.117
0EX6500251903059320019A
0.010 0.080 0.050 0.117
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
12.23 0.040 12.22 12.21 12.15 0.070 UCL Range Violation - A
11.57 0.020 11.6 11.68 11.59 0.090
12.22 0.030 12.25 12.23 12.29 0.060
12.27 0.070 12.22 12.28 12.23 0.060
12.72 0.030 12.72 12.73 12.72 0.010
12.72 0.020 12.71 12.72 12.73 0.020
11.93 0.010 11.93 11.93 12.02 0.090
11.72 0.020 11.68 11.73 11.73 0.050
12.13 0.060 12.07 12.1 12.07 0.030
11.62 0.080 11.62 11.57 11.58 0.050
12.101 0.038 Average = 12.110 0.053
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
13.000
Average
12.500
12.000
11.500
11.000
10.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
12.293 12.230 12.193
0EX65002519030592T00026
11.580 11.580 11.623
0EX6500251903059320006E
12.233 12.223 12.257
0EX65002519030593200073
12.213 12.227 12.243
0EX65002519030593200076
12.740 12.717 12.723
0EX650025190305932000A2
12.713 12.707 12.720
0EX650025190305932000CD
11.923 11.927 11.960
0EX65002519030593200166
11.713 11.730 11.713
0EX6500251903059320018F
12.090 12.093 12.080
0EX6500251903059320019A
11.537 11.573 11.590
control limit
9 10
Part Name: 613376 USL = 16
Dimension: 2480 3DH5 LSL = 6
Characteristic: #N/A 10
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.160 0.040 0.070 0.110
0EX65002519030592T00026
0.030 0.010 0.070 0.110
0EX6500251903059320006E
0.010 0.030 0.050 0.110
0EX65002519030593200073
0.050 0.070 0.060 0.110
0EX65002519030593200076
0.020 0.020 0.000 0.110
0EX650025190305932000A2
0.060 0.030 0.020 0.110
0EX650025190305932000CD
0.060 0.010 0.080 0.110
0EX65002519030593200166
0.040 0.000 0.060 0.110
0EX6500251903059320018F
0.020 0.040 0.020 0.110
0EX6500251903059320019A
0.030 0.070 0.050 0.110
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
12.9 0.040 12.89 12.88 12.82 0.070 UCL Range Violation - A
12.25 0.010 12.26 12.33 12.26 0.070
13.07 0.030 13.1 13.09 13.14 0.050
13.07 0.070 13.03 13.09 13.03 0.060
13.71 0.020 13.71 13.71 13.71 0.000
13.56 0.030 13.55 13.56 13.57 0.020
13.01 0.010 13.02 13.02 13.1 0.080
12.59 0.000 12.53 12.59 12.58 0.060
13.12 0.040 13.06 13.08 13.06 0.020
12.49 0.070 12.5 12.45 12.46 0.050
12.964 0.032 Average = 12.973 0.048
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
14.000
Average
13.500
13.000
12.500
12.000
11.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
12.967 12.893 12.863
0EX65002519030592T00026
12.243 12.253 12.283
0EX6500251903059320006E
13.083 13.083 13.110
0EX65002519030593200073
13.010 13.030 13.050
0EX65002519030593200076
13.723 13.703 13.710
0EX650025190305932000A2
13.553 13.543 13.560
0EX650025190305932000CD
13.013 13.007 13.047
0EX65002519030593200166
12.577 12.590 12.567
0EX6500251903059320018F
13.090 13.093 13.067
0EX6500251903059320019A
12.400 12.447 12.470
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2402 1LE LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.100
Range
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.110 0.040 0.090 0.085
0EX65002519030592T00026
0.030 0.020 0.080 0.085
0EX6500251903059320006E
0.010 0.030 0.080 0.085
0EX65002519030593200073
0.030 0.020 0.020 0.085
0EX65002519030593200076
0.020 0.030 0.010 0.085
0EX650025190305932000A2
0.010 0.020 0.030 0.085
0EX650025190305932000CD
0.010 0.010 0.060 0.085
0EX65002519030593200166
0.020 0.010 0.020 0.085
0EX6500251903059320018F
0.020 0.030 0.050 0.085
0EX6500251903059320019A
0.030 0.010 0.040 0.085
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
15.07 0.040 15.06 15.05 14.97 0.090 UCL Range Violation - A
14.51 0.020 14.52 14.59 14.51 0.080
14.99 0.030 15.01 15.01 15.09 0.080
15.06 0.020 15.07 15.08 15.06 0.020
15.46 0.030 15.46 15.45 15.45 0.010
15.53 0.020 15.52 15.55 15.54 0.030
14.59 0.010 14.58 14.59 14.64 0.060
14.48 0.010 14.46 14.48 14.48 0.020
14.83 0.030 14.81 14.85 14.8 0.050
14.34 0.010 14.38 14.34 14.35 0.040
14.880 0.022 Average = 14.892 0.048
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
16.000
Average
15.500
15.000
14.500
14.000
13.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
15.130 15.063 15.027
0EX65002519030592T00026
14.507 14.510 14.540
0EX6500251903059320006E
15.007 15.000 15.037
0EX65002519030593200073
15.047 15.047 15.070
0EX65002519030593200076
15.470 15.450 15.453
0EX650025190305932000A2
15.513 15.520 15.537
0EX650025190305932000CD
14.567 14.583 14.603
0EX65002519030593200166
14.487 14.477 14.473
0EX6500251903059320018F
14.820 14.817 14.820
0EX6500251903059320019A
14.313 14.337 14.357
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2440 1LE LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.150 0.050 0.110 0.087
0EX65002519030592T00026
0.030 0.020 0.070 0.087
0EX6500251903059320006E
0.020 0.030 0.070 0.087
0EX65002519030593200073
0.020 0.030 0.020 0.087
0EX65002519030593200076
0.020 0.020 0.020 0.087
0EX650025190305932000A2
0.030 0.020 0.020 0.087
0EX650025190305932000CD
0.000 0.030 0.090 0.087
0EX65002519030593200166
0.010 0.020 0.010 0.087
0EX6500251903059320018F
0.010 0.010 0.020 0.087
0EX6500251903059320019A
0.000 0.010 0.050 0.087
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
16.07 0.050 16.07 16.06 15.96 0.110 UCL Range Violation - A
15.4 0.020 15.41 15.47 15.4 0.070
16.02 0.030 16.05 16.03 16.1 0.070
16.08 0.030 16.07 16.09 16.08 0.020
16.55 0.020 16.55 16.53 16.53 0.020
16.52 0.020 16.51 16.53 16.53 0.020
15.7 0.030 15.7 15.7 15.79 0.090 UCL Range Violation - C
15.52 0.020 15.5 15.51 15.51 0.010
15.9 0.010 15.88 15.9 15.88 0.020
15.35 0.010 15.4 15.35 15.37 0.050
15.904 0.024 Average = 15.915 0.048
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
17.000
Average
16.500
16.000
15.500
15.000
14.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
16.137 16.067 16.030
0EX65002519030592T00026
15.383 15.390 15.427
0EX6500251903059320006E
16.017 16.023 16.060
0EX65002519030593200073
16.043 16.063 16.080
0EX65002519030593200076
16.553 16.543 16.537
0EX650025190305932000A2
16.507 16.510 16.523
0EX650025190305932000CD
15.690 15.697 15.730
0EX65002519030593200166
15.507 15.507 15.507
0EX6500251903059320018F
15.897 15.893 15.887
0EX6500251903059320019A
15.330 15.347 15.373
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 2480 1LE LSL = 10.5
Characteristic: #N/A 10
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.040 0.090 0.085
0EX65002519030592T00026
0.030 0.000 0.070 0.085
0EX6500251903059320006E
0.010 0.040 0.070 0.085
0EX65002519030593200073
0.020 0.050 0.020 0.085
0EX65002519030593200076
0.020 0.030 0.000 0.085
0EX650025190305932000A2
0.020 0.040 0.010 0.085
0EX650025190305932000CD
0.010 0.010 0.070 0.085
0EX65002519030593200166
0.000 0.020 0.030 0.085
0EX6500251903059320018F
0.020 0.010 0.030 0.085
0EX6500251903059320019A
0.020 0.030 0.040 0.085
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
16.79 0.040 16.78 16.77 16.69 0.090 UCL Range Violation - A
16.1 0.000 16.11 16.18 16.12 0.070
16.92 0.040 16.94 16.93 17 0.070
16.94 0.050 16.93 16.94 16.92 0.020
17.57 0.030 17.57 17.57 17.57 0.000
17.41 0.040 17.4 17.41 17.41 0.010
16.82 0.010 16.83 16.83 16.9 0.070
16.41 0.020 16.39 16.42 16.41 0.030
16.94 0.010 16.93 16.96 16.93 0.030
16.28 0.030 16.32 16.28 16.29 0.040
16.810 0.027 Average = 16.824 0.043
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.000
17.500
Average
17.000
16.500
16.000
15.500
15.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
16.847 16.790 16.747
0EX65002519030592T00026
16.090 16.100 16.137
0EX6500251903059320006E
16.917 16.920 16.957
0EX65002519030593200073
16.890 16.910 16.930
0EX65002519030593200076
17.580 17.557 17.570
0EX650025190305932000A2
17.380 17.387 17.407
0EX650025190305932000CD
16.813 16.823 16.853
0EX65002519030593200166
16.410 16.410 16.407
0EX6500251903059320018F
16.947 16.937 16.940
0EX6500251903059320019A
16.230 16.263 16.297
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2402 2LE LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.050 0.070 0.077
0EX65002519030592T00026
0.020 0.030 0.070 0.077
0EX6500251903059320006E
0.020 0.040 0.070 0.077
0EX65002519030593200073
0.010 0.010 0.010 0.077
0EX65002519030593200076
0.000 0.030 0.010 0.077
0EX650025190305932000A2
0.010 0.010 0.020 0.077
0EX650025190305932000CD
0.030 0.010 0.060 0.077
0EX65002519030593200166
0.020 0.000 0.010 0.077
0EX6500251903059320018F
0.020 0.010 0.050 0.077
0EX6500251903059320019A
0.020 0.010 0.040 0.077
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
15.14 0.050 15.13 15.12 15.06 0.070 UCL Range Violation - A
14.58 0.030 14.57 14.64 14.58 0.070
15.03 0.040 15.08 15.06 15.13 0.070
15.13 0.010 15.14 15.15 15.14 0.010
15.55 0.030 15.54 15.54 15.55 0.010
15.59 0.010 15.58 15.6 15.6 0.020
14.63 0.010 14.63 14.63 14.69 0.060
14.54 0.000 14.53 14.54 14.53 0.010
14.86 0.010 14.85 14.9 14.85 0.050
14.4 0.010 14.45 14.41 14.42 0.040
14.942 0.020 Average = 14.955 0.041
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
16.000
Average
15.500
15.000
14.500
14.000
13.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
15.200 15.137 15.103
0EX65002519030592T00026
14.570 14.567 14.597
0EX6500251903059320006E
15.060 15.043 15.090
0EX65002519030593200073
15.107 15.123 15.143
0EX65002519030593200076
15.560 15.537 15.543
0EX650025190305932000A2
15.583 15.587 15.593
0EX650025190305932000CD
14.623 14.627 14.650
0EX65002519030593200166
14.537 14.540 14.533
0EX6500251903059320018F
14.880 14.863 14.867
0EX6500251903059320019A
14.370 14.397 14.427
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2440 2LE LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.050 0.080 0.090
0EX65002519030592T00026
0.030 0.030 0.060 0.090
0EX6500251903059320006E
0.020 0.030 0.070 0.090
0EX65002519030593200073
0.010 0.020 0.020 0.090
0EX65002519030593200076
0.020 0.030 0.010 0.090
0EX650025190305932000A2
0.030 0.030 0.020 0.090
0EX650025190305932000CD
0.030 0.000 0.090 0.090
0EX65002519030593200166
0.030 0.020 0.020 0.090
0EX6500251903059320018F
0.010 0.010 0.050 0.090
0EX6500251903059320019A
0.020 0.020 0.060 0.090
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
16.14 0.050 16.14 16.13 16.06 0.080 UCL Range Violation - A
15.49 0.030 15.48 15.54 15.48 0.060
16.07 0.030 16.1 16.1 16.17 0.070
16.15 0.020 16.14 16.16 16.16 0.020
16.64 0.030 16.63 16.64 16.63 0.010
16.6 0.030 16.58 16.59 16.6 0.020
15.75 0.000 15.74 15.78 15.83 0.090
15.57 0.020 15.57 15.58 15.59 0.020
15.96 0.010 15.93 15.98 15.93 0.050
15.43 0.020 15.48 15.42 15.45 0.060
15.974 0.024 Average = 15.987 0.048
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
17.000
Average
16.500
16.000
15.500
15.000
14.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
16.217 16.150 16.110
0EX65002519030592T00026
15.457 15.473 15.500
0EX6500251903059320006E
16.093 16.080 16.123
0EX65002519030593200073
16.117 16.137 16.153
0EX65002519030593200076
16.650 16.627 16.633
0EX650025190305932000A2
16.573 16.583 16.590
0EX650025190305932000CD
15.753 15.750 15.783
0EX65002519030593200166
15.577 15.570 15.580
0EX6500251903059320018F
15.967 15.953 15.947
0EX6500251903059320019A
15.400 15.420 15.450
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 2480 2LE LSL = 10.5
Characteristic: #N/A 10
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.060 0.080 0.092
0EX65002519030592T00026
0.040 0.020 0.080 0.092
0EX6500251903059320006E
0.020 0.050 0.070 0.092
0EX65002519030593200073
0.010 0.030 0.010 0.092
0EX65002519030593200076
0.030 0.030 0.000 0.092
0EX650025190305932000A2
0.010 0.030 0.030 0.092
0EX650025190305932000CD
0.040 0.010 0.090 0.092
0EX65002519030593200166
0.010 0.010 0.010 0.092
0EX6500251903059320018F
0.010 0.010 0.050 0.092
0EX6500251903059320019A
0.020 0.030 0.040 0.092
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
16.88 0.060 16.87 16.87 16.79 0.080 UCL Range Violation - A
16.19 0.020 16.19 16.26 16.18 0.080
16.98 0.050 17.01 17.01 17.08 0.070
17.01 0.030 17.02 17.02 17.01 0.010
17.66 0.030 17.67 17.67 17.67 0.000
17.49 0.030 17.47 17.48 17.5 0.030
16.88 0.010 16.9 16.89 16.98 0.090
16.48 0.010 16.48 16.49 16.49 0.010
17.02 0.010 17.01 17.04 16.99 0.050
16.36 0.030 16.41 16.37 16.38 0.040
16.891 0.028 Average = 16.907 0.046
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.000
17.500
Average
17.000
16.500
16.000
15.500
15.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
16.950 16.880 16.843
0EX65002519030592T00026
16.170 16.180 16.210
0EX6500251903059320006E
17.000 16.990 17.033
0EX65002519030593200073
16.987 16.993 17.017
0EX65002519030593200076
17.690 17.657 17.670
0EX650025190305932000A2
17.463 17.470 17.483
0EX650025190305932000CD
16.887 16.887 16.923
0EX65002519030593200166
16.477 16.483 16.487
0EX6500251903059320018F
17.023 17.017 17.013
0EX6500251903059320019A
16.323 16.350 16.387
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2402 125KLE LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.150 0.060 0.080 0.085
0EX65002519030592T00026
0.040 0.050 0.080 0.085
0EX6500251903059320006E
0.020 0.030 0.080 0.085
0EX65002519030593200073
0.010 0.030 0.020 0.085
0EX65002519030593200076
0.030 0.010 0.010 0.085
0EX650025190305932000A2
0.000 0.020 0.020 0.085
0EX650025190305932000CD
0.020 0.010 0.090 0.085
0EX65002519030593200166
0.010 0.020 0.010 0.085
0EX6500251903059320018F
0.010 0.010 0.010 0.085
0EX6500251903059320019A
0.020 0.020 0.020 0.085
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
15.02 0.060 15.02 15.02 14.94 0.080 UCL Range Violation - A
14.49 0.050 14.49 14.56 14.48 0.080
14.95 0.030 14.97 14.96 15.04 0.080
15.03 0.030 15.02 15.04 15.04 0.020
15.42 0.010 15.42 15.41 15.41 0.010
15.49 0.020 15.48 15.49 15.5 0.020
14.55 0.010 14.55 14.54 14.63 0.090 UCL Range Violation - C
14.43 0.020 14.43 14.44 14.43 0.010
14.79 0.010 14.77 14.78 14.77 0.010
14.3 0.020 14.31 14.29 14.3 0.020
14.839 0.026 Average = 14.851 0.042
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
15.600
15.400
Average
15.200
15.000
14.800
14.600
14.400
14.200
14.000
13.800
13.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
15.093 15.013 14.993
0EX65002519030592T00026
14.460 14.470 14.510
0EX6500251903059320006E
14.950 14.953 14.990
0EX65002519030593200073
15.003 15.017 15.033
0EX65002519030593200076
15.427 15.413 15.413
0EX650025190305932000A2
15.470 15.480 15.490
0EX650025190305932000CD
14.540 14.547 14.573
0EX65002519030593200166
14.427 14.430 14.433
0EX6500251903059320018F
14.793 14.783 14.773
0EX6500251903059320019A
14.263 14.287 14.300
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2440 125KLE LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.160 0.070 0.090 0.083
0EX65002519030592T00026
0.030 0.030 0.090 0.083
0EX6500251903059320006E
0.020 0.030 0.090 0.083
0EX65002519030593200073
0.010 0.030 0.010 0.083
0EX65002519030593200076
0.020 0.000 0.010 0.083
0EX650025190305932000A2
0.020 0.030 0.010 0.083
0EX650025190305932000CD
0.020 0.000 0.100 0.083
0EX65002519030593200166
0.010 0.010 0.010 0.083
0EX6500251903059320018F
0.010 0.010 0.010 0.083
0EX6500251903059320019A
0.030 0.000 0.010 0.083
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
15.99 0.070 15.99 15.99 15.9 0.090 UCL Range Violation - A
15.34 0.030 15.33 15.42 15.34 0.090 UCL Range Violation - C
15.94 0.030 15.97 15.96 16.05 0.090 UCL Range Violation - C
16.01 0.030 15.99 16 15.99 0.010
16.47 0.000 16.45 16.45 16.46 0.010
16.45 0.030 16.46 16.45 16.45 0.010
15.64 0.000 15.63 15.64 15.73 0.100 UCL Range Violation - C
15.43 0.010 15.44 15.44 15.43 0.010
15.83 0.010 15.83 15.83 15.82 0.010
15.28 0.000 15.29 15.29 15.3 0.010
15.834 0.021 Average = 15.844 0.043
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
16.600
16.400
Average
16.200
16.000
15.800
15.600
15.400
15.200
15.000
14.800
14.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
16.067 15.987 15.960
0EX65002519030592T00026
15.317 15.330 15.363
0EX6500251903059320006E
15.950 15.953 15.993
0EX65002519030593200073
15.973 15.990 15.993
0EX65002519030593200076
16.470 16.470 16.453
0EX650025190305932000A2
16.430 16.433 16.453
0EX650025190305932000CD
15.640 15.640 15.667
0EX65002519030593200166
15.433 15.427 15.437
0EX6500251903059320018F
15.833 15.833 15.827
0EX6500251903059320019A
15.257 15.280 15.293
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 2480 125KLE LSL = 10.5
Characteristic: #N/A 10
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.060 0.080 0.076
0EX65002519030592T00026
0.020 0.020 0.080 0.076
0EX6500251903059320006E
0.030 0.030 0.080 0.076
0EX65002519030593200073
0.020 0.020 0.010 0.076
0EX65002519030593200076
0.030 0.000 0.010 0.076
0EX650025190305932000A2
0.000 0.030 0.020 0.076
0EX650025190305932000CD
0.020 0.010 0.080 0.076
0EX65002519030593200166
0.010 0.010 0.000 0.076
0EX6500251903059320018F
0.000 0.010 0.010 0.076
0EX6500251903059320019A
0.020 0.020 0.010 0.076
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
16.69 0.060 16.68 16.68 16.6 0.080 UCL Range Violation - A
16.03 0.020 16.03 16.1 16.02 0.080 UCL Range Violation - C
16.83 0.030 16.84 16.84 16.92 0.080 UCL Range Violation - C
16.83 0.020 16.83 16.83 16.84 0.010
17.47 0.000 17.47 17.47 17.48 0.010
17.32 0.030 17.32 17.31 17.33 0.020
16.75 0.010 16.75 16.76 16.83 0.080 UCL Range Violation - C
16.32 0.010 16.32 16.32 16.32 0.000
16.85 0.010 16.85 16.85 16.84 0.010
16.19 0.020 16.2 16.2 16.19 0.010
16.723 0.021 Average = 16.734 0.038
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.000
17.500
Average
17.000
16.500
16.000
15.500
15.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
16.757 16.690 16.653
0EX65002519030592T00026
16.007 16.023 16.050
0EX6500251903059320006E
16.827 16.833 16.867
0EX65002519030593200073
16.797 16.820 16.833
0EX65002519030593200076
17.490 17.470 17.473
0EX650025190305932000A2
17.290 17.300 17.320
0EX650025190305932000CD
16.747 16.747 16.780
0EX65002519030593200166
16.303 16.317 16.320
0EX6500251903059320018F
16.870 16.857 16.847
0EX6500251903059320019A
16.153 16.177 16.197
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2402 500KLE LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.070 0.080 0.079
0EX65002519030592T00026
0.020 0.040 0.070 0.079
0EX6500251903059320006E
0.030 0.020 0.090 0.079
0EX65002519030593200073
0.020 0.030 0.010 0.079
0EX65002519030593200076
0.020 0.010 0.010 0.079
0EX650025190305932000A2
0.010 0.020 0.000 0.079
0EX650025190305932000CD
0.010 0.020 0.100 0.079
0EX65002519030593200166
0.010 0.010 0.020 0.079
0EX6500251903059320018F
0.010 0.000 0.010 0.079
0EX6500251903059320019A
0.010 0.030 0.010 0.079
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
15.11 0.070 15.1 15.11 15.03 0.080 UCL Range Violation - A
14.56 0.040 14.57 14.62 14.55 0.070
15.02 0.020 15.04 15.03 15.12 0.090 UCL Range Violation - C
15.11 0.030 15.11 15.12 15.12 0.010
15.51 0.010 15.51 15.5 15.51 0.010
15.56 0.020 15.57 15.57 15.57 0.000
14.63 0.020 14.62 14.63 14.72 0.100 UCL Range Violation - C
14.5 0.010 14.51 14.52 14.5 0.020
14.86 0.000 14.85 14.85 14.84 0.010
14.38 0.030 14.37 14.37 14.38 0.010
14.919 0.025 Average = 14.930 0.040
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
16.000
Average
15.500
15.000
14.500
14.000
13.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
15.173 15.113 15.080
0EX65002519030592T00026
14.540 14.543 14.580
0EX6500251903059320006E
15.023 15.027 15.063
0EX65002519030593200073
15.087 15.097 15.117
0EX65002519030593200076
15.520 15.513 15.507
0EX650025190305932000A2
15.547 15.550 15.570
0EX650025190305932000CD
14.613 14.617 14.657
0EX65002519030593200166
14.497 14.503 14.510
0EX6500251903059320018F
14.867 14.860 14.847
0EX6500251903059320019A
14.347 14.367 14.373
control limit
9 10
Part Name: 613376 USL = 18.5
Dimension: 2440 500KLE LSL = 10.5
Characteristic: #N/A 8
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.060 0.100 0.080
0EX65002519030592T00026
0.020 0.020 0.090 0.080
0EX6500251903059320006E
0.020 0.020 0.070 0.080
0EX65002519030593200073
0.020 0.020 0.030 0.080
0EX65002519030593200076
0.020 0.000 0.010 0.080
0EX650025190305932000A2
0.000 0.030 0.010 0.080
0EX650025190305932000CD
0.030 0.010 0.110 0.080
0EX65002519030593200166
0.020 0.000 0.000 0.080
0EX6500251903059320018F
0.000 0.010 0.010 0.080
0EX6500251903059320019A
0.030 0.020 0.010 0.080
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
16.1 0.060 16.1 16.08 16 0.100 UCL Range Violation - A
15.43 0.020 15.43 15.51 15.42 0.090 UCL Range Violation - C
16.05 0.020 16.06 16.06 16.13 0.070
16.11 0.020 16.11 16.13 16.1 0.030
16.58 0.000 16.57 16.57 16.58 0.010
16.55 0.030 16.56 16.55 16.55 0.010
15.73 0.010 15.73 15.75 15.84 0.110 UCL Range Violation - C
15.53 0.000 15.53 15.53 15.53 0.000
15.93 0.010 15.92 15.91 15.92 0.010
15.39 0.020 15.39 15.39 15.4 0.010
15.936 0.019 Average = 15.945 0.044
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
17.000
Average
16.500
16.000
15.500
15.000
14.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
16.170 16.107 16.060
0EX65002519030592T00026
15.413 15.430 15.453
0EX6500251903059320006E
16.050 16.050 16.083
0EX65002519030593200073
16.080 16.097 16.113
0EX65002519030593200076
16.590 16.580 16.573
0EX650025190305932000A2
16.530 16.530 16.553
0EX650025190305932000CD
15.727 15.733 15.773
0EX65002519030593200166
15.530 15.530 15.530
0EX6500251903059320018F
15.940 15.923 15.917
0EX6500251903059320019A
15.357 15.383 15.393
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 2480 500KLE LSL = 10.5
Characteristic: #N/A 10
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
Range
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.060 0.070 0.079
0EX65002519030592T00026
0.030 0.020 0.090 0.079
0EX6500251903059320006E
0.030 0.030 0.070 0.079
0EX65002519030593200073
0.030 0.020 0.020 0.079
0EX65002519030593200076
0.020 0.010 0.010 0.079
0EX650025190305932000A2
0.010 0.020 0.010 0.079
0EX650025190305932000CD
0.030 0.010 0.090 0.079
0EX65002519030593200166
0.010 0.000 0.020 0.079
0EX6500251903059320018F
0.020 0.010 0.010 0.079
0EX6500251903059320019A
0.010 0.020 0.010 0.079
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
16.82 0.060 16.8 16.8 16.73 0.070 UCL Range Violation - A
16.13 0.020 16.15 16.21 16.12 0.090 UCL Range Violation - C
16.94 0.030 16.96 16.96 17.03 0.070
16.95 0.020 16.95 16.97 16.95 0.020
17.61 0.010 17.6 17.6 17.61 0.010
17.42 0.020 17.43 17.43 17.44 0.010
16.86 0.010 16.87 16.88 16.96 0.090 UCL Range Violation - C
16.43 0.000 16.44 16.42 16.43 0.020
16.97 0.010 16.96 16.95 16.96 0.010
16.3 0.020 16.3 16.31 16.31 0.010
16.840 0.020 Average = 16.851 0.040
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.000
17.500
Average
17.000
16.500
16.000
15.500
15.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
16.887 16.813 16.777
0EX65002519030592T00026
16.120 16.130 16.160
0EX6500251903059320006E
16.943 16.943 16.983
0EX65002519030593200073
16.920 16.937 16.957
0EX65002519030593200076
17.620 17.613 17.603
0EX650025190305932000A2
17.403 17.407 17.433
0EX650025190305932000CD
16.857 16.863 16.903
0EX65002519030593200166
16.417 16.430 16.430
0EX6500251903059320018F
16.980 16.967 16.957
0EX6500251903059320019A
16.273 16.293 16.307
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5180 OFDM-6 NON_HT BW-20 TX1 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.180 0.170 0.400 0.386
0EX65002519030592T00026
0.270 0.130 0.280 0.386
0EX6500251903059320006E
0.270 0.050 0.080 0.386
0EX65002519030593200073
0.120 0.050 0.220 0.386
0EX65002519030593200076
0.130 0.160 0.110 0.386
0EX650025190305932000A2
0.070 0.080 0.350 0.386
0EX650025190305932000CD
0.270 0.030 0.070 0.386
0EX65002519030593200166
0.090 0.110 0.010 0.386
0EX6500251903059320018F
0.130 0.240 0.100 0.386
0EX6500251903059320019A
0.030 0.130 0.160 0.386
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.39 0.170 22.53 22.13 22.5 0.400 UCL Range Violation - C
22.42 0.130 22.67 22.39 22.65 0.280
22.55 0.050 22.55 22.63 22.56 0.080
22.42 0.050 22.28 22.5 22.42 0.220
22.46 0.160 22.55 22.45 22.44 0.110
22.43 0.080 22.71 22.51 22.36 0.350
22.59 0.030 22.58 22.65 22.63 0.070
22.63 0.110 22.61 22.62 22.62 0.010
22.37 0.240 22.5 22.43 22.53 0.100
22.54 0.130 22.44 22.6 22.45 0.160
22.511 0.115 Average = 22.516 0.178
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.700
22.650
Average
22.600
22.550
22.500
22.450
22.400
22.350
22.300
22.250
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.563 22.497 22.387
0EX65002519030592T00026
22.537 22.390 22.570
0EX6500251903059320006E
22.530 22.547 22.580
0EX65002519030593200073
22.533 22.447 22.400
0EX65002519030593200076
22.573 22.563 22.480
0EX650025190305932000A2
22.483 22.430 22.527
0EX650025190305932000CD
22.657 22.593 22.620
0EX65002519030593200166
22.623 22.640 22.617
0EX6500251903059320018F
22.447 22.510 22.487
0EX6500251903059320019A
22.397 22.490 22.497
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5180 OFDM-6 NON_HT BW-20 TX2 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.180 0.130 0.060 0.267
0EX65002519030592T00026
0.070 0.090 0.070 0.267
0EX6500251903059320006E
0.060 0.330 0.120 0.267
0EX65002519030593200073
0.100 0.050 0.080 0.267
0EX65002519030593200076
0.160 0.170 0.100 0.267
0EX650025190305932000A2
0.090 0.160 0.030 0.267
0EX650025190305932000CD
0.230 0.270 0.030 0.267
0EX65002519030593200166
0.120 0.010 0.030 0.267
0EX6500251903059320018F
0.010 0.100 0.070 0.267
0EX6500251903059320019A
0.030 0.040 0.110 0.267
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.88 0.130 22.83 22.85 22.79 0.060
22.64 0.090 22.71 22.65 22.72 0.070
23.05 0.330 22.72 22.78 22.84 0.120 UCL Range Violation - B
23 0.050 22.92 22.85 22.93 0.080
22.8 0.170 22.73 22.83 22.83 0.100
22.71 0.160 22.68 22.68 22.71 0.030
22.69 0.270 22.76 22.73 22.74 0.030 UCL Range Violation - B
22.68 0.010 22.7 22.69 22.67 0.030
22.88 0.100 22.8 22.87 22.86 0.070
22.76 0.040 22.79 22.73 22.68 0.110
22.791 0.135 Average = 22.769 0.070
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.100
23.000
Average
22.900
22.800
22.700
22.600
22.500
22.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.813 22.813 22.823
0EX65002519030592T00026
22.710 22.677 22.693
0EX6500251903059320006E
22.823 22.853 22.780
0EX65002519030593200073
22.867 22.983 22.900
0EX65002519030593200076
22.793 22.763 22.797
0EX650025190305932000A2
22.730 22.787 22.690
0EX650025190305932000CD
22.810 22.780 22.743
0EX65002519030593200166
22.640 22.673 22.687
0EX6500251903059320018F
22.763 22.837 22.843
0EX6500251903059320019A
22.757 22.740 22.733
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5180 OFDM-6 NON_HT BW-20 TX3 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.120 0.050 0.030 0.214
0EX65002519030592T00026
0.020 0.040 0.040 0.214
0EX6500251903059320006E
0.070 0.060 0.170 0.214
0EX65002519030593200073
0.160 0.110 0.130 0.214
0EX65002519030593200076
0.130 0.090 0.090 0.214
0EX650025190305932000A2
0.070 0.080 0.120 0.214
0EX650025190305932000CD
0.040 0.080 0.150 0.214
0EX65002519030593200166
0.030 0.070 0.180 0.214
0EX6500251903059320018F
0.090 0.100 0.010 0.214
0EX6500251903059320019A
0.060 0.060 0.040 0.214
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.57 0.050 22.52 22.55 22.55 0.030
22.72 0.040 22.72 22.68 22.72 0.040
22.67 0.060 22.57 22.74 22.7 0.170
22.75 0.110 22.87 22.74 22.78 0.130
22.85 0.090 22.85 22.85 22.76 0.090
22.69 0.080 22.72 22.62 22.6 0.120
22.73 0.080 22.69 22.82 22.67 0.150
22.79 0.070 22.89 22.71 22.81 0.180
22.68 0.100 22.69 22.68 22.68 0.010
22.86 0.060 22.81 22.77 22.78 0.040
22.728 0.074 Average = 22.718 0.096
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.900
22.800
Average
22.700
22.600
22.500
22.400
22.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.570 22.580 22.540
0EX65002519030592T00026
22.727 22.737 22.707
0EX6500251903059320006E
22.720 22.683 22.670
0EX65002519030593200073
22.777 22.797 22.797
0EX65002519030593200076
22.843 22.790 22.820
0EX650025190305932000A2
22.657 22.677 22.647
0EX650025190305932000CD
22.720 22.677 22.727
0EX65002519030593200166
22.777 22.760 22.803
0EX6500251903059320018F
22.693 22.743 22.683
0EX6500251903059320019A
22.807 22.833 22.787
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5180 OFDM-6 NON_HT BW-20 TX4 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.040 0.060 0.217
0EX65002519030592T00026
0.040 0.160 0.070 0.217
0EX6500251903059320006E
0.140 0.050 0.130 0.217
0EX65002519030593200073
0.060 0.060 0.090 0.217
0EX65002519030593200076
0.080 0.160 0.100 0.217
0EX650025190305932000A2
0.060 0.070 0.020 0.217
0EX650025190305932000CD
0.150 0.070 0.030 0.217
0EX65002519030593200166
0.060 0.020 0.110 0.217
0EX6500251903059320018F
0.080 0.130 0.060 0.217
0EX6500251903059320019A
0.050 0.120 0.120 0.217
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.53 0.040 22.62 22.56 22.6 0.060
22.82 0.160 22.69 22.74 22.76 0.070
22.77 0.050 22.83 22.74 22.87 0.130
22.66 0.060 22.67 22.64 22.73 0.090
22.6 0.160 22.82 22.83 22.73 0.100
22.78 0.070 22.78 22.79 22.8 0.020
22.64 0.070 22.64 22.67 22.66 0.030
22.67 0.020 22.71 22.64 22.6 0.110
22.66 0.130 22.56 22.62 22.59 0.060
22.64 0.120 22.67 22.67 22.55 0.120
22.683 0.088 Average = 22.693 0.079
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.900
22.800
Average
22.700
22.600
22.500
22.400
22.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.620 22.547 22.593
0EX65002519030592T00026
22.687 22.740 22.730
0EX6500251903059320006E
22.840 22.793 22.813
0EX65002519030593200073
22.640 22.623 22.680
0EX65002519030593200076
22.777 22.707 22.793
0EX650025190305932000A2
22.757 22.757 22.790
0EX650025190305932000CD
22.683 22.673 22.657
0EX65002519030593200166
22.693 22.660 22.650
0EX6500251903059320018F
22.603 22.630 22.590
0EX6500251903059320019A
22.683 22.703 22.630
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5500 OFDM-6 NON_HT BW-20 TX1 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.240 0.110 0.250 0.294
0EX65002519030592T00026
0.250 0.000 0.100 0.294
0EX6500251903059320006E
0.020 0.110 0.070 0.294
0EX65002519030593200073
0.070 0.190 0.170 0.294
0EX65002519030593200076
0.260 0.060 0.040 0.294
0EX650025190305932000A2
0.040 0.150 0.150 0.294
0EX650025190305932000CD
0.080 0.070 0.030 0.294
0EX65002519030593200166
0.110 0.140 0.140 0.294
0EX6500251903059320018F
0.030 0.120 0.120 0.294
0EX6500251903059320019A
0.040 0.140 0.120 0.294
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.88 0.110 22.84 22.59 22.72 0.250
22.91 0.000 22.91 22.81 22.91 0.100
22.67 0.110 22.71 22.75 22.68 0.070
22.84 0.190 22.89 22.72 22.77 0.170
22.9 0.060 22.92 22.89 22.88 0.040
22.59 0.150 22.77 22.66 22.62 0.150
22.85 0.070 22.74 22.73 22.76 0.030
22.84 0.140 22.9 22.93 22.79 0.140
22.58 0.120 22.71 22.59 22.7 0.120
22.77 0.140 22.67 22.79 22.72 0.120
22.770 0.109 Average = 22.769 0.119
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.000
22.900
Average
22.800
22.700
22.600
22.500
22.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.790 22.837 22.717
0EX65002519030592T00026
22.933 22.910 22.877
0EX6500251903059320006E
22.643 22.633 22.713
0EX65002519030593200073
22.583 22.720 22.793
0EX65002519030593200076
22.833 22.930 22.897
0EX650025190305932000A2
22.653 22.660 22.683
0EX650025190305932000CD
22.837 22.840 22.743
0EX65002519030593200166
22.843 22.827 22.873
0EX6500251903059320018F
22.613 22.633 22.667
0EX6500251903059320019A
22.643 22.713 22.727
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5500 OFDM-6 NON_HT BW-20 TX2 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.030 0.070 0.282
0EX65002519030592T00026
0.200 0.040 0.190 0.282
0EX6500251903059320006E
0.040 0.070 0.040 0.282
0EX65002519030593200073
0.140 0.260 0.120 0.282
0EX65002519030593200076
0.130 0.030 0.110 0.282
0EX650025190305932000A2
0.050 0.080 0.150 0.282
0EX650025190305932000CD
0.130 0.090 0.210 0.282
0EX65002519030593200166
0.110 0.130 0.060 0.282
0EX6500251903059320018F
0.140 0.070 0.070 0.282
0EX6500251903059320019A
0.210 0.030 0.150 0.282
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.72 0.030 22.72 22.72 22.79 0.070
22.84 0.040 22.79 22.98 22.87 0.190
22.66 0.070 22.73 22.75 22.77 0.040
22.92 0.260 22.83 22.79 22.71 0.120
22.79 0.030 22.91 22.84 22.8 0.110
22.72 0.080 22.74 22.63 22.78 0.150
22.76 0.090 22.83 22.82 22.62 0.210
22.77 0.130 22.9 22.86 22.84 0.060
22.82 0.070 22.87 22.91 22.84 0.070
22.71 0.030 22.55 22.66 22.7 0.150
22.765 0.083 Average = 22.785 0.117
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.950
22.900
Average
22.850
22.800
22.750
22.700
22.650
22.600
22.550
22.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.713 22.723 22.743
0EX65002519030592T00026
22.883 22.863 22.880
0EX6500251903059320006E
22.753 22.700 22.750
0EX65002519030593200073
22.840 22.797 22.777
0EX65002519030593200076
22.810 22.793 22.850
0EX650025190305932000A2
22.723 22.690 22.717
0EX650025190305932000CD
22.847 22.807 22.757
0EX65002519030593200166
22.773 22.787 22.867
0EX6500251903059320018F
22.803 22.793 22.873
0EX6500251903059320019A
22.710 22.693 22.637
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5500 OFDM-6 NON_HT BW-20 TX3 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.050 0.020 0.010 0.169
0EX65002519030592T00026
0.090 0.020 0.150 0.169
0EX6500251903059320006E
0.000 0.030 0.160 0.169
0EX65002519030593200073
0.040 0.090 0.030 0.169
0EX65002519030593200076
0.030 0.040 0.030 0.169
0EX650025190305932000A2
0.120 0.090 0.080 0.169
0EX650025190305932000CD
0.090 0.030 0.070 0.169
0EX65002519030593200166
0.020 0.180 0.110 0.169
0EX6500251903059320018F
0.030 0.090 0.120 0.169
0EX6500251903059320019A
0.050 0.010 0.080 0.169
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.78 0.020 22.76 22.77 22.77 0.010
22.87 0.020 22.89 22.97 22.82 0.150
22.67 0.030 22.55 22.68 22.71 0.160
22.76 0.090 22.78 22.75 22.75 0.030
22.86 0.040 22.76 22.77 22.74 0.030
22.66 0.090 22.55 22.62 22.63 0.080
22.71 0.030 22.68 22.64 22.61 0.070
22.72 0.180 22.7 22.71 22.6 0.110 UCL Range Violation - B
22.67 0.090 22.67 22.56 22.55 0.120
22.73 0.010 22.74 22.66 22.68 0.080
22.734 0.060 Average = 22.702 0.084
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.000
22.900
Average
22.800
22.700
22.600
22.500
22.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.720 22.767 22.767
0EX65002519030592T00026
22.913 22.870 22.893
0EX6500251903059320006E
22.660 22.667 22.647
0EX65002519030593200073
22.737 22.817 22.760
0EX65002519030593200076
22.750 22.837 22.757
0EX650025190305932000A2
22.647 22.657 22.600
0EX650025190305932000CD
22.640 22.707 22.643
0EX65002519030593200166
22.667 22.680 22.670
0EX6500251903059320018F
22.680 22.617 22.593
0EX6500251903059320019A
22.680 22.727 22.693
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5500 OFDM-6 NON_HT BW-20 TX4 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.050 0.270 0.020 0.222
0EX65002519030592T00026
0.090 0.080 0.030 0.222
0EX6500251903059320006E
0.050 0.010 0.020 0.222
0EX65002519030593200073
0.110 0.140 0.100 0.222
0EX65002519030593200076
0.210 0.040 0.060 0.222
0EX650025190305932000A2
0.120 0.040 0.070 0.222
0EX650025190305932000CD
0.050 0.100 0.090 0.222
0EX65002519030593200166
0.050 0.070 0.030 0.222
0EX6500251903059320018F
0.060 0.080 0.260 0.222
0EX6500251903059320019A
0.120 0.090 0.070 0.222
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.96 0.270 23.01 23.01 22.99 0.020 UCL Range Violation - B
23.31 0.080 23.27 23.24 23.24 0.030
23.24 0.010 23.23 23.25 23.25 0.020
23.06 0.140 23.05 23.13 23.03 0.100
23.31 0.040 23.32 23.26 23.29 0.060
23.17 0.040 23.23 23.18 23.16 0.070
23.22 0.100 23.28 23.19 23.27 0.090
23.24 0.070 23.19 23.22 23.2 0.030
23.02 0.080 22.88 22.92 23.14 0.260 UCL Range Violation - C
23.14 0.090 23.15 23.16 23.09 0.070
23.165 0.092 Average = 23.161 0.075
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.400
23.300
Average
23.200
23.100
23.000
22.900
22.800
22.700
22.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.900 23.063 23.003
0EX65002519030592T00026
23.353 23.337 23.250
0EX6500251903059320006E
23.237 23.237 23.243
0EX65002519030593200073
23.000 23.000 23.070
0EX65002519030593200076
23.273 23.303 23.290
0EX650025190305932000A2
23.240 23.170 23.190
0EX650025190305932000CD
23.227 23.277 23.247
0EX65002519030593200166
23.230 23.197 23.203
0EX6500251903059320018F
22.977 22.967 22.980
0EX6500251903059320019A
23.103 23.097 23.133
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5825 OFDM-6 NON_HT BW-20 TX1 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.500
Range
0.400
0.300
0.200
0.100
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.220 0.120 0.210 0.280
0EX65002519030592T00026
0.070 0.030 0.010 0.280
0EX6500251903059320006E
0.010 0.030 0.020 0.280
0EX65002519030593200073
0.110 0.520 0.050 0.280
0EX65002519030593200076
0.040 0.090 0.010 0.280
0EX650025190305932000A2
0.060 0.160 0.220 0.280
0EX650025190305932000CD
0.060 0.040 0.080 0.280
0EX65002519030593200166
0.120 0.110 0.100 0.280
0EX6500251903059320018F
0.230 0.090 0.140 0.280
0EX6500251903059320019A
0.180 0.100 0.030 0.280
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.79 0.120 22.76 22.65 22.86 0.210
23.49 0.030 23.44 23.45 23.44 0.010
22.77 0.030 22.75 22.76 22.74 0.020
22.94 0.520 23 23.05 23.01 0.050 UCL Range Violation - B
23.34 0.090 23.24 23.24 23.25 0.010
22.97 0.160 23.13 22.91 22.92 0.220
23.33 0.040 23.35 23.37 23.29 0.080
23.02 0.110 23.06 23.08 23.16 0.100
22.96 0.090 22.96 22.82 22.84 0.140
22.81 0.100 22.86 22.87 22.89 0.030
23.045 0.129 Average = 23.038 0.087
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.600
23.400
Average
23.200
23.000
22.800
22.600
22.400
22.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.793 22.830 22.757
0EX65002519030592T00026
23.450 23.470 23.443
0EX6500251903059320006E
22.697 22.750 22.750
0EX65002519030593200073
23.007 23.123 23.020
0EX65002519030593200076
23.237 23.283 23.243
0EX650025190305932000A2
22.940 22.923 22.987
0EX650025190305932000CD
23.267 23.347 23.337
0EX65002519030593200166
23.053 23.063 23.100
0EX6500251903059320018F
22.757 22.910 22.873
0EX6500251903059320019A
22.803 22.753 22.873
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5825 OFDM-6 NON_HT BW-20 TX2 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.130 0.040 0.288
0EX65002519030592T00026
0.160 0.080 0.100 0.288
0EX6500251903059320006E
0.050 0.090 0.060 0.288
0EX65002519030593200073
0.240 0.200 0.040 0.288
0EX65002519030593200076
0.100 0.070 0.090 0.288
0EX650025190305932000A2
0.000 0.280 0.070 0.288
0EX650025190305932000CD
0.310 0.200 0.200 0.288
0EX65002519030593200166
0.020 0.090 0.130 0.288
0EX6500251903059320018F
0.090 0.110 0.100 0.288
0EX6500251903059320019A
0.020 0.010 0.130 0.288
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.75 0.130 22.63 22.64 22.6 0.040
22.68 0.080 22.69 22.67 22.77 0.100
22.59 0.090 22.7 22.68 22.64 0.060
22.72 0.200 22.7 22.71 22.74 0.040
22.69 0.070 22.69 22.67 22.6 0.090
22.66 0.280 22.68 22.74 22.75 0.070
22.7 0.200 22.72 22.71 22.52 0.200 UCL Range Violation - A
22.63 0.090 22.78 22.65 22.77 0.130
22.69 0.110 22.69 22.79 22.72 0.100
22.85 0.010 22.97 22.86 22.84 0.130
22.690 0.126 Average = 22.711 0.096
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.000
22.900
Average
22.800
22.700
22.600
22.500
22.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.733 22.677 22.623
0EX65002519030592T00026
22.677 22.667 22.710
0EX6500251903059320006E
22.647 22.643 22.673
0EX65002519030593200073
22.720 22.660 22.717
0EX65002519030593200076
22.633 22.647 22.653
0EX650025190305932000A2
22.930 22.843 22.723
0EX650025190305932000CD
22.673 22.603 22.650
0EX65002519030593200166
22.630 22.613 22.733
0EX6500251903059320018F
22.677 22.700 22.733
0EX6500251903059320019A
22.810 22.843 22.890
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5825 OFDM-6 NON_HT BW-20 TX3 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.050 0.070 0.237
0EX65002519030592T00026
0.080 0.000 0.100 0.237
0EX6500251903059320006E
0.060 0.060 0.040 0.237
0EX65002519030593200073
0.290 0.090 0.280 0.237
0EX65002519030593200076
0.110 0.040 0.090 0.237
0EX650025190305932000A2
0.030 0.030 0.130 0.237
0EX650025190305932000CD
0.100 0.090 0.120 0.237
0EX65002519030593200166
0.020 0.060 0.020 0.237
0EX6500251903059320018F
0.150 0.140 0.120 0.237
0EX6500251903059320019A
0.050 0.110 0.090 0.237
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.68 0.050 22.64 22.63 22.7 0.070
22.93 0.000 22.91 22.83 22.93 0.100
22.68 0.060 22.69 22.65 22.69 0.040
22.73 0.090 22.9 22.62 22.82 0.280 UCL Range Violation - A
22.86 0.040 22.89 22.82 22.91 0.090
22.7 0.030 22.58 22.71 22.6 0.130
22.82 0.090 22.85 22.74 22.86 0.120
22.82 0.060 22.84 22.85 22.86 0.020
22.69 0.140 22.68 22.69 22.57 0.120
22.87 0.110 22.89 22.98 22.9 0.090
22.765 0.067 Average = 22.774 0.106
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.000
22.900
Average
22.800
22.700
22.600
22.500
22.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.723 22.653 22.657
0EX65002519030592T00026
22.817 22.930 22.890
0EX6500251903059320006E
22.657 22.673 22.677
0EX65002519030593200073
22.847 22.707 22.780
0EX65002519030593200076
22.873 22.883 22.873
0EX650025190305932000A2
22.657 22.680 22.630
0EX650025190305932000CD
22.793 22.797 22.817
0EX65002519030593200166
22.810 22.807 22.850
0EX6500251903059320018F
22.610 22.637 22.647
0EX6500251903059320019A
22.873 22.887 22.923
control limit
9 10
Part Name: 613376 USL = 23.5
Dimension: 5825 OFDM-6 NON_HT BW-20 TX4 LSL = 19.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.040 0.030 0.310 0.228
0EX65002519030592T00026
0.120 0.230 0.200 0.228
0EX6500251903059320006E
0.140 0.100 0.020 0.228
0EX65002519030593200073
0.070 0.030 0.120 0.228
0EX65002519030593200076
0.050 0.090 0.080 0.228
0EX650025190305932000A2
0.100 0.040 0.080 0.228
0EX650025190305932000CD
0.010 0.040 0.090 0.228
0EX65002519030593200166
0.060 0.120 0.040 0.228
0EX6500251903059320018F
0.150 0.060 0.160 0.228
0EX6500251903059320019A
0.010 0.030 0.030 0.228
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.7 0.030 22.67 22.54 22.36 0.310 UCL Range Violation - C
22.91 0.230 22.69 22.75 22.89 0.200 UCL Range Violation - B
22.61 0.100 22.62 22.64 22.64 0.020
22.73 0.030 22.74 22.69 22.62 0.120
22.81 0.090 22.73 22.66 22.65 0.080
22.7 0.040 22.68 22.76 22.69 0.080
22.82 0.040 22.83 22.77 22.74 0.090
22.84 0.120 22.74 22.78 22.74 0.040
22.67 0.060 22.5 22.66 22.64 0.160
22.65 0.030 22.7 22.7 22.67 0.030
22.731 0.077 Average = 22.683 0.113
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.900
22.800
Average
22.700
22.600
22.500
22.400
22.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.647 22.683 22.523
0EX65002519030592T00026
22.867 22.820 22.777
0EX6500251903059320006E
22.723 22.667 22.633
0EX65002519030593200073
22.707 22.720 22.683
0EX65002519030593200076
22.687 22.773 22.680
0EX650025190305932000A2
22.627 22.700 22.710
0EX650025190305932000CD
22.777 22.800 22.780
0EX65002519030593200166
22.790 22.783 22.753
0EX6500251903059320018F
22.683 22.693 22.600
0EX6500251903059320019A
22.663 22.667 22.690
control limit
9 10
Part Name: 613376 USL = 21.5
Dimension: 5180 OFDM-54 NON_HT BW-20 TX1 LSL = 17.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.500
Range
0.400
0.300
0.200
0.100
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.190 0.060 0.180 0.347
0EX65002519030592T00026
0.150 0.140 0.120 0.347
0EX6500251903059320006E
0.250 0.050 0.010 0.347
0EX65002519030593200073
0.020 0.150 0.190 0.347
0EX65002519030593200076
0.100 0.110 0.030 0.347
0EX650025190305932000A2
0.080 0.040 0.150 0.347
0EX650025190305932000CD
0.180 0.230 0.160 0.347
0EX65002519030593200166
0.160 0.160 0.130 0.347
0EX6500251903059320018F
0.210 0.500 0.060 0.347
0EX6500251903059320019A
0.040 0.070 0.110 0.347
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.19 0.060 19.24 19.14 19.06 0.180
19.35 0.140 19.16 19.12 19.24 0.120
19.32 0.050 19.32 19.33 19.33 0.010
19.31 0.150 19.28 19.35 19.47 0.190
19.26 0.110 19.3 19.27 19.27 0.030
19.2 0.040 19.31 19.32 19.17 0.150
19.35 0.230 19.47 19.34 19.31 0.160
19.27 0.160 19.24 19.25 19.37 0.130
18.95 0.500 19.07 19.07 19.13 0.060 UCL Range Violation - B
19.28 0.070 19.16 19.27 19.21 0.110
19.281 0.151 Average = 19.252 0.114
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.500
19.400
Average
19.300
19.200
19.100
19.000
18.900
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.170 19.190 19.147
0EX65002519030592T00026
19.367 19.260 19.173
0EX6500251903059320006E
19.383 19.350 19.327
0EX65002519030593200073
19.330 19.373 19.367
0EX65002519030593200076
19.257 19.303 19.280
0EX650025190305932000A2
19.203 19.180 19.267
0EX650025190305932000CD
19.377 19.353 19.373
0EX65002519030593200166
19.323 19.360 19.287
0EX6500251903059320018F
19.190 19.187 19.090
0EX6500251903059320019A
19.210 19.257 19.213
control limit
9 10
Part Name: 613376 USL = 21.5
Dimension: 5180 OFDM-54 NON_HT BW-20 TX2 LSL = 17.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.120 0.180 0.130 0.261
0EX65002519030592T00026
0.070 0.270 0.050 0.261
0EX6500251903059320006E
0.080 0.130 0.010 0.261
0EX65002519030593200073
0.020 0.020 0.020 0.261
0EX65002519030593200076
0.120 0.030 0.090 0.261
0EX650025190305932000A2
0.110 0.040 0.070 0.261
0EX650025190305932000CD
0.040 0.150 0.130 0.261
0EX65002519030593200166
0.130 0.030 0.090 0.261
0EX6500251903059320018F
0.160 0.090 0.120 0.261
0EX6500251903059320019A
0.120 0.200 0.210 0.261
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.5 0.180 19.4 19.53 19.49 0.130
19.57 0.270 19.75 19.7 19.71 0.050 UCL Range Violation - B
19.8 0.130 19.72 19.73 19.73 0.010
19.66 0.020 19.64 19.63 19.65 0.020
19.74 0.030 19.74 19.65 19.73 0.090
19.63 0.040 19.46 19.5 19.53 0.070
19.6 0.150 19.76 19.65 19.63 0.130
19.68 0.030 19.72 19.63 19.71 0.090
19.71 0.090 19.63 19.67 19.55 0.120
19.66 0.200 19.54 19.48 19.69 0.210
19.638 0.114 Average = 19.632 0.092
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.800
19.700
Average
19.600
19.500
19.400
19.300
19.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.437 19.427 19.473
0EX65002519030592T00026
19.663 19.683 19.720
0EX6500251903059320006E
19.687 19.720 19.727
0EX65002519030593200073
19.557 19.650 19.640
0EX65002519030593200076
19.743 19.743 19.707
0EX650025190305932000A2
19.530 19.607 19.497
0EX650025190305932000CD
19.603 19.623 19.680
0EX65002519030593200166
19.660 19.670 19.687
0EX6500251903059320018F
19.710 19.673 19.617
0EX6500251903059320019A
19.523 19.587 19.570
control limit
9 10
Part Name: 613376 USL = 21.5
Dimension: 5180 OFDM-54 NON_HT BW-20 TX3 LSL = 17.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.110 0.100 0.110 0.341
0EX65002519030592T00026
0.090 0.130 0.050 0.341
0EX6500251903059320006E
0.070 0.020 0.270 0.341
0EX65002519030593200073
0.250 0.120 0.100 0.341
0EX65002519030593200076
0.140 0.040 0.150 0.341
0EX650025190305932000A2
0.120 0.150 0.160 0.341
0EX650025190305932000CD
0.310 0.020 0.160 0.341
0EX65002519030593200166
0.060 0.160 0.200 0.341
0EX6500251903059320018F
0.120 0.080 0.220 0.341
0EX6500251903059320019A
0.070 0.130 0.260 0.341
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.54 0.100 19.43 19.45 19.54 0.110
19.81 0.130 19.72 19.71 19.76 0.050
19.72 0.020 19.48 19.75 19.73 0.270
19.82 0.120 19.82 19.77 19.87 0.100
19.98 0.040 19.93 19.81 19.96 0.150
19.6 0.150 19.72 19.69 19.85 0.160
19.62 0.020 19.65 19.74 19.58 0.160
19.69 0.160 19.76 19.76 19.56 0.200
19.61 0.080 19.59 19.47 19.69 0.220
19.67 0.130 19.93 19.72 19.98 0.260
19.698 0.095 Average = 19.714 0.168
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.100
20.000
Average
19.900
19.800
19.700
19.600
19.500
19.400
19.300
19.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.513 19.540 19.473
0EX65002519030592T00026
19.880 19.787 19.730
0EX6500251903059320006E
19.697 19.713 19.653
0EX65002519030593200073
19.680 19.750 19.820
0EX65002519030593200076
19.913 19.967 19.900
0EX650025190305932000A2
19.663 19.690 19.753
0EX650025190305932000CD
19.727 19.610 19.657
0EX65002519030593200166
19.817 19.657 19.693
0EX6500251903059320018F
19.570 19.610 19.583
0EX6500251903059320019A
19.603 19.653 19.877
control limit
9 10
Part Name: 613376 USL = 21.5
Dimension: 5180 OFDM-54 NON_HT BW-20 TX4 LSL = 17.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.080 0.190 0.180 0.383
0EX65002519030592T00026
0.090 0.380 0.240 0.383
0EX6500251903059320006E
0.090 0.130 0.240 0.383
0EX65002519030593200073
0.110 0.010 0.170 0.383
0EX65002519030593200076
0.180 0.160 0.030 0.383
0EX650025190305932000A2
0.120 0.130 0.120 0.383
0EX650025190305932000CD
0.040 0.180 0.080 0.383
0EX65002519030593200166
0.100 0.200 0.090 0.383
0EX6500251903059320018F
0.170 0.040 0.140 0.383
0EX6500251903059320019A
0.140 0.300 0.320 0.383
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.45 0.190 19.64 19.46 19.53 0.180
19.92 0.380 19.63 19.73 19.87 0.240
19.84 0.130 20.09 19.85 19.87 0.240
19.7 0.010 19.76 19.59 19.64 0.170
19.81 0.160 19.76 19.76 19.79 0.030
19.72 0.130 19.8 19.9 19.78 0.120
19.73 0.180 19.66 19.7 19.74 0.080
19.59 0.200 19.61 19.7 19.61 0.090
19.61 0.040 19.69 19.55 19.57 0.140
19.45 0.300 19.63 19.57 19.31 0.320
19.689 0.172 Average = 19.693 0.161
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.000
19.900
Average
19.800
19.700
19.600
19.500
19.400
19.300
19.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.547 19.537 19.543
0EX65002519030592T00026
19.810 19.720 19.743
0EX6500251903059320006E
19.860 19.793 19.937
0EX65002519030593200073
19.600 19.707 19.663
0EX65002519030593200076
19.753 19.763 19.770
0EX650025190305932000A2
19.870 19.787 19.827
0EX650025190305932000CD
19.680 19.710 19.700
0EX65002519030593200166
19.580 19.707 19.640
0EX6500251903059320018F
19.630 19.587 19.603
0EX6500251903059320019A
19.530 19.577 19.503
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 5500 OFDM-54 NON_HT BW-20 TX1 LSL = 17
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.170 0.180 0.080 0.415
0EX65002519030592T00026
0.160 0.060 0.170 0.415
0EX6500251903059320006E
0.260 0.200 0.070 0.415
0EX65002519030593200073
0.210 0.170 0.280 0.415
0EX65002519030593200076
0.280 0.080 0.160 0.415
0EX650025190305932000A2
0.260 0.380 0.090 0.415
0EX650025190305932000CD
0.250 0.040 0.090 0.415
0EX65002519030593200166
0.160 0.240 0.160 0.415
0EX6500251903059320018F
0.080 0.100 0.160 0.415
0EX6500251903059320019A
0.150 0.050 0.090 0.415
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.97 0.180 18.88 18.93 18.85 0.080
19.13 0.060 19.32 19.23 19.15 0.170
18.95 0.200 19.02 19.02 18.95 0.070
19.02 0.170 19.4 19.12 19.2 0.280
19.06 0.080 19.23 19.07 19.12 0.160
18.8 0.380 19.02 19.04 18.95 0.090
19.14 0.040 19.09 19 19.08 0.090
19.13 0.240 19.14 19.22 19.06 0.160
18.87 0.100 18.99 18.83 18.97 0.160
18.94 0.050 19.03 19.03 19.12 0.090
19.025 0.150 Average = 19.069 0.135
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.400
19.300
Average
19.200
19.100
19.000
18.900
18.800
18.700
18.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.870 18.867 18.887
0EX65002519030592T00026
19.283 19.153 19.233
0EX6500251903059320006E
18.913 18.937 18.997
0EX65002519030593200073
18.920 19.077 19.240
0EX65002519030593200076
19.087 19.100 19.140
0EX650025190305932000A2
18.943 18.970 19.003
0EX650025190305932000CD
19.173 19.147 19.057
0EX65002519030593200166
19.170 19.110 19.140
0EX6500251903059320018F
18.873 18.937 18.930
0EX6500251903059320019A
18.923 18.957 19.060
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 5500 OFDM-54 NON_HT BW-20 TX2 LSL = 17
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.210 0.060 0.140 0.303
0EX65002519030592T00026
0.050 0.040 0.200 0.303
0EX6500251903059320006E
0.160 0.080 0.070 0.303
0EX65002519030593200073
0.200 0.010 0.190 0.303
0EX65002519030593200076
0.070 0.080 0.060 0.303
0EX650025190305932000A2
0.000 0.060 0.040 0.303
0EX650025190305932000CD
0.060 0.080 0.230 0.303
0EX65002519030593200166
0.120 0.080 0.230 0.303
0EX6500251903059320018F
0.280 0.070 0.190 0.303
0EX6500251903059320019A
0.120 0.150 0.190 0.303
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.02 0.060 18.93 18.97 19.07 0.140
19.22 0.040 19.25 19.45 19.3 0.200
19.09 0.080 19.16 19.12 19.19 0.070
19.21 0.010 19.13 19.32 19.2 0.190
19.36 0.080 19.38 19.32 19.34 0.060
19.09 0.060 19.11 19.1 19.07 0.040
19.23 0.080 19.34 19.31 19.11 0.230
19.19 0.080 19.38 19.24 19.15 0.230
19.07 0.070 19.04 19.17 19.23 0.190
19.13 0.150 18.97 19.1 19.16 0.190
19.166 0.071 Average = 19.187 0.154
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.400
19.300
Average
19.200
19.100
19.000
18.900
18.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.057 19.047 18.990
0EX65002519030592T00026
19.290 19.227 19.333
0EX6500251903059320006E
19.193 19.137 19.157
0EX65002519030593200073
19.263 19.203 19.217
0EX65002519030593200076
19.327 19.333 19.347
0EX650025190305932000A2
19.120 19.060 19.093
0EX650025190305932000CD
19.307 19.260 19.253
0EX65002519030593200166
19.190 19.223 19.257
0EX6500251903059320018F
19.153 19.107 19.147
0EX6500251903059320019A
19.120 19.060 19.077
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 5500 OFDM-54 NON_HT BW-20 TX3 LSL = 17
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.050 0.090 0.100 0.318
0EX65002519030592T00026
0.030 0.040 0.060 0.318
0EX6500251903059320006E
0.070 0.170 0.150 0.318
0EX65002519030593200073
0.100 0.090 0.070 0.318
0EX65002519030593200076
0.110 0.050 0.050 0.318
0EX650025190305932000A2
0.150 0.130 0.110 0.318
0EX650025190305932000CD
0.310 0.150 0.020 0.318
0EX65002519030593200166
0.060 0.270 0.210 0.318
0EX6500251903059320018F
0.220 0.040 0.280 0.318
0EX6500251903059320019A
0.130 0.220 0.170 0.318
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.21 0.090 19.24 19.14 19.16 0.100
19.34 0.040 19.39 19.33 19.37 0.060
19 0.170 18.93 18.97 19.08 0.150
19.19 0.090 19.22 19.18 19.25 0.070
19.31 0.050 19.22 19.19 19.24 0.050
19.13 0.130 19.06 19.13 19.02 0.110
18.96 0.150 19.08 19.09 19.1 0.020
19.16 0.270 19.15 19.02 19.23 0.210
18.98 0.040 18.84 19.12 19.04 0.280
19.3 0.220 19.06 19.21 19.23 0.170
19.138 0.125 Average = 19.143 0.122
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.500
19.400
Average
19.300
19.200
19.100
19.000
18.900
18.800
18.700
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.150 19.213 19.180
0EX65002519030592T00026
19.397 19.347 19.363
0EX6500251903059320006E
19.000 19.010 18.993
0EX65002519030593200073
19.120 19.207 19.217
0EX65002519030593200076
19.207 19.290 19.217
0EX650025190305932000A2
19.007 19.073 19.070
0EX650025190305932000CD
19.110 19.020 19.090
0EX65002519030593200166
19.150 19.063 19.133
0EX6500251903059320018F
18.953 19.000 19.000
0EX6500251903059320019A
19.107 19.160 19.167
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 5500 OFDM-54 NON_HT BW-20 TX4 LSL = 17
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.100 0.430 0.090 0.291
0EX65002519030592T00026
0.060 0.140 0.060 0.291
0EX6500251903059320006E
0.100 0.150 0.070 0.291
0EX65002519030593200073
0.020 0.150 0.070 0.291
0EX65002519030593200076
0.130 0.180 0.090 0.291
0EX650025190305932000A2
0.120 0.040 0.090 0.291
0EX650025190305932000CD
0.060 0.140 0.030 0.291
0EX65002519030593200166
0.140 0.200 0.020 0.291
0EX6500251903059320018F
0.090 0.120 0.070 0.291
0EX6500251903059320019A
0.150 0.020 0.250 0.291
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.37 0.430 19.5 19.5 19.41 0.090 UCL Range Violation - B
19.86 0.140 19.92 19.87 19.86 0.060
19.78 0.150 19.81 19.84 19.77 0.070
19.66 0.150 19.5 19.57 19.51 0.070
19.94 0.180 19.83 19.92 19.87 0.090
19.69 0.040 19.74 19.65 19.67 0.090
19.72 0.140 19.76 19.76 19.79 0.030
19.79 0.200 19.67 19.69 19.69 0.020
19.42 0.120 19.37 19.44 19.37 0.070
19.65 0.020 19.51 19.76 19.53 0.250
19.694 0.157 Average = 19.669 0.084
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.200
20.000
Average
19.800
19.600
19.400
19.200
19.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.370 19.547 19.470
0EX65002519030592T00026
19.963 19.940 19.883
0EX6500251903059320006E
19.840 19.763 19.807
0EX65002519030593200073
19.570 19.580 19.527
0EX65002519030593200076
19.900 19.867 19.873
0EX650025190305932000A2
19.757 19.713 19.687
0EX650025190305932000CD
19.747 19.780 19.770
0EX65002519030593200166
19.690 19.683 19.683
0EX6500251903059320018F
19.473 19.427 19.393
0EX6500251903059320019A
19.617 19.643 19.600
control limit
9 10
Part Name: 613376 USL = 21.5
Dimension: 5825 OFDM-54 NON_HT BW-20 TX1 LSL = 17.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.160 0.020 0.240 0.337
0EX65002519030592T00026
0.060 0.280 0.100 0.337
0EX6500251903059320006E
0.070 0.130 0.100 0.337
0EX65002519030593200073
0.080 0.100 0.110 0.337
0EX65002519030593200076
0.140 0.020 0.120 0.337
0EX650025190305932000A2
0.250 0.130 0.170 0.337
0EX650025190305932000CD
0.110 0.120 0.050 0.337
0EX65002519030593200166
0.150 0.060 0.150 0.337
0EX6500251903059320018F
0.260 0.200 0.060 0.337
0EX6500251903059320019A
0.200 0.140 0.140 0.337
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.68 0.020 19.55 19.79 19.66 0.240
20.41 0.280 20.51 20.41 20.41 0.100
19.71 0.130 19.68 19.58 19.68 0.100
19.95 0.100 20.05 20.03 20.14 0.110
20.24 0.020 20.24 20.29 20.17 0.120
19.9 0.130 19.97 19.8 19.91 0.170
20.27 0.120 20.27 20.3 20.25 0.050
20.03 0.060 20.04 19.99 20.14 0.150
19.86 0.200 19.77 19.72 19.78 0.060
19.68 0.140 19.76 19.62 19.73 0.140
19.962 0.120 Average = 19.975 0.124
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.600
20.400
Average
20.200
20.000
19.800
19.600
19.400
19.200
19.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.623 19.693 19.667
0EX65002519030592T00026
20.370 20.470 20.443
0EX6500251903059320006E
19.613 19.653 19.647
0EX65002519030593200073
20.020 19.993 20.073
0EX65002519030593200076
20.217 20.247 20.233
0EX650025190305932000A2
19.787 19.863 19.893
0EX650025190305932000CD
20.210 20.257 20.273
0EX65002519030593200166
19.940 20.060 20.057
0EX6500251903059320018F
19.663 19.770 19.757
0EX6500251903059320019A
19.590 19.610 19.703
control limit
9 10
Part Name: 613376 USL = 21.5
Dimension: 5825 OFDM-54 NON_HT BW-20 TX2 LSL = 17.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.150 0.160 0.100 0.285
0EX65002519030592T00026
0.080 0.060 0.230 0.285
0EX6500251903059320006E
0.080 0.210 0.040 0.285
0EX65002519030593200073
0.220 0.110 0.080 0.285
0EX65002519030593200076
0.130 0.200 0.070 0.285
0EX650025190305932000A2
0.070 0.090 0.060 0.285
0EX650025190305932000CD
0.190 0.040 0.140 0.285
0EX65002519030593200166
0.140 0.100 0.050 0.285
0EX6500251903059320018F
0.090 0.070 0.120 0.285
0EX6500251903059320019A
0.040 0.140 0.050 0.285
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.39 0.160 19.44 19.35 19.45 0.100
19.64 0.060 19.7 19.47 19.63 0.230
19.45 0.210 19.55 19.51 19.55 0.040
19.51 0.110 19.52 19.58 19.5 0.080
19.69 0.200 19.53 19.54 19.47 0.070
19.47 0.090 19.52 19.58 19.55 0.060
19.53 0.040 19.54 19.52 19.66 0.140
19.54 0.100 19.61 19.56 19.59 0.050
19.58 0.070 19.5 19.62 19.57 0.120
19.51 0.140 19.48 19.43 19.44 0.050
19.518 0.118 Average = 19.532 0.094
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.650
19.600
Average
19.550
19.500
19.450
19.400
19.350
19.300
19.250
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.403 19.437 19.413
0EX65002519030592T00026
19.553 19.613 19.600
0EX6500251903059320006E
19.523 19.550 19.537
0EX65002519030593200073
19.550 19.460 19.533
0EX65002519030593200076
19.583 19.573 19.513
0EX650025190305932000A2
19.510 19.523 19.550
0EX650025190305932000CD
19.537 19.507 19.573
0EX65002519030593200166
19.567 19.527 19.587
0EX6500251903059320018F
19.613 19.550 19.563
0EX6500251903059320019A
19.430 19.437 19.450
control limit
9 10
Part Name: 613376 USL = 21.5
Dimension: 5825 OFDM-54 NON_HT BW-20 TX3 LSL = 17.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.110 0.100 0.304
0EX65002519030592T00026
0.160 0.070 0.050 0.304
0EX6500251903059320006E
0.130 0.120 0.050 0.304
0EX65002519030593200073
0.120 0.050 0.160 0.304
0EX65002519030593200076
0.100 0.080 0.080 0.304
0EX650025190305932000A2
0.080 0.160 0.250 0.304
0EX650025190305932000CD
0.140 0.160 0.130 0.304
0EX65002519030593200166
0.030 0.090 0.120 0.304
0EX6500251903059320018F
0.120 0.120 0.230 0.304
0EX6500251903059320019A
0.090 0.220 0.090 0.304
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.63 0.110 19.56 19.57 19.47 0.100
19.78 0.070 19.76 19.72 19.77 0.050
19.5 0.120 19.51 19.51 19.46 0.050
19.63 0.050 19.7 19.55 19.71 0.160
19.89 0.080 19.82 19.8 19.88 0.080
19.55 0.160 19.41 19.36 19.61 0.250
19.58 0.160 19.61 19.51 19.64 0.130
19.73 0.090 19.64 19.7 19.76 0.120
19.48 0.120 19.5 19.65 19.42 0.230
19.68 0.220 19.65 19.71 19.74 0.090
19.629 0.118 Average = 19.623 0.126
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.000
19.900
Average
19.800
19.700
19.600
19.500
19.400
19.300
19.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.587 19.560 19.533
0EX65002519030592T00026
19.747 19.763 19.750
0EX6500251903059320006E
19.533 19.513 19.493
0EX65002519030593200073
19.647 19.603 19.653
0EX65002519030593200076
19.873 19.860 19.833
0EX650025190305932000A2
19.453 19.463 19.460
0EX650025190305932000CD
19.650 19.673 19.587
0EX65002519030593200166
19.757 19.700 19.700
0EX6500251903059320018F
19.507 19.453 19.523
0EX6500251903059320019A
19.713 19.700 19.700
control limit
9 10
Part Name: 613376 USL = 21.5
Dimension: 5825 OFDM-54 NON_HT BW-20 TX4 LSL = 17.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.140
0.120
0.100
0.080
0.060
0.040
0.020
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.190 0.070 0.120 0.263
0EX65002519030592T00026
0.150 0.170 0.120 0.263
0EX6500251903059320006E
0.090 0.100 0.090 0.263
0EX65002519030593200073
0.080 0.090 0.130 0.263
0EX65002519030593200076
0.070 0.110 0.070 0.263
0EX650025190305932000A2
0.100 0.110 0.150 0.263
0EX650025190305932000CD
0.080 0.090 0.170 0.263
0EX65002519030593200166
0.040 0.040 0.070 0.263
0EX6500251903059320018F
0.170 0.060 0.040 0.263
0EX6500251903059320019A
0.150 0.090 0.050 0.263
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
19.44 0.070 19.54 19.43 19.55 0.120
19.77 0.170 19.61 19.73 19.72 0.120
19.51 0.100 19.5 19.48 19.57 0.090
19.49 0.090 19.5 19.56 19.43 0.130
19.61 0.110 19.59 19.52 19.54 0.070
19.5 0.110 19.52 19.65 19.5 0.150
19.77 0.090 19.77 19.68 19.6 0.170
19.7 0.040 19.58 19.51 19.53 0.070
19.62 0.060 19.49 19.51 19.53 0.040
19.55 0.090 19.48 19.43 19.46 0.050
19.587 0.093 Average = 19.550 0.101
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.800
19.700
Average
19.600
19.500
19.400
19.300
19.200
19.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
19.373 19.407 19.507
0EX65002519030592T00026
19.593 19.703 19.687
0EX6500251903059320006E
19.573 19.567 19.517
0EX65002519030593200073
19.580 19.520 19.497
0EX65002519030593200076
19.623 19.620 19.550
0EX650025190305932000A2
19.543 19.553 19.557
0EX650025190305932000CD
19.627 19.730 19.683
0EX65002519030593200166
19.647 19.680 19.540
0EX6500251903059320018F
19.553 19.597 19.510
0EX6500251903059320019A
19.530 19.497 19.457
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5180 MCS0 HT_MF BW-20 TX1 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.070 0.130 0.100 0.369
0EX65002519030592T00026
0.160 0.090 0.050 0.369
0EX6500251903059320006E
0.360 0.140 0.030 0.369
0EX65002519030593200073
0.330 0.110 0.310 0.369
0EX65002519030593200076
0.110 0.110 0.200 0.369
0EX650025190305932000A2
0.110 0.050 0.240 0.369
0EX650025190305932000CD
0.280 0.080 0.180 0.369
0EX65002519030593200166
0.160 0.230 0.010 0.369
0EX6500251903059320018F
0.050 0.200 0.030 0.369
0EX6500251903059320019A
0.070 0.060 0.240 0.369
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.64 0.130 22.5 22.48 22.58 0.100
22.62 0.090 22.67 22.62 22.63 0.050
22.7 0.140 22.73 22.73 22.7 0.030
22.72 0.110 22.6 22.81 22.91 0.310
22.62 0.110 22.55 22.69 22.75 0.200
22.5 0.050 22.79 22.74 22.55 0.240
22.86 0.080 22.91 22.73 22.79 0.180
22.44 0.230 22.59 22.59 22.6 0.010
22.56 0.200 22.59 22.59 22.62 0.030
22.63 0.060 22.63 22.78 22.54 0.240
22.639 0.120 Average = 22.666 0.139
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.850
22.800
Average
22.750
22.700
22.650
22.600
22.550
22.500
22.450
22.400
22.350
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.627 22.557 22.520
0EX65002519030592T00026
22.690 22.590 22.640
0EX6500251903059320006E
22.770 22.693 22.720
0EX65002519030593200073
22.700 22.710 22.773
0EX65002519030593200076
22.643 22.637 22.663
0EX650025190305932000A2
22.590 22.517 22.693
0EX650025190305932000CD
22.757 22.810 22.810
0EX65002519030593200166
22.620 22.557 22.593
0EX6500251903059320018F
22.600 22.673 22.600
0EX6500251903059320019A
22.503 22.650 22.650
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5180 MCS0 HT_MF BW-20 TX2 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.170 0.020 0.253
0EX65002519030592T00026
0.090 0.140 0.090 0.253
0EX6500251903059320006E
0.090 0.250 0.100 0.253
0EX65002519030593200073
0.120 0.080 0.040 0.253
0EX65002519030593200076
0.160 0.170 0.030 0.253
0EX650025190305932000A2
0.020 0.170 0.000 0.253
0EX650025190305932000CD
0.150 0.120 0.070 0.253
0EX65002519030593200166
0.130 0.010 0.100 0.253
0EX6500251903059320018F
0.010 0.100 0.140 0.253
0EX6500251903059320019A
0.060 0.100 0.080 0.253
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.89 0.170 22.87 22.85 22.85 0.020
22.92 0.140 23.02 22.99 23.08 0.090
23.27 0.250 23.02 23.03 23.12 0.100
23.15 0.080 23.02 23.04 23.06 0.040
23.22 0.170 23.15 23.12 23.14 0.030
22.96 0.170 22.95 22.95 22.95 0.000
23.01 0.120 23.05 23 22.98 0.070
22.95 0.010 22.94 22.95 23.04 0.100
23.21 0.100 23.07 23.21 23.2 0.140
23.06 0.100 23.07 22.99 23.05 0.080
23.041 0.131 Average = 23.025 0.067
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.300
23.200
Average
23.100
23.000
22.900
22.800
22.700
22.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.807 22.820 22.857
0EX65002519030592T00026
22.973 22.947 23.030
0EX6500251903059320006E
23.080 23.123 23.057
0EX65002519030593200073
23.063 23.113 23.040
0EX65002519030593200076
23.140 23.160 23.137
0EX650025190305932000A2
23.040 23.047 22.950
0EX650025190305932000CD
23.040 23.043 23.010
0EX65002519030593200166
22.963 22.943 22.977
0EX6500251903059320018F
23.137 23.177 23.160
0EX6500251903059320019A
22.980 23.040 23.037
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5180 MCS0 HT_MF BW-20 TX3 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.080 0.070 0.070 0.241
0EX65002519030592T00026
0.040 0.070 0.110 0.241
0EX6500251903059320006E
0.090 0.090 0.140 0.241
0EX65002519030593200073
0.100 0.140 0.110 0.241
0EX65002519030593200076
0.240 0.110 0.090 0.241
0EX650025190305932000A2
0.090 0.100 0.070 0.241
0EX650025190305932000CD
0.100 0.130 0.210 0.241
0EX65002519030593200166
0.010 0.090 0.030 0.241
0EX6500251903059320018F
0.120 0.050 0.060 0.241
0EX6500251903059320019A
0.060 0.040 0.090 0.241
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.68 0.070 22.62 22.62 22.69 0.070
23.04 0.070 23.04 22.93 23.03 0.110
23.02 0.090 22.84 22.93 22.98 0.140
23.16 0.140 23.23 23.13 23.12 0.110
23.03 0.110 23.13 23.04 23.06 0.090
22.93 0.100 22.97 22.9 22.94 0.070
22.93 0.130 22.92 23.03 22.82 0.210
23.05 0.090 23.07 23.04 23.07 0.030
22.94 0.050 22.9 22.91 22.96 0.060
23.04 0.040 23.14 23.05 23.14 0.090
22.979 0.089 Average = 22.975 0.098
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.300
23.200
Average
23.100
23.000
22.900
22.800
22.700
22.600
22.500
22.400
22.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.720 22.717 22.643
0EX65002519030592T00026
23.020 23.063 23.000
0EX6500251903059320006E
22.987 22.970 22.917
0EX65002519030593200073
23.157 23.147 23.160
0EX65002519030593200076
23.133 23.073 23.077
0EX650025190305932000A2
22.940 22.977 22.937
0EX650025190305932000CD
22.957 22.847 22.923
0EX65002519030593200166
23.047 23.010 23.060
0EX6500251903059320018F
22.950 22.967 22.923
0EX6500251903059320019A
23.020 23.020 23.110
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5180 MCS0 HT_MF BW-20 TX4 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.180 0.070 0.080 0.265
0EX65002519030592T00026
0.040 0.120 0.140 0.265
0EX6500251903059320006E
0.170 0.030 0.150 0.265
0EX65002519030593200073
0.080 0.020 0.130 0.265
0EX65002519030593200076
0.110 0.200 0.150 0.265
0EX650025190305932000A2
0.090 0.130 0.090 0.265
0EX650025190305932000CD
0.080 0.060 0.070 0.265
0EX65002519030593200166
0.150 0.040 0.080 0.265
0EX6500251903059320018F
0.060 0.130 0.160 0.265
0EX6500251903059320019A
0.090 0.080 0.100 0.265
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.79 0.070 22.78 22.71 22.79 0.080
23.04 0.120 22.92 23 23.06 0.140
23.06 0.030 23.16 23.01 23.11 0.150
22.97 0.020 22.88 22.8 22.93 0.130
22.93 0.200 23.03 23.18 23.04 0.150
22.92 0.130 22.98 23.06 23.07 0.090
22.92 0.060 22.91 22.88 22.95 0.070
22.92 0.040 22.97 22.89 22.89 0.080
22.8 0.130 22.84 22.86 22.7 0.160
22.9 0.080 22.87 22.9 22.8 0.100
22.934 0.088 Average = 22.932 0.115
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.200
23.100
Average
23.000
22.900
22.800
22.700
22.600
22.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.800 22.780 22.760
0EX65002519030592T00026
22.950 22.967 22.993
0EX6500251903059320006E
23.083 23.047 23.093
0EX65002519030593200073
22.920 22.977 22.870
0EX65002519030593200076
23.063 23.030 23.083
0EX650025190305932000A2
22.983 22.983 23.037
0EX650025190305932000CD
22.940 22.950 22.913
0EX65002519030593200166
22.920 22.920 22.917
0EX6500251903059320018F
22.853 22.790 22.800
0EX6500251903059320019A
22.883 22.900 22.857
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5500 MCS0 HT_MF BW-20 TX1 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.220 0.080 0.110 0.333
0EX65002519030592T00026
0.050 0.140 0.190 0.333
0EX6500251903059320006E
0.110 0.120 0.020 0.333
0EX65002519030593200073
0.120 0.140 0.230 0.333
0EX65002519030593200076
0.150 0.230 0.120 0.333
0EX650025190305932000A2
0.120 0.310 0.170 0.333
0EX650025190305932000CD
0.090 0.070 0.060 0.333
0EX65002519030593200166
0.040 0.150 0.160 0.333
0EX6500251903059320018F
0.110 0.160 0.090 0.333
0EX6500251903059320019A
0.120 0.120 0.070 0.333
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.9 0.080 22.87 22.79 22.9 0.110
23.2 0.140 23.1 23.2 23.01 0.190
22.86 0.120 22.86 22.88 22.86 0.020
23.12 0.140 23.23 23 23.06 0.230
22.95 0.230 23.11 23.01 22.99 0.120
22.74 0.310 22.98 22.95 22.81 0.170
23.01 0.070 23.01 23.04 23.07 0.060
22.92 0.150 23.11 23.06 22.95 0.160
22.81 0.160 22.89 22.81 22.8 0.090
22.98 0.120 22.97 23 22.93 0.070
22.971 0.152 Average = 22.975 0.122
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.300
23.200
Average
23.100
23.000
22.900
22.800
22.700
22.600
22.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.870 22.867 22.853
0EX65002519030592T00026
23.240 23.213 23.103
0EX6500251903059320006E
22.900 22.783 22.867
0EX65002519030593200073
22.917 23.060 23.097
0EX65002519030593200076
23.030 23.073 23.037
0EX650025190305932000A2
22.877 22.913 22.913
0EX650025190305932000CD
23.030 23.043 23.040
0EX65002519030593200166
22.910 22.963 23.040
0EX6500251903059320018F
22.797 22.890 22.833
0EX6500251903059320019A
22.790 22.907 22.967
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5500 MCS0 HT_MF BW-20 TX2 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.110 0.040 0.170 0.290
0EX65002519030592T00026
0.270 0.100 0.290 0.290
0EX6500251903059320006E
0.070 0.040 0.050 0.290
0EX65002519030593200073
0.040 0.130 0.090 0.290
0EX65002519030593200076
0.160 0.100 0.100 0.290
0EX650025190305932000A2
0.060 0.200 0.120 0.290
0EX650025190305932000CD
0.070 0.080 0.160 0.290
0EX65002519030593200166
0.050 0.040 0.110 0.290
0EX6500251903059320018F
0.180 0.120 0.030 0.290
0EX6500251903059320019A
0.060 0.130 0.200 0.290
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.82 0.040 22.8 22.85 22.97 0.170
23.09 0.100 22.98 23.27 23.12 0.290 UCL Range Violation - C
22.92 0.040 22.9 22.92 22.95 0.050
22.96 0.130 22.94 23.02 23.03 0.090
23.03 0.100 23.13 23.13 23.03 0.100
23.03 0.200 23.02 22.9 23.02 0.120
23.04 0.080 23.09 23.12 22.96 0.160
23.09 0.040 23.11 23.18 23.07 0.110
22.92 0.120 22.91 22.92 22.94 0.030
22.96 0.130 22.74 22.94 22.87 0.200
22.973 0.098 Average = 22.994 0.132
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.200
23.100
Average
23.000
22.900
22.800
22.700
22.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.933 22.797 22.873
0EX65002519030592T00026
23.137 23.133 23.123
0EX6500251903059320006E
22.993 22.907 22.923
0EX65002519030593200073
23.023 22.970 22.997
0EX65002519030593200076
23.113 23.090 23.097
0EX650025190305932000A2
22.917 22.940 22.980
0EX650025190305932000CD
23.093 23.070 23.057
0EX65002519030593200166
23.057 23.073 23.120
0EX6500251903059320018F
22.903 22.860 22.923
0EX6500251903059320019A
22.937 22.890 22.850
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5500 MCS0 HT_MF BW-20 TX3 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.010 0.140 0.080 0.215
0EX65002519030592T00026
0.140 0.030 0.120 0.215
0EX6500251903059320006E
0.080 0.030 0.030 0.215
0EX65002519030593200073
0.020 0.000 0.090 0.215
0EX65002519030593200076
0.110 0.110 0.100 0.215
0EX650025190305932000A2
0.210 0.030 0.070 0.215
0EX650025190305932000CD
0.050 0.150 0.040 0.215
0EX65002519030593200166
0.180 0.240 0.120 0.215
0EX6500251903059320018F
0.120 0.080 0.040 0.215
0EX6500251903059320019A
0.060 0.010 0.010 0.215
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
23.17 0.140 23.11 23.16 23.19 0.080
22.99 0.030 22.97 23.09 23 0.120
22.86 0.030 22.87 22.87 22.9 0.030
23.1 0.000 23.11 23.09 23.02 0.090
23.19 0.110 23 23.1 23.01 0.100
22.88 0.030 22.78 22.81 22.85 0.070
22.88 0.150 22.95 22.91 22.92 0.040
23.04 0.240 23.06 22.97 22.94 0.120 UCL Range Violation - B
22.92 0.080 22.79 22.79 22.83 0.040
22.94 0.010 22.99 22.98 22.99 0.010
22.984 0.082 Average = 22.968 0.070
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.200
23.100
Average
23.000
22.900
22.800
22.700
22.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
23.103 23.150 23.153
0EX65002519030592T00026
23.070 22.993 23.020
0EX6500251903059320006E
22.880 22.863 22.880
0EX65002519030593200073
23.073 23.100 23.073
0EX65002519030593200076
23.043 23.140 23.037
0EX650025190305932000A2
22.810 22.897 22.813
0EX650025190305932000CD
22.927 22.917 22.927
0EX65002519030593200166
23.010 22.960 22.990
0EX6500251903059320018F
22.893 22.880 22.803
0EX6500251903059320019A
22.890 22.943 22.987
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5500 MCS0 HT_MF BW-20 TX4 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.030 0.210 0.030 0.260
0EX65002519030592T00026
0.040 0.100 0.100 0.260
0EX6500251903059320006E
0.150 0.040 0.120 0.260
0EX65002519030593200073
0.030 0.130 0.130 0.260
0EX65002519030593200076
0.400 0.130 0.050 0.260
0EX650025190305932000A2
0.090 0.020 0.060 0.260
0EX650025190305932000CD
0.020 0.050 0.060 0.260
0EX65002519030593200166
0.140 0.120 0.040 0.260
0EX6500251903059320018F
0.140 0.110 0.060 0.260
0EX6500251903059320019A
0.120 0.150 0.150 0.260
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
23.17 0.210 23.29 23.3 23.27 0.030
23.83 0.100 23.71 23.7 23.8 0.100
23.39 0.040 23.37 23.48 23.49 0.120
23.49 0.130 23.4 23.5 23.53 0.130
23.74 0.130 23.68 23.68 23.73 0.050 UCL Range Violation - A
23.56 0.020 23.53 23.49 23.55 0.060
23.6 0.050 23.61 23.56 23.55 0.060
23.64 0.120 23.53 23.57 23.53 0.040
23.35 0.110 23.18 23.23 23.24 0.060
23.49 0.150 23.51 23.47 23.36 0.150
23.510 0.106 Average = 23.495 0.080
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
24.000
23.800
Average
23.600
23.400
23.200
23.000
22.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
23.190 23.260 23.287
0EX65002519030592T00026
23.873 23.837 23.737
0EX6500251903059320006E
23.440 23.417 23.447
0EX65002519030593200073
23.437 23.420 23.477
0EX65002519030593200076
23.657 23.680 23.697
0EX650025190305932000A2
23.613 23.550 23.523
0EX650025190305932000CD
23.530 23.633 23.573
0EX65002519030593200166
23.620 23.590 23.543
0EX6500251903059320018F
23.243 23.277 23.217
0EX6500251903059320019A
23.420 23.433 23.447
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5825 MCS0 HT_MF BW-20 TX1 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.600
Range
0.500
0.400
0.300
0.200
0.100
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.130 0.210 0.324
0EX65002519030592T00026
0.050 0.200 0.020 0.324
0EX6500251903059320006E
0.020 0.030 0.030 0.324
0EX65002519030593200073
0.110 0.630 0.070 0.324
0EX65002519030593200076
0.040 0.060 0.050 0.324
0EX650025190305932000A2
0.060 0.140 0.180 0.324
0EX650025190305932000CD
0.040 0.090 0.070 0.324
0EX65002519030593200166
0.140 0.190 0.100 0.324
0EX6500251903059320018F
0.270 0.160 0.130 0.324
0EX6500251903059320019A
0.190 0.200 0.020 0.324
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.96 0.130 22.94 23.15 22.98 0.210
23.77 0.200 23.74 23.76 23.74 0.020
23.02 0.030 23.02 23.04 23.05 0.030
23.34 0.630 23.43 23.38 23.36 0.070 UCL Range Violation - B
23.71 0.060 23.73 23.72 23.68 0.050
23.07 0.140 23.21 23.03 23.13 0.180
23.74 0.090 23.81 23.8 23.74 0.070
23.35 0.190 23.37 23.38 23.47 0.100
23.1 0.160 23.01 23.14 23.14 0.130
23.07 0.200 22.98 22.99 23 0.020
23.332 0.183 Average = 23.331 0.088
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
24.000
23.800
Average
23.600
23.400
23.200
23.000
22.800
22.600
22.400
22.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.980 22.983 23.023
0EX65002519030592T00026
23.787 23.840 23.747
0EX6500251903059320006E
23.000 23.017 23.037
0EX65002519030593200073
23.377 23.573 23.390
0EX65002519030593200076
23.687 23.687 23.710
0EX650025190305932000A2
23.090 23.110 23.123
0EX650025190305932000CD
23.707 23.700 23.783
0EX65002519030593200166
23.373 23.423 23.407
0EX6500251903059320018F
23.037 23.033 23.097
0EX6500251903059320019A
22.880 22.957 22.990
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5825 MCS0 HT_MF BW-20 TX2 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.090 0.050 0.100 0.313
0EX65002519030592T00026
0.140 0.190 0.100 0.313
0EX6500251903059320006E
0.080 0.180 0.030 0.313
0EX65002519030593200073
0.150 0.180 0.140 0.313
0EX65002519030593200076
0.060 0.130 0.120 0.313
0EX650025190305932000A2
0.090 0.240 0.040 0.313
0EX650025190305932000CD
0.340 0.120 0.220 0.313
0EX65002519030593200166
0.080 0.120 0.060 0.313
0EX6500251903059320018F
0.120 0.080 0.190 0.313
0EX6500251903059320019A
0.150 0.020 0.030 0.313
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.98 0.050 22.94 22.84 22.91 0.100
23.06 0.190 23.05 22.95 22.99 0.100
22.79 0.180 22.89 22.9 22.92 0.030
22.95 0.180 22.88 23.02 23.01 0.140
23.04 0.130 23.04 22.94 22.92 0.120
22.83 0.240 22.95 22.96 22.99 0.040
22.93 0.120 23.03 23.02 22.81 0.220 UCL Range Violation - A
22.99 0.120 23.09 23.03 23.03 0.060
22.97 0.080 22.92 23.11 22.94 0.190
22.88 0.020 22.99 22.97 22.96 0.030
22.929 0.131 Average = 22.967 0.103
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.150
23.100
Average
23.050
23.000
22.950
22.900
22.850
22.800
22.750
22.700
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.970 22.953 22.897
0EX65002519030592T00026
22.980 22.973 22.997
0EX6500251903059320006E
22.853 22.877 22.903
0EX65002519030593200073
22.957 22.890 22.970
0EX65002519030593200076
22.967 22.970 22.967
0EX650025190305932000A2
23.083 22.990 22.967
0EX650025190305932000CD
22.923 22.853 22.953
0EX65002519030593200166
22.960 22.957 23.050
0EX6500251903059320018F
22.940 22.930 22.990
0EX6500251903059320019A
22.960 22.893 22.973
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5825 MCS0 HT_MF BW-20 TX3 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.070 0.070 0.180 0.216
0EX65002519030592T00026
0.030 0.010 0.120 0.216
0EX6500251903059320006E
0.020 0.020 0.050 0.216
0EX65002519030593200073
0.080 0.100 0.070 0.216
0EX65002519030593200076
0.060 0.020 0.120 0.216
0EX650025190305932000A2
0.010 0.060 0.080 0.216
0EX650025190305932000CD
0.110 0.100 0.120 0.216
0EX65002519030593200166
0.040 0.080 0.110 0.216
0EX6500251903059320018F
0.130 0.120 0.050 0.216
0EX6500251903059320019A
0.130 0.140 0.210 0.216
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.92 0.070 22.88 22.85 23.03 0.180
23.17 0.010 23.17 23.05 23.17 0.120
22.89 0.020 22.9 22.91 22.95 0.050
22.99 0.100 23.04 22.97 23.01 0.070
23.21 0.020 23.23 23.15 23.27 0.120
22.91 0.060 22.91 22.84 22.92 0.080
22.84 0.100 22.84 22.84 22.96 0.120
23.13 0.080 23.14 23.06 23.17 0.110
22.94 0.120 22.88 22.93 22.91 0.050
22.99 0.140 22.9 23.09 23.11 0.210
22.988 0.072 Average = 23.003 0.111
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.300
23.200
Average
23.100
23.000
22.900
22.800
22.700
22.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.970 22.880 22.920
0EX65002519030592T00026
23.133 23.163 23.130
0EX6500251903059320006E
22.870 22.897 22.920
0EX65002519030593200073
23.050 23.010 23.007
0EX65002519030593200076
23.253 23.220 23.217
0EX650025190305932000A2
22.873 22.877 22.890
0EX650025190305932000CD
22.867 22.873 22.880
0EX65002519030593200166
23.130 23.080 23.123
0EX6500251903059320018F
22.890 22.883 22.907
0EX6500251903059320019A
22.983 22.997 23.033
control limit
9 10
Part Name: 613376 USL = 24
Dimension: 5825 MCS0 HT_MF BW-20 TX4 LSL = 20
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.210 0.170 0.240 0.310
0EX65002519030592T00026
0.110 0.230 0.210 0.310
0EX6500251903059320006E
0.150 0.090 0.080 0.310
0EX65002519030593200073
0.120 0.110 0.120 0.310
0EX65002519030593200076
0.100 0.050 0.070 0.310
0EX650025190305932000A2
0.090 0.070 0.090 0.310
0EX650025190305932000CD
0.140 0.040 0.110 0.310
0EX65002519030593200166
0.100 0.100 0.080 0.310
0EX6500251903059320018F
0.230 0.070 0.210 0.310
0EX6500251903059320019A
0.070 0.120 0.030 0.310
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
22.97 0.170 22.92 22.74 22.68 0.240
23.2 0.230 22.99 23.04 23.2 0.210
22.9 0.090 22.81 22.89 22.89 0.080
22.93 0.110 23.06 23 22.94 0.120
23.07 0.050 23.06 22.99 23.02 0.070
22.95 0.070 22.97 22.94 22.88 0.090
23.12 0.040 23.14 23.1 23.03 0.110
23.12 0.100 23.02 22.99 22.94 0.080
23.01 0.070 22.71 22.92 22.76 0.210
22.84 0.120 22.91 22.88 22.88 0.030
22.996 0.105 Average = 22.943 0.124
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
23.200
23.100
Average
23.000
22.900
22.800
22.700
22.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
22.857 22.880 22.780
0EX65002519030592T00026
23.097 23.107 23.077
0EX6500251903059320006E
22.997 22.933 22.863
0EX65002519030593200073
22.887 22.980 23.000
0EX65002519030593200076
23.040 23.087 23.023
0EX650025190305932000A2
22.830 22.980 22.930
0EX650025190305932000CD
23.030 23.120 23.090
0EX65002519030593200166
23.037 23.073 22.983
0EX6500251903059320018F
22.940 22.970 22.797
0EX6500251903059320019A
22.867 22.833 22.890
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5180 MCS7 HT_MF BW-20 TX1 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.120 0.100 0.100 0.390
0EX65002519030592T00026
0.090 0.120 0.110 0.390
0EX6500251903059320006E
0.120 0.120 0.130 0.390
0EX65002519030593200073
0.130 0.350 0.290 0.390
0EX65002519030593200076
0.170 0.150 0.110 0.390
0EX650025190305932000A2
0.090 0.170 0.280 0.390
0EX650025190305932000CD
0.110 0.190 0.100 0.390
0EX65002519030593200166
0.090 0.270 0.230 0.390
0EX6500251903059320018F
0.160 0.290 0.100 0.390
0EX6500251903059320019A
0.010 0.020 0.220 0.390
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.01 0.100 18.1 18.16 18.2 0.100
18.25 0.120 18.38 18.28 18.39 0.110
18.19 0.120 18.3 18.17 18.29 0.130
18.14 0.350 18.19 18.39 18.48 0.290
18.26 0.150 18.22 18.29 18.33 0.110
18.24 0.170 18.36 18.39 18.11 0.280
18.31 0.190 18.34 18.44 18.39 0.100
18.2 0.270 18.16 18.28 18.39 0.230
18.19 0.290 18.19 18.18 18.09 0.100
18.28 0.020 18.19 18.41 18.29 0.220
18.252 0.178 Average = 18.279 0.167
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.500
18.400
Average
18.300
18.200
18.100
18.000
17.900
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.147 18.073 18.153
0EX65002519030592T00026
18.363 18.310 18.350
0EX6500251903059320006E
18.280 18.203 18.253
0EX65002519030593200073
18.210 18.283 18.353
0EX65002519030593200076
18.230 18.290 18.280
0EX650025190305932000A2
18.190 18.143 18.287
0EX650025190305932000CD
18.387 18.380 18.390
0EX65002519030593200166
18.290 18.333 18.277
0EX6500251903059320018F
18.183 18.227 18.153
0EX6500251903059320019A
18.243 18.273 18.297
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5180 MCS7 HT_MF BW-20 TX2 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.280 0.130 0.170 0.349
0EX65002519030592T00026
0.070 0.220 0.030 0.349
0EX6500251903059320006E
0.140 0.090 0.110 0.349
0EX65002519030593200073
0.120 0.030 0.050 0.349
0EX65002519030593200076
0.070 0.170 0.090 0.349
0EX650025190305932000A2
0.060 0.250 0.070 0.349
0EX650025190305932000CD
0.190 0.080 0.170 0.349
0EX65002519030593200166
0.300 0.050 0.100 0.349
0EX6500251903059320018F
0.130 0.110 0.010 0.349
0EX6500251903059320019A
0.190 0.140 0.440 0.349
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.36 0.130 18.33 18.5 18.35 0.170
18.65 0.220 18.77 18.76 18.74 0.030
18.68 0.090 18.66 18.55 18.65 0.110
18.47 0.030 18.44 18.47 18.49 0.050
18.77 0.170 18.69 18.61 18.7 0.090
18.71 0.250 18.53 18.52 18.59 0.070
18.57 0.080 18.75 18.58 18.62 0.170
18.48 0.050 18.51 18.52 18.61 0.100
18.46 0.110 18.47 18.46 18.47 0.010
18.58 0.140 18.42 18.25 18.69 0.440 UCL Range Violation - C
18.549 0.127 Average = 18.557 0.124
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.900
18.800
Average
18.700
18.600
18.500
18.400
18.300
18.200
18.100
18.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.370 18.310 18.393
0EX65002519030592T00026
18.650 18.677 18.757
0EX6500251903059320006E
18.540 18.647 18.620
0EX65002519030593200073
18.450 18.467 18.467
0EX65002519030593200076
18.703 18.773 18.667
0EX650025190305932000A2
18.577 18.560 18.547
0EX650025190305932000CD
18.523 18.543 18.650
0EX65002519030593200166
18.583 18.503 18.547
0EX6500251903059320018F
18.550 18.490 18.467
0EX6500251903059320019A
18.487 18.520 18.453
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5180 MCS7 HT_MF BW-20 TX3 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.160 0.120 0.342
0EX65002519030592T00026
0.080 0.200 0.050 0.342
0EX6500251903059320006E
0.210 0.140 0.100 0.342
0EX65002519030593200073
0.220 0.070 0.140 0.342
0EX65002519030593200076
0.160 0.050 0.150 0.342
0EX650025190305932000A2
0.130 0.090 0.240 0.342
0EX650025190305932000CD
0.290 0.110 0.130 0.342
0EX65002519030593200166
0.070 0.040 0.170 0.342
0EX6500251903059320018F
0.120 0.090 0.370 0.342
0EX6500251903059320019A
0.060 0.060 0.030 0.342
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.42 0.160 18.34 18.44 18.46 0.120
18.83 0.200 18.72 18.74 18.69 0.050
18.68 0.140 18.53 18.6 18.63 0.100
18.86 0.070 18.77 18.9 18.91 0.140
18.87 0.050 18.88 18.78 18.93 0.150
18.55 0.090 18.64 18.59 18.83 0.240
18.7 0.110 18.61 18.56 18.48 0.130
18.74 0.040 18.72 18.83 18.66 0.170
18.55 0.090 18.54 18.32 18.69 0.370 UCL Range Violation - C
18.76 0.060 18.85 18.87 18.84 0.030
18.694 0.101 Average = 18.678 0.150
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.000
18.900
Average
18.800
18.700
18.600
18.500
18.400
18.300
18.200
18.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.490 18.490 18.413
0EX65002519030592T00026
18.857 18.790 18.717
0EX6500251903059320006E
18.623 18.673 18.587
0EX65002519030593200073
18.873 18.833 18.860
0EX65002519030593200076
18.897 18.900 18.863
0EX650025190305932000A2
18.633 18.600 18.687
0EX650025190305932000CD
18.647 18.630 18.550
0EX65002519030593200166
18.787 18.727 18.737
0EX6500251903059320018F
18.627 18.573 18.517
0EX6500251903059320019A
18.657 18.723 18.853
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5180 MCS7 HT_MF BW-20 TX4 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.110 0.180 0.100 0.324
0EX65002519030592T00026
0.080 0.090 0.120 0.324
0EX6500251903059320006E
0.150 0.110 0.190 0.324
0EX65002519030593200073
0.050 0.150 0.100 0.324
0EX65002519030593200076
0.190 0.060 0.140 0.324
0EX650025190305932000A2
0.140 0.080 0.080 0.324
0EX650025190305932000CD
0.010 0.130 0.070 0.324
0EX65002519030593200166
0.120 0.140 0.280 0.324
0EX6500251903059320018F
0.230 0.070 0.220 0.324
0EX6500251903059320019A
0.150 0.190 0.040 0.324
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.34 0.180 18.49 18.51 18.41 0.100
18.83 0.090 18.7 18.82 18.78 0.120
18.79 0.110 18.91 18.72 18.87 0.190
18.66 0.150 18.71 18.62 18.61 0.100
18.76 0.060 18.72 18.86 18.85 0.140
18.73 0.080 18.8 18.79 18.72 0.080
18.75 0.130 18.79 18.84 18.77 0.070
18.71 0.140 18.59 18.87 18.75 0.280
18.56 0.070 18.74 18.52 18.56 0.220
18.62 0.190 18.63 18.62 18.59 0.040
18.686 0.120 Average = 18.705 0.134
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.900
18.800
Average
18.700
18.600
18.500
18.400
18.300
18.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.450 18.443 18.470
0EX65002519030592T00026
18.780 18.800 18.767
0EX6500251903059320006E
18.767 18.760 18.833
0EX65002519030593200073
18.643 18.610 18.647
0EX65002519030593200076
18.767 18.780 18.810
0EX650025190305932000A2
18.770 18.760 18.770
0EX650025190305932000CD
18.723 18.727 18.800
0EX65002519030593200166
18.710 18.787 18.737
0EX6500251903059320018F
18.567 18.533 18.607
0EX6500251903059320019A
18.650 18.657 18.613
control limit
9 10
Part Name: 613376 USL = 20
Dimension: 5500 MCS7 HT_MF BW-20 TX1 LSL = 16
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.070 0.020 0.020 0.412
0EX65002519030592T00026
0.070 0.190 0.250 0.412
0EX6500251903059320006E
0.030 0.090 0.200 0.412
0EX65002519030593200073
0.280 0.200 0.340 0.412
0EX65002519030593200076
0.160 0.240 0.050 0.412
0EX650025190305932000A2
0.150 0.310 0.100 0.412
0EX650025190305932000CD
0.270 0.160 0.140 0.412
0EX65002519030593200166
0.250 0.190 0.140 0.412
0EX6500251903059320018F
0.200 0.210 0.040 0.412
0EX6500251903059320019A
0.140 0.070 0.210 0.412
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.83 0.020 17.97 17.96 17.98 0.020
18.26 0.190 18.23 18.25 18 0.250
17.87 0.090 17.91 18 17.8 0.200
17.85 0.200 18.34 18.06 18 0.340
17.97 0.240 18.08 18.03 18.06 0.050
17.77 0.310 17.88 17.98 17.94 0.100
18.01 0.160 18.02 17.94 18.08 0.140
18.11 0.190 18.02 18.16 18.07 0.140
17.9 0.210 17.91 17.87 17.89 0.040
17.93 0.070 17.89 18.1 17.95 0.210
17.995 0.168 Average = 18.012 0.149
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.400
18.300
Average
18.200
18.100
18.000
17.900
17.800
17.700
17.600
17.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.827 17.837 17.970
0EX65002519030592T00026
18.323 18.283 18.160
0EX6500251903059320006E
17.930 17.827 17.903
0EX65002519030593200073
17.900 17.973 18.133
0EX65002519030593200076
18.027 18.083 18.057
0EX650025190305932000A2
17.853 17.923 17.933
0EX650025190305932000CD
18.030 18.083 18.013
0EX65002519030593200166
18.077 18.047 18.083
0EX6500251903059320018F
17.823 17.997 17.890
0EX6500251903059320019A
17.867 17.893 17.980
control limit
9 10
Part Name: 613376 USL = 20
Dimension: 5500 MCS7 HT_MF BW-20 TX2 LSL = 16
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.420 0.180 0.050 0.401
0EX65002519030592T00026
0.360 0.130 0.210 0.401
0EX6500251903059320006E
0.180 0.200 0.160 0.401
0EX65002519030593200073
0.130 0.230 0.150 0.401
0EX65002519030593200076
0.100 0.060 0.120 0.401
0EX650025190305932000A2
0.140 0.040 0.100 0.401
0EX650025190305932000CD
0.050 0.120 0.140 0.401
0EX65002519030593200166
0.030 0.200 0.060 0.401
0EX6500251903059320018F
0.220 0.190 0.060 0.401
0EX6500251903059320019A
0.320 0.210 0.100 0.401
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.93 0.180 17.87 17.82 17.86 0.050 UCL Range Violation - A
18.25 0.130 18.16 18.34 18.37 0.210
18.12 0.200 18.04 18.11 18.2 0.160
18.23 0.230 18.1 18.25 18.1 0.150
18.33 0.060 18.39 18.29 18.27 0.120
17.96 0.040 18.08 18.12 18.02 0.100
18.13 0.120 18.26 18.24 18.12 0.140
18.08 0.200 18.22 18.2 18.16 0.060
17.91 0.190 18.03 18.07 18.09 0.060
18.12 0.210 18.04 18.08 17.98 0.100
18.110 0.156 Average = 18.129 0.115
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.400
18.300
Average
18.200
18.100
18.000
17.900
17.800
17.700
17.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.980 18.003 17.850
0EX65002519030592T00026
18.190 18.197 18.290
0EX6500251903059320006E
18.120 18.127 18.117
0EX65002519030593200073
18.123 18.150 18.150
0EX65002519030593200076
18.330 18.343 18.317
0EX650025190305932000A2
18.033 17.967 18.073
0EX650025190305932000CD
18.257 18.193 18.207
0EX65002519030593200166
18.177 18.113 18.193
0EX6500251903059320018F
18.120 18.027 18.063
0EX6500251903059320019A
18.077 17.983 18.033
control limit
9 10
Part Name: 613376 USL = 20
Dimension: 5500 MCS7 HT_MF BW-20 TX3 LSL = 16
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.120 0.100 0.230 0.342
0EX65002519030592T00026
0.170 0.090 0.170 0.342
0EX6500251903059320006E
0.120 0.110 0.050 0.342
0EX65002519030593200073
0.030 0.090 0.090 0.342
0EX65002519030593200076
0.200 0.150 0.190 0.342
0EX650025190305932000A2
0.260 0.150 0.030 0.342
0EX650025190305932000CD
0.230 0.070 0.090 0.342
0EX65002519030593200166
0.070 0.140 0.100 0.342
0EX6500251903059320018F
0.010 0.170 0.180 0.342
0EX6500251903059320019A
0.160 0.260 0.150 0.342
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.02 0.100 18.3 18.11 18.07 0.230
18.19 0.090 18.4 18.23 18.29 0.170
18.04 0.110 17.99 18.01 17.96 0.050
18.26 0.090 18.24 18.18 18.27 0.090
18.13 0.150 18.31 18.12 18.17 0.190
18.2 0.150 18.06 18.08 18.09 0.030
18.03 0.070 18.14 18.06 18.05 0.090
18.19 0.140 18.17 18.07 18.16 0.100
17.86 0.170 17.89 18.07 18.02 0.180
18.25 0.260 18.05 18.2 18.15 0.150
18.115 0.133 Average = 18.130 0.128
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.400
18.300
Average
18.200
18.100
18.000
17.900
17.800
17.700
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.017 18.077 18.160
0EX65002519030592T00026
18.287 18.243 18.307
0EX6500251903059320006E
18.057 18.057 17.987
0EX65002519030593200073
18.243 18.230 18.230
0EX65002519030593200076
18.093 18.193 18.200
0EX650025190305932000A2
18.007 18.123 18.077
0EX650025190305932000CD
18.113 18.057 18.083
0EX65002519030593200166
18.210 18.110 18.133
0EX6500251903059320018F
17.993 17.953 17.993
0EX6500251903059320019A
18.043 18.110 18.133
control limit
9 10
Part Name: 613376 USL = 20
Dimension: 5500 MCS7 HT_MF BW-20 TX4 LSL = 16
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.060 0.360 0.170 0.454
0EX65002519030592T00026
0.180 0.160 0.210 0.454
0EX6500251903059320006E
0.210 0.220 0.120 0.454
0EX65002519030593200073
0.190 0.100 0.070 0.454
0EX65002519030593200076
0.180 0.210 0.090 0.454
0EX650025190305932000A2
0.110 0.120 0.180 0.454
0EX650025190305932000CD
0.150 0.210 0.090 0.454
0EX65002519030593200166
0.350 0.310 0.350 0.454
0EX6500251903059320018F
0.180 0.200 0.080 0.454
0EX6500251903059320019A
0.190 0.150 0.080 0.454
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.26 0.360 18.37 18.47 18.3 0.170
18.77 0.160 18.96 18.78 18.75 0.210
18.64 0.220 18.61 18.64 18.73 0.120
18.58 0.100 18.45 18.38 18.38 0.070
18.94 0.210 18.81 18.9 18.82 0.090
18.58 0.120 18.69 18.51 18.56 0.180
18.56 0.210 18.72 18.79 18.7 0.090
18.83 0.310 18.48 18.83 18.73 0.350
18.43 0.200 18.32 18.4 18.37 0.080
18.53 0.150 18.59 18.63 18.55 0.080
18.612 0.204 Average = 18.607 0.144
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.200
19.000
Average
18.800
18.600
18.400
18.200
18.000
17.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.313 18.437 18.380
0EX65002519030592T00026
18.973 18.873 18.830
0EX6500251903059320006E
18.733 18.613 18.660
0EX65002519030593200073
18.430 18.527 18.403
0EX65002519030593200076
18.837 18.827 18.843
0EX650025190305932000A2
18.730 18.613 18.587
0EX650025190305932000CD
18.650 18.687 18.737
0EX65002519030593200166
18.670 18.653 18.680
0EX6500251903059320018F
18.430 18.410 18.363
0EX6500251903059320019A
18.503 18.480 18.590
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5825 MCS7 HT_MF BW-20 TX1 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.160 0.160 0.340 0.402
0EX65002519030592T00026
0.120 0.100 0.210 0.402
0EX6500251903059320006E
0.090 0.090 0.170 0.402
0EX65002519030593200073
0.070 0.190 0.110 0.402
0EX65002519030593200076
0.300 0.050 0.140 0.402
0EX650025190305932000A2
0.200 0.180 0.230 0.402
0EX650025190305932000CD
0.150 0.030 0.250 0.402
0EX65002519030593200166
0.220 0.160 0.200 0.402
0EX6500251903059320018F
0.320 0.190 0.050 0.402
0EX6500251903059320019A
0.070 0.050 0.070 0.402
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.67 0.160 18.42 18.76 18.55 0.340
19.09 0.100 19.24 19.06 19.03 0.210
18.61 0.090 18.62 18.47 18.64 0.170
18.91 0.190 18.89 18.87 18.78 0.110
18.96 0.050 18.96 19.03 18.89 0.140
18.8 0.180 18.89 18.66 18.69 0.230
18.98 0.030 18.98 19.23 19.11 0.250
18.79 0.160 18.77 18.89 18.97 0.200
18.71 0.190 18.6 18.55 18.6 0.050
18.53 0.050 18.61 18.56 18.54 0.070
18.792 0.120 Average = 18.795 0.177
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.200
19.100
Average
19.000
18.900
18.800
18.700
18.600
18.500
18.400
18.300
18.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.537 18.683 18.577
0EX65002519030592T00026
19.090 19.110 19.110
0EX6500251903059320006E
18.637 18.587 18.577
0EX65002519030593200073
18.820 18.823 18.847
0EX65002519030593200076
18.927 18.993 18.960
0EX650025190305932000A2
18.663 18.727 18.747
0EX650025190305932000CD
18.950 18.967 19.107
0EX65002519030593200166
18.810 18.790 18.877
0EX6500251903059320018F
18.567 18.687 18.583
0EX6500251903059320019A
18.597 18.550 18.570
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5825 MCS7 HT_MF BW-20 TX2 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.040 0.180 0.010 0.361
0EX65002519030592T00026
0.110 0.180 0.140 0.361
0EX6500251903059320006E
0.250 0.120 0.170 0.361
0EX65002519030593200073
0.180 0.090 0.260 0.361
0EX65002519030593200076
0.180 0.240 0.090 0.361
0EX650025190305932000A2
0.090 0.110 0.050 0.361
0EX650025190305932000CD
0.210 0.120 0.230 0.361
0EX65002519030593200166
0.110 0.040 0.160 0.361
0EX6500251903059320018F
0.140 0.060 0.240 0.361
0EX6500251903059320019A
0.150 0.060 0.190 0.361
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.35 0.180 18.35 18.36 18.36 0.010
18.61 0.180 18.56 18.42 18.48 0.140
18.46 0.120 18.58 18.41 18.48 0.170
18.37 0.090 18.57 18.49 18.31 0.260
18.68 0.240 18.44 18.48 18.39 0.090
18.38 0.110 18.51 18.51 18.46 0.050
18.53 0.120 18.48 18.44 18.67 0.230
18.48 0.040 18.6 18.5 18.44 0.160
18.55 0.060 18.4 18.64 18.44 0.240
18.31 0.060 18.53 18.34 18.36 0.190
18.464 0.120 Average = 18.467 0.154
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.600
18.550
Average
18.500
18.450
18.400
18.350
18.300
18.250
18.200
18.150
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.433 18.443 18.357
0EX65002519030592T00026
18.497 18.533 18.487
0EX6500251903059320006E
18.513 18.530 18.490
0EX65002519030593200073
18.433 18.367 18.457
0EX65002519030593200076
18.513 18.543 18.437
0EX650025190305932000A2
18.467 18.427 18.493
0EX650025190305932000CD
18.490 18.460 18.530
0EX65002519030593200166
18.507 18.487 18.513
0EX6500251903059320018F
18.510 18.543 18.493
0EX6500251903059320019A
18.437 18.310 18.410
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5825 MCS7 HT_MF BW-20 TX3 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.210 0.300 0.070 0.344
0EX65002519030592T00026
0.180 0.110 0.110 0.344
0EX6500251903059320006E
0.120 0.180 0.090 0.344
0EX65002519030593200073
0.120 0.190 0.100 0.344
0EX65002519030593200076
0.160 0.090 0.140 0.344
0EX650025190305932000A2
0.040 0.080 0.100 0.344
0EX650025190305932000CD
0.120 0.160 0.160 0.344
0EX65002519030593200166
0.100 0.030 0.240 0.344
0EX6500251903059320018F
0.110 0.100 0.230 0.344
0EX6500251903059320019A
0.150 0.130 0.080 0.344
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.77 0.300 18.5 18.47 18.43 0.070
18.76 0.110 18.74 18.72 18.83 0.110
18.51 0.180 18.5 18.59 18.56 0.090
18.67 0.190 18.63 18.54 18.64 0.100
18.83 0.090 18.77 18.7 18.84 0.140
18.53 0.080 18.49 18.54 18.59 0.100
18.5 0.160 18.47 18.41 18.57 0.160
18.68 0.030 18.55 18.44 18.68 0.240
18.54 0.100 18.4 18.63 18.4 0.230
18.6 0.130 18.59 18.59 18.67 0.080
18.596 0.137 Average = 18.583 0.132
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.900
18.800
Average
18.700
18.600
18.500
18.400
18.300
18.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.543 18.580 18.467
0EX65002519030592T00026
18.727 18.713 18.763
0EX6500251903059320006E
18.577 18.483 18.550
0EX65002519030593200073
18.583 18.563 18.603
0EX65002519030593200076
18.833 18.777 18.770
0EX650025190305932000A2
18.460 18.477 18.540
0EX650025190305932000CD
18.643 18.597 18.483
0EX65002519030593200166
18.690 18.667 18.557
0EX6500251903059320018F
18.443 18.477 18.477
0EX6500251903059320019A
18.587 18.623 18.617
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5825 MCS7 HT_MF BW-20 TX4 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.100 0.010 0.070 0.299
0EX65002519030592T00026
0.020 0.090 0.200 0.299
0EX6500251903059320006E
0.150 0.090 0.050 0.299
0EX65002519030593200073
0.050 0.050 0.100 0.299
0EX65002519030593200076
0.170 0.200 0.250 0.299
0EX650025190305932000A2
0.090 0.180 0.420 0.299
0EX650025190305932000CD
0.100 0.050 0.180 0.299
0EX65002519030593200166
0.030 0.060 0.170 0.299
0EX6500251903059320018F
0.070 0.080 0.080 0.299
0EX6500251903059320019A
0.150 0.190 0.030 0.299
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.35 0.010 18.4 18.35 18.42 0.070
18.56 0.090 18.43 18.56 18.63 0.200
18.51 0.090 18.49 18.47 18.52 0.050
18.43 0.050 18.39 18.49 18.49 0.100
18.51 0.200 18.61 18.45 18.36 0.250
18.43 0.180 18.31 18.59 18.17 0.420 UCL Range Violation - C
18.59 0.050 18.63 18.53 18.45 0.180
18.61 0.060 18.42 18.35 18.52 0.170
18.49 0.080 18.49 18.41 18.48 0.080
18.46 0.190 18.32 18.29 18.3 0.030
18.492 0.100 Average = 18.444 0.155
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.650
18.600
Average
18.550
18.500
18.450
18.400
18.350
18.300
18.250
18.200
18.150
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.307 18.353 18.390
0EX65002519030592T00026
18.510 18.513 18.540
0EX6500251903059320006E
18.437 18.557 18.493
0EX65002519030593200073
18.497 18.427 18.457
0EX65002519030593200076
18.497 18.597 18.473
0EX650025190305932000A2
18.350 18.410 18.357
0EX650025190305932000CD
18.490 18.573 18.537
0EX65002519030593200166
18.570 18.583 18.430
0EX6500251903059320018F
18.477 18.530 18.460
0EX6500251903059320019A
18.433 18.373 18.303
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 5190 MCS0 HT_MF BW-40 TX1 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.200 0.130 0.325
0EX65002519030592T00026
0.080 0.150 0.140 0.325
0EX6500251903059320006E
0.310 0.100 0.020 0.325
0EX65002519030593200073
0.180 0.190 0.290 0.325
0EX65002519030593200076
0.080 0.060 0.140 0.325
0EX650025190305932000A2
0.020 0.150 0.300 0.325
0EX650025190305932000CD
0.010 0.050 0.120 0.325
0EX65002519030593200166
0.090 0.070 0.120 0.325
0EX6500251903059320018F
0.080 0.090 0.110 0.325
0EX6500251903059320019A
0.030 0.120 0.220 0.325
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.31 0.200 21.24 21.11 21.22 0.130
21.24 0.150 21.35 21.21 21.24 0.140
21.3 0.100 21.29 21.3 21.31 0.020
21.19 0.190 21.03 21.31 21.32 0.290
21.2 0.060 21.15 21.29 21.29 0.140
21.13 0.150 21.48 21.42 21.18 0.300
21.38 0.050 21.49 21.4 21.52 0.120
21.19 0.070 21.16 21.28 21.23 0.120
21.28 0.090 21.21 21.25 21.32 0.110
21.37 0.120 21.26 21.38 21.16 0.220
21.255 0.118 Average = 21.280 0.159
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.500
21.400
Average
21.300
21.200
21.100
21.000
20.900
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.220 21.237 21.190
0EX65002519030592T00026
21.350 21.203 21.267
0EX6500251903059320006E
21.313 21.300 21.300
0EX65002519030593200073
21.223 21.153 21.220
0EX65002519030593200076
21.230 21.237 21.243
0EX650025190305932000A2
21.267 21.173 21.360
0EX650025190305932000CD
21.327 21.397 21.470
0EX65002519030593200166
21.307 21.233 21.223
0EX6500251903059320018F
21.237 21.323 21.260
0EX6500251903059320019A
21.207 21.297 21.267
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 5190 MCS0 HT_MF BW-40 TX2 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.180 0.160 0.080 0.264
0EX65002519030592T00026
0.060 0.130 0.070 0.264
0EX6500251903059320006E
0.070 0.180 0.010 0.264
0EX65002519030593200073
0.140 0.160 0.160 0.264
0EX65002519030593200076
0.140 0.160 0.010 0.264
0EX650025190305932000A2
0.020 0.100 0.040 0.264
0EX650025190305932000CD
0.200 0.160 0.010 0.264
0EX65002519030593200166
0.060 0.070 0.120 0.264
0EX6500251903059320018F
0.070 0.010 0.160 0.264
0EX6500251903059320019A
0.150 0.100 0.090 0.264
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.44 0.160 21.31 21.35 21.39 0.080
21.42 0.130 21.52 21.47 21.54 0.070
21.72 0.180 21.52 21.53 21.52 0.010
21.59 0.160 21.65 21.49 21.5 0.160
21.65 0.160 21.57 21.57 21.56 0.010
21.47 0.100 21.48 21.44 21.46 0.040
21.44 0.160 21.44 21.45 21.44 0.010
21.5 0.070 21.53 21.41 21.53 0.120
21.61 0.010 21.52 21.67 21.68 0.160
21.56 0.100 21.53 21.46 21.55 0.090
21.522 0.123 Average = 21.503 0.075
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.650
21.600
Average
21.550
21.500
21.450
21.400
21.350
21.300
21.250
21.200
21.150
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.333 21.343 21.350
0EX65002519030592T00026
21.517 21.487 21.510
0EX6500251903059320006E
21.577 21.603 21.523
0EX65002519030593200073
21.510 21.583 21.547
0EX65002519030593200076
21.597 21.597 21.567
0EX650025190305932000A2
21.470 21.533 21.460
0EX650025190305932000CD
21.500 21.447 21.443
0EX65002519030593200166
21.470 21.497 21.490
0EX6500251903059320018F
21.597 21.613 21.623
0EX6500251903059320019A
21.507 21.520 21.513
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 5190 MCS0 HT_MF BW-40 TX3 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.070 0.060 0.050 0.244
0EX65002519030592T00026
0.040 0.100 0.080 0.244
0EX6500251903059320006E
0.140 0.030 0.150 0.244
0EX65002519030593200073
0.130 0.120 0.110 0.244
0EX65002519030593200076
0.090 0.140 0.040 0.244
0EX650025190305932000A2
0.120 0.040 0.170 0.244
0EX650025190305932000CD
0.030 0.120 0.210 0.244
0EX65002519030593200166
0.080 0.080 0.100 0.244
0EX6500251903059320018F
0.090 0.180 0.050 0.244
0EX6500251903059320019A
0.060 0.060 0.100 0.244
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.28 0.060 21.27 21.22 21.25 0.050
21.51 0.100 21.49 21.43 21.51 0.080
21.49 0.030 21.29 21.39 21.44 0.150
21.63 0.120 21.64 21.53 21.6 0.110
21.61 0.140 21.58 21.62 21.61 0.040
21.45 0.040 21.51 21.34 21.39 0.170
21.53 0.120 21.49 21.52 21.31 0.210
21.56 0.080 21.57 21.47 21.57 0.100
21.34 0.180 21.36 21.36 21.41 0.050
21.55 0.060 21.57 21.53 21.63 0.100
21.489 0.093 Average = 21.463 0.106
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.700
21.600
Average
21.500
21.400
21.300
21.200
21.100
21.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.273 21.267 21.247
0EX65002519030592T00026
21.517 21.503 21.477
0EX6500251903059320006E
21.473 21.480 21.373
0EX65002519030593200073
21.617 21.590 21.590
0EX65002519030593200076
21.613 21.643 21.603
0EX650025190305932000A2
21.453 21.470 21.413
0EX650025190305932000CD
21.473 21.450 21.440
0EX65002519030593200166
21.570 21.530 21.537
0EX6500251903059320018F
21.420 21.443 21.377
0EX6500251903059320019A
21.540 21.510 21.577
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 5190 MCS0 HT_MF BW-40 TX4 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.090 0.120 0.110 0.251
0EX65002519030592T00026
0.060 0.150 0.080 0.251
0EX6500251903059320006E
0.060 0.090 0.120 0.251
0EX65002519030593200073
0.050 0.080 0.210 0.251
0EX65002519030593200076
0.120 0.190 0.120 0.251
0EX650025190305932000A2
0.030 0.100 0.010 0.251
0EX650025190305932000CD
0.130 0.080 0.040 0.251
0EX65002519030593200166
0.010 0.040 0.130 0.251
0EX6500251903059320018F
0.150 0.150 0.150 0.251
0EX6500251903059320019A
0.070 0.080 0.100 0.251
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.33 0.120 21.42 21.4 21.51 0.110
21.66 0.150 21.52 21.59 21.6 0.080
21.6 0.090 21.66 21.57 21.69 0.120
21.35 0.080 21.39 21.29 21.5 0.210
21.45 0.190 21.62 21.72 21.6 0.120
21.49 0.100 21.6 21.6 21.59 0.010
21.45 0.080 21.45 21.49 21.49 0.040
21.48 0.040 21.5 21.37 21.41 0.130
21.45 0.150 21.48 21.47 21.33 0.150
21.39 0.080 21.45 21.47 21.37 0.100
21.489 0.108 Average = 21.505 0.107
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.700
21.650
Average
21.600
21.550
21.500
21.450
21.400
21.350
21.300
21.250
21.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.407 21.380 21.443
0EX65002519030592T00026
21.547 21.590 21.570
0EX6500251903059320006E
21.610 21.590 21.640
0EX65002519030593200073
21.360 21.400 21.393
0EX65002519030593200076
21.630 21.557 21.647
0EX650025190305932000A2
21.557 21.550 21.597
0EX650025190305932000CD
21.513 21.487 21.477
0EX65002519030593200166
21.467 21.467 21.427
0EX6500251903059320018F
21.457 21.433 21.427
0EX6500251903059320019A
21.473 21.433 21.430
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 5795 MCS0 HT_MF BW-40 TX1 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.090 0.210 0.292
0EX65002519030592T00026
0.120 0.280 0.170 0.292
0EX6500251903059320006E
0.070 0.050 0.100 0.292
0EX65002519030593200073
0.040 0.190 0.160 0.292
0EX65002519030593200076
0.200 0.050 0.020 0.292
0EX650025190305932000A2
0.180 0.120 0.090 0.292
0EX650025190305932000CD
0.010 0.120 0.160 0.292
0EX65002519030593200166
0.180 0.100 0.020 0.292
0EX6500251903059320018F
0.210 0.060 0.030 0.292
0EX6500251903059320019A
0.050 0.060 0.120 0.292
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.59 0.090 21.51 21.61 21.72 0.210
22.38 0.280 22.59 22.42 22.51 0.170
21.54 0.050 21.59 21.63 21.53 0.100
21.76 0.190 21.93 21.89 21.77 0.160
22.12 0.050 22.14 22.13 22.12 0.020
21.7 0.120 21.75 21.68 21.77 0.090
21.98 0.120 22.09 21.96 21.93 0.160
21.83 0.100 21.84 21.86 21.86 0.020
21.64 0.060 21.53 21.53 21.56 0.030
21.54 0.060 21.53 21.64 21.52 0.120
21.832 0.112 Average = 21.838 0.108
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.600
22.400
Average
22.200
22.000
21.800
21.600
21.400
21.200
21.000
20.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.600 21.630 21.613
0EX65002519030592T00026
22.373 22.510 22.507
0EX6500251903059320006E
21.530 21.523 21.583
0EX65002519030593200073
21.833 21.837 21.863
0EX65002519030593200076
22.070 22.123 22.130
0EX650025190305932000A2
21.723 21.707 21.733
0EX650025190305932000CD
21.983 21.973 21.993
0EX65002519030593200166
21.830 21.857 21.853
0EX6500251903059320018F
21.530 21.660 21.540
0EX6500251903059320019A
21.457 21.503 21.563
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 5795 MCS0 HT_MF BW-40 TX2 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.200
Range
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.090 0.170 0.090 0.276
0EX65002519030592T00026
0.030 0.190 0.090 0.276
0EX6500251903059320006E
0.050 0.150 0.030 0.276
0EX65002519030593200073
0.130 0.150 0.090 0.276
0EX65002519030593200076
0.020 0.080 0.120 0.276
0EX650025190305932000A2
0.100 0.100 0.120 0.276
0EX650025190305932000CD
0.190 0.100 0.120 0.276
0EX65002519030593200166
0.100 0.060 0.120 0.276
0EX6500251903059320018F
0.060 0.070 0.130 0.276
0EX6500251903059320019A
0.070 0.220 0.170 0.276
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.59 0.170 21.53 21.46 21.44 0.090
21.79 0.190 21.49 21.56 21.58 0.090
21.42 0.150 21.5 21.51 21.53 0.030
21.56 0.150 21.63 21.54 21.61 0.090
21.58 0.080 21.44 21.56 21.54 0.120
21.45 0.100 21.43 21.43 21.55 0.120
21.54 0.100 21.61 21.49 21.51 0.120
21.46 0.060 21.65 21.64 21.53 0.120
21.53 0.070 21.48 21.61 21.48 0.130
21.57 0.220 21.37 21.5 21.54 0.170
21.534 0.129 Average = 21.525 0.108
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.800
21.700
Average
21.600
21.500
21.400
21.300
21.200
21.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.307 21.530 21.477
0EX65002519030592T00026
21.597 21.707 21.543
0EX6500251903059320006E
21.490 21.497 21.513
0EX65002519030593200073
21.533 21.523 21.593
0EX65002519030593200076
21.547 21.540 21.513
0EX650025190305932000A2
21.477 21.507 21.470
0EX650025190305932000CD
21.533 21.547 21.537
0EX65002519030593200166
21.510 21.497 21.607
0EX6500251903059320018F
21.527 21.560 21.523
0EX6500251903059320019A
21.513 21.437 21.470
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 5795 MCS0 HT_MF BW-40 TX3 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.050 0.060 0.200 0.275
0EX65002519030592T00026
0.010 0.100 0.060 0.275
0EX6500251903059320006E
0.290 0.120 0.110 0.275
0EX65002519030593200073
0.120 0.020 0.090 0.275
0EX65002519030593200076
0.130 0.110 0.110 0.275
0EX650025190305932000A2
0.100 0.110 0.090 0.275
0EX650025190305932000CD
0.080 0.200 0.120 0.275
0EX65002519030593200166
0.070 0.140 0.210 0.275
0EX6500251903059320018F
0.020 0.070 0.050 0.275
0EX6500251903059320019A
0.110 0.060 0.190 0.275
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.59 0.060 21.62 21.68 21.48 0.200
21.9 0.100 21.87 21.83 21.81 0.060
21.79 0.120 21.71 21.6 21.68 0.110 UCL Range Violation - A
21.83 0.020 21.78 21.87 21.8 0.090
21.92 0.110 21.9 21.84 21.95 0.110
21.78 0.110 21.69 21.69 21.6 0.090
21.71 0.200 21.76 21.65 21.77 0.120
21.94 0.140 21.76 21.97 21.77 0.210
21.7 0.070 21.75 21.77 21.8 0.050
21.83 0.060 21.78 21.71 21.9 0.190
21.791 0.099 Average = 21.760 0.123
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
22.000
21.900
Average
21.800
21.700
21.600
21.500
21.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.650 21.617 21.593
0EX65002519030592T00026
21.867 21.837 21.837
0EX6500251903059320006E
21.757 21.763 21.663
0EX65002519030593200073
21.857 21.823 21.817
0EX65002519030593200076
21.953 21.937 21.897
0EX650025190305932000A2
21.683 21.710 21.660
0EX650025190305932000CD
21.847 21.813 21.727
0EX65002519030593200166
21.897 21.860 21.833
0EX6500251903059320018F
21.770 21.743 21.773
0EX6500251903059320019A
21.787 21.810 21.797
control limit
9 10
Part Name: 613376 USL = 23
Dimension: 5795 MCS0 HT_MF BW-40 TX4 LSL = 19
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.060 0.080 0.030 0.276
0EX65002519030592T00026
0.070 0.040 0.120 0.276
0EX6500251903059320006E
0.130 0.050 0.010 0.276
0EX65002519030593200073
0.230 0.270 0.090 0.276
0EX65002519030593200076
0.040 0.090 0.140 0.276
0EX650025190305932000A2
0.080 0.140 0.120 0.276
0EX650025190305932000CD
0.040 0.070 0.030 0.276
0EX65002519030593200166
0.240 0.130 0.140 0.276
0EX6500251903059320018F
0.150 0.130 0.140 0.276
0EX6500251903059320019A
0.130 0.110 0.110 0.276
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
21.51 0.080 21.51 21.53 21.54 0.030
21.64 0.040 21.67 21.62 21.74 0.120
21.37 0.050 21.41 21.42 21.42 0.010
21.57 0.270 21.45 21.47 21.54 0.090
21.58 0.090 21.52 21.62 21.48 0.140
21.48 0.140 21.46 21.54 21.58 0.120
21.62 0.070 21.63 21.6 21.62 0.030
21.6 0.130 21.49 21.43 21.57 0.140
21.61 0.130 21.43 21.51 21.57 0.140
21.41 0.110 21.54 21.43 21.49 0.110
21.539 0.111 Average = 21.528 0.093
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.800
21.700
Average
21.600
21.500
21.400
21.300
21.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
21.553 21.550 21.527
0EX65002519030592T00026
21.607 21.667 21.677
0EX6500251903059320006E
21.363 21.387 21.417
0EX65002519030593200073
21.560 21.553 21.487
0EX65002519030593200076
21.510 21.530 21.540
0EX650025190305932000A2
21.500 21.473 21.527
0EX650025190305932000CD
21.567 21.593 21.617
0EX65002519030593200166
21.607 21.553 21.497
0EX6500251903059320018F
21.537 21.613 21.503
0EX6500251903059320019A
21.527 21.467 21.487
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5190 MCS7 HT_MF BW-40 TX1 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.120 0.220 0.150 0.435
0EX65002519030592T00026
0.120 0.050 0.200 0.435
0EX6500251903059320006E
0.200 0.070 0.280 0.435
0EX65002519030593200073
0.200 0.260 0.190 0.435
0EX65002519030593200076
0.270 0.080 0.190 0.435
0EX650025190305932000A2
0.130 0.100 0.260 0.435
0EX650025190305932000CD
0.210 0.070 0.120 0.435
0EX65002519030593200166
0.170 0.260 0.260 0.435
0EX6500251903059320018F
0.130 0.310 0.050 0.435
0EX6500251903059320019A
0.160 0.080 0.150 0.435
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.06 0.220 18.15 18.22 18.07 0.150
18.32 0.050 18.48 18.28 18.41 0.200
18.31 0.070 18.48 18.2 18.28 0.280
18.21 0.260 18.2 18.37 18.39 0.190
18.35 0.080 18.34 18.27 18.46 0.190
18.34 0.100 18.5 18.45 18.24 0.260
18.46 0.070 18.55 18.52 18.43 0.120
18.29 0.260 18.24 18.3 18.5 0.260
18.32 0.310 18.18 18.18 18.23 0.050
18.32 0.080 18.29 18.44 18.29 0.150
18.333 0.150 Average = 18.331 0.185
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.600
18.500
Average
18.400
18.300
18.200
18.100
18.000
17.900
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.260 18.193 18.147
0EX65002519030592T00026
18.387 18.353 18.390
0EX6500251903059320006E
18.390 18.287 18.320
0EX65002519030593200073
18.263 18.323 18.320
0EX65002519030593200076
18.220 18.377 18.357
0EX650025190305932000A2
18.280 18.277 18.397
0EX650025190305932000CD
18.473 18.490 18.500
0EX65002519030593200166
18.357 18.380 18.347
0EX6500251903059320018F
18.297 18.337 18.197
0EX6500251903059320019A
18.363 18.313 18.340
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5190 MCS7 HT_MF BW-40 TX2 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.150 0.120 0.060 0.297
0EX65002519030592T00026
0.110 0.150 0.030 0.297
0EX6500251903059320006E
0.240 0.100 0.060 0.297
0EX65002519030593200073
0.040 0.090 0.120 0.297
0EX65002519030593200076
0.060 0.180 0.110 0.297
0EX650025190305932000A2
0.040 0.240 0.070 0.297
0EX650025190305932000CD
0.090 0.080 0.060 0.297
0EX65002519030593200166
0.250 0.030 0.120 0.297
0EX6500251903059320018F
0.140 0.040 0.160 0.297
0EX6500251903059320019A
0.160 0.130 0.220 0.297
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.38 0.120 18.38 18.43 18.37 0.060
18.63 0.150 18.84 18.86 18.87 0.030
18.77 0.100 18.67 18.63 18.69 0.060
18.58 0.090 18.47 18.59 18.58 0.120
18.82 0.180 18.78 18.67 18.69 0.110
18.71 0.240 18.58 18.53 18.51 0.070
18.7 0.080 18.73 18.68 18.67 0.060
18.59 0.030 18.68 18.62 18.56 0.120
18.6 0.040 18.46 18.62 18.5 0.160
18.67 0.130 18.53 18.43 18.65 0.220
18.613 0.116 Average = 18.609 0.101
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.900
18.800
Average
18.700
18.600
18.500
18.400
18.300
18.200
18.100
18.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.387 18.340 18.393
0EX65002519030592T00026
18.680 18.683 18.857
0EX6500251903059320006E
18.683 18.710 18.663
0EX65002519030593200073
18.530 18.617 18.547
0EX65002519030593200076
18.717 18.773 18.713
0EX650025190305932000A2
18.610 18.557 18.540
0EX650025190305932000CD
18.623 18.670 18.693
0EX65002519030593200166
18.637 18.577 18.620
0EX6500251903059320018F
18.700 18.600 18.527
0EX6500251903059320019A
18.563 18.600 18.537
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5190 MCS7 HT_MF BW-40 TX3 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.100 0.110 0.160 0.369
0EX65002519030592T00026
0.040 0.120 0.030 0.369
0EX6500251903059320006E
0.220 0.080 0.250 0.369
0EX65002519030593200073
0.170 0.280 0.160 0.369
0EX65002519030593200076
0.200 0.130 0.130 0.369
0EX650025190305932000A2
0.160 0.020 0.190 0.369
0EX650025190305932000CD
0.220 0.180 0.140 0.369
0EX65002519030593200166
0.060 0.010 0.130 0.369
0EX6500251903059320018F
0.120 0.190 0.350 0.369
0EX6500251903059320019A
0.090 0.080 0.170 0.369
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.36 0.110 18.37 18.36 18.52 0.160
18.81 0.120 18.76 18.74 18.73 0.030
18.71 0.080 18.46 18.71 18.69 0.250
18.99 0.280 18.73 18.89 18.87 0.160
18.95 0.130 18.95 18.82 18.9 0.130
18.68 0.020 18.6 18.61 18.79 0.190
18.78 0.180 18.56 18.7 18.57 0.140
18.79 0.010 18.77 18.83 18.7 0.130
18.7 0.190 18.64 18.44 18.79 0.350
18.77 0.080 18.97 18.8 18.8 0.170
18.710 0.120 Average = 18.702 0.171
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.000
18.900
Average
18.800
18.700
18.600
18.500
18.400
18.300
18.200
18.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.490 18.427 18.417
0EX65002519030592T00026
18.827 18.810 18.743
0EX6500251903059320006E
18.587 18.660 18.620
0EX65002519030593200073
18.890 18.850 18.830
0EX65002519030593200076
18.880 18.880 18.890
0EX650025190305932000A2
18.610 18.670 18.667
0EX650025190305932000CD
18.680 18.690 18.610
0EX65002519030593200166
18.793 18.783 18.767
0EX6500251903059320018F
18.647 18.603 18.623
0EX6500251903059320019A
18.727 18.730 18.857
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5190 MCS7 HT_MF BW-40 TX4 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.200 0.110 0.340
0EX65002519030592T00026
0.140 0.130 0.080 0.340
0EX6500251903059320006E
0.040 0.160 0.090 0.340
0EX65002519030593200073
0.100 0.150 0.250 0.340
0EX65002519030593200076
0.170 0.070 0.100 0.340
0EX650025190305932000A2
0.030 0.110 0.120 0.340
0EX650025190305932000CD
0.050 0.080 0.030 0.340
0EX65002519030593200166
0.030 0.220 0.170 0.340
0EX6500251903059320018F
0.150 0.080 0.210 0.340
0EX6500251903059320019A
0.230 0.290 0.230 0.340
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.43 0.200 18.65 18.54 18.58 0.110
18.94 0.130 18.79 18.87 18.86 0.080
18.84 0.160 18.99 18.9 18.99 0.090
18.71 0.150 18.84 18.59 18.67 0.250
18.81 0.070 18.8 18.84 18.9 0.100
18.79 0.110 18.94 18.89 18.82 0.120
18.85 0.080 18.91 18.88 18.88 0.030
18.76 0.220 18.68 18.85 18.82 0.170
18.7 0.080 18.84 18.63 18.72 0.210
18.65 0.290 18.79 18.82 18.59 0.230
18.767 0.149 Average = 18.796 0.139
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.000
18.900
Average
18.800
18.700
18.600
18.500
18.400
18.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.537 18.527 18.590
0EX65002519030592T00026
18.863 18.873 18.840
0EX6500251903059320006E
18.877 18.833 18.960
0EX65002519030593200073
18.680 18.627 18.700
0EX65002519030593200076
18.783 18.827 18.847
0EX650025190305932000A2
18.887 18.847 18.883
0EX650025190305932000CD
18.790 18.857 18.890
0EX65002519030593200166
18.827 18.853 18.783
0EX6500251903059320018F
18.700 18.670 18.730
0EX6500251903059320019A
18.713 18.760 18.733
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5795 MCS7 HT_MF BW-40 TX1 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.230 0.250 0.270 0.419
0EX65002519030592T00026
0.100 0.230 0.070 0.419
0EX6500251903059320006E
0.140 0.100 0.180 0.419
0EX65002519030593200073
0.020 0.230 0.210 0.419
0EX65002519030593200076
0.170 0.160 0.130 0.419
0EX650025190305932000A2
0.290 0.150 0.230 0.419
0EX650025190305932000CD
0.160 0.300 0.170 0.419
0EX65002519030593200166
0.230 0.120 0.090 0.419
0EX6500251903059320018F
0.140 0.120 0.120 0.419
0EX6500251903059320019A
0.090 0.080 0.090 0.419
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.62 0.250 18.47 18.74 18.68 0.270
19.6 0.230 19.48 19.55 19.49 0.070
18.62 0.100 18.79 18.88 18.7 0.180
18.88 0.230 19.02 19.14 18.93 0.210
19.18 0.160 19.41 19.38 19.28 0.130
18.79 0.150 19 18.77 18.95 0.230
19.31 0.300 19.28 19.11 19.14 0.170
19.03 0.120 18.94 19 18.91 0.090
18.81 0.120 18.66 18.73 18.61 0.120
18.6 0.080 18.61 18.64 18.7 0.090
18.954 0.174 Average = 18.966 0.156
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.800
19.600
Average
19.400
19.200
19.000
18.800
18.600
18.400
18.200
18.000
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.670 18.733 18.630
0EX65002519030592T00026
19.533 19.570 19.507
0EX6500251903059320006E
18.577 18.640 18.790
0EX65002519030593200073
19.003 18.963 19.030
0EX65002519030593200076
19.303 19.260 19.357
0EX650025190305932000A2
18.733 18.767 18.907
0EX650025190305932000CD
19.173 19.193 19.177
0EX65002519030593200166
18.967 19.030 18.950
0EX6500251903059320018F
18.643 18.783 18.667
0EX6500251903059320019A
18.683 18.600 18.650
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5795 MCS7 HT_MF BW-40 TX2 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.170 0.040 0.190 0.458
0EX65002519030592T00026
0.150 0.180 0.030 0.458
0EX6500251903059320006E
0.150 0.130 0.140 0.458
0EX65002519030593200073
0.200 0.140 0.270 0.458
0EX65002519030593200076
0.080 0.100 0.140 0.458
0EX650025190305932000A2
0.330 0.100 0.110 0.458
0EX650025190305932000CD
0.140 0.390 0.170 0.458
0EX65002519030593200166
0.140 0.210 0.140 0.458
0EX6500251903059320018F
0.180 0.280 0.280 0.458
0EX6500251903059320019A
0.120 0.210 0.420 0.458
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.5 0.040 18.58 18.39 18.54 0.190
18.65 0.180 18.81 18.8 18.78 0.030
18.53 0.130 18.67 18.53 18.57 0.140
18.6 0.140 18.67 18.82 18.55 0.270
18.66 0.100 18.62 18.76 18.74 0.140
18.67 0.100 18.53 18.5 18.42 0.110
18.67 0.390 18.77 18.6 18.64 0.170
18.7 0.210 18.78 18.79 18.65 0.140
18.67 0.280 18.5 18.78 18.61 0.280
18.64 0.210 18.54 18.84 18.42 0.420
18.637 0.178 Average = 18.640 0.189
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.900
18.800
Average
18.700
18.600
18.500
18.400
18.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.523 18.493 18.503
0EX65002519030592T00026
18.717 18.740 18.797
0EX6500251903059320006E
18.607 18.607 18.590
0EX65002519030593200073
18.693 18.587 18.680
0EX65002519030593200076
18.670 18.710 18.707
0EX650025190305932000A2
18.630 18.710 18.483
0EX650025190305932000CD
18.667 18.687 18.670
0EX65002519030593200166
18.560 18.643 18.740
0EX6500251903059320018F
18.577 18.677 18.630
0EX6500251903059320019A
18.530 18.520 18.600
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5795 MCS7 HT_MF BW-40 TX3 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.180 0.190 0.190 0.409
0EX65002519030592T00026
0.220 0.030 0.060 0.409
0EX6500251903059320006E
0.180 0.210 0.140 0.409
0EX65002519030593200073
0.190 0.220 0.050 0.409
0EX65002519030593200076
0.360 0.140 0.200 0.409
0EX650025190305932000A2
0.150 0.210 0.180 0.409
0EX650025190305932000CD
0.090 0.200 0.250 0.409
0EX65002519030593200166
0.030 0.160 0.070 0.409
0EX6500251903059320018F
0.130 0.210 0.120 0.409
0EX6500251903059320019A
0.110 0.140 0.150 0.409
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.67 0.190 18.92 18.86 18.73 0.190
19.11 0.030 19.03 18.97 18.99 0.060
18.91 0.210 18.85 18.79 18.71 0.140
19.07 0.220 19.07 19.08 19.03 0.050
19.18 0.140 19.09 18.98 19.18 0.200
18.94 0.210 18.75 18.88 18.93 0.180
18.84 0.200 19 18.86 19.11 0.250
19.1 0.160 18.96 19.02 19.03 0.070
18.76 0.210 18.97 19.05 18.93 0.120
18.98 0.140 18.93 19.06 19.08 0.150
18.939 0.171 Average = 18.961 0.141
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.200
19.100
Average
19.000
18.900
18.800
18.700
18.600
18.500
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.797 18.733 18.837
0EX65002519030592T00026
19.143 19.100 18.997
0EX6500251903059320006E
18.840 18.860 18.783
0EX65002519030593200073
19.023 18.953 19.060
0EX65002519030593200076
19.147 19.113 19.083
0EX650025190305932000A2
18.857 18.807 18.853
0EX650025190305932000CD
18.930 18.957 18.990
0EX65002519030593200166
18.987 19.020 19.003
0EX6500251903059320018F
18.973 18.890 18.983
0EX6500251903059320019A
18.940 18.953 19.023
control limit
9 10
Part Name: 613376 USL = 20.5
Dimension: 5795 MCS7 HT_MF BW-40 TX4 LSL = 16.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.140 0.320 0.040 0.338
0EX65002519030592T00026
0.090 0.020 0.130 0.338
0EX6500251903059320006E
0.130 0.150 0.090 0.338
0EX65002519030593200073
0.330 0.020 0.110 0.338
0EX65002519030593200076
0.190 0.290 0.140 0.338
0EX650025190305932000A2
0.100 0.070 0.120 0.338
0EX650025190305932000CD
0.190 0.230 0.060 0.338
0EX65002519030593200166
0.070 0.180 0.050 0.338
0EX6500251903059320018F
0.010 0.120 0.210 0.338
0EX6500251903059320019A
0.170 0.100 0.060 0.338
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.53 0.320 18.53 18.5 18.54 0.040
18.85 0.020 18.82 18.72 18.85 0.130
18.68 0.150 18.69 18.6 18.67 0.090
18.59 0.020 18.34 18.36 18.45 0.110
18.82 0.290 18.7 18.64 18.56 0.140
18.51 0.070 18.46 18.54 18.42 0.120
18.7 0.230 18.75 18.69 18.72 0.060
18.57 0.180 18.55 18.52 18.57 0.050
18.63 0.120 18.41 18.53 18.62 0.210
18.41 0.100 18.52 18.53 18.47 0.060
18.629 0.150 Average = 18.576 0.101
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.900
18.800
Average
18.700
18.600
18.500
18.400
18.300
18.200
18.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.530 18.577 18.523
0EX65002519030592T00026
18.767 18.857 18.797
0EX6500251903059320006E
18.570 18.620 18.653
0EX65002519030593200073
18.540 18.590 18.383
0EX65002519030593200076
18.757 18.700 18.633
0EX650025190305932000A2
18.587 18.540 18.473
0EX650025190305932000CD
18.670 18.750 18.720
0EX65002519030593200166
18.623 18.623 18.547
0EX6500251903059320018F
18.493 18.617 18.520
0EX6500251903059320019A
18.500 18.417 18.507
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5190 MCS9 VHT BW-40 TX1 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.110 0.180 0.090 0.436
0EX65002519030592T00026
0.140 0.160 0.170 0.436
0EX6500251903059320006E
0.110 0.340 0.140 0.436
0EX65002519030593200073
0.140 0.260 0.090 0.436
0EX65002519030593200076
0.340 0.240 0.040 0.436
0EX650025190305932000A2
0.110 0.150 0.330 0.436
0EX650025190305932000CD
0.090 0.100 0.090 0.436
0EX65002519030593200166
0.360 0.210 0.250 0.436
0EX6500251903059320018F
0.060 0.150 0.150 0.436
0EX6500251903059320019A
0.090 0.150 0.230 0.436
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.24 0.180 17.19 17.17 17.1 0.090
17.41 0.160 17.48 17.34 17.51 0.170
17.29 0.340 17.21 17.27 17.35 0.140
17.17 0.260 17.23 17.32 17.31 0.090
17.28 0.240 17.32 17.29 17.28 0.040
17.22 0.150 17.48 17.25 17.15 0.330
17.49 0.100 17.43 17.52 17.46 0.090
17.31 0.210 17.19 17.4 17.44 0.250
17.41 0.150 17.13 17.28 17.21 0.150
17.27 0.150 17.23 17.44 17.46 0.230
17.310 0.194 Average = 17.315 0.158
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
17.600
17.500
Average
17.400
17.300
17.200
17.100
17.000
16.900
16.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.263 17.193 17.153
0EX65002519030592T00026
17.333 17.307 17.443
0EX6500251903059320006E
17.370 17.270 17.277
0EX65002519030593200073
17.243 17.250 17.287
0EX65002519030593200076
17.073 17.313 17.297
0EX650025190305932000A2
17.257 17.177 17.293
0EX650025190305932000CD
17.387 17.447 17.470
0EX65002519030593200166
17.363 17.423 17.343
0EX6500251903059320018F
17.273 17.387 17.207
0EX6500251903059320019A
17.393 17.337 17.377
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5190 MCS9 VHT BW-40 TX2 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.180 0.210 0.150 0.340
0EX65002519030592T00026
0.130 0.130 0.100 0.340
0EX6500251903059320006E
0.200 0.160 0.000 0.340
0EX65002519030593200073
0.070 0.030 0.220 0.340
0EX65002519030593200076
0.080 0.060 0.140 0.340
0EX650025190305932000A2
0.110 0.160 0.100 0.340
0EX650025190305932000CD
0.050 0.080 0.200 0.340
0EX65002519030593200166
0.270 0.130 0.080 0.340
0EX6500251903059320018F
0.340 0.080 0.020 0.340
0EX6500251903059320019A
0.100 0.170 0.200 0.340
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.42 0.210 17.51 17.48 17.36 0.150
17.75 0.130 17.75 17.69 17.65 0.100
17.64 0.160 17.61 17.61 17.61 0.000
17.65 0.030 17.51 17.73 17.59 0.220
17.83 0.060 17.77 17.63 17.77 0.140
17.62 0.160 17.52 17.55 17.45 0.100
17.63 0.080 17.61 17.81 17.75 0.200
17.65 0.130 17.52 17.52 17.6 0.080
17.51 0.080 17.56 17.55 17.57 0.020 UCL Range Violation - A
17.65 0.170 17.52 17.47 17.67 0.200
17.620 0.121 Average = 17.598 0.121
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
17.900
17.800
Average
17.700
17.600
17.500
17.400
17.300
17.200
17.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.333 17.333 17.450
0EX65002519030592T00026
17.777 17.767 17.697
0EX6500251903059320006E
17.710 17.673 17.610
0EX65002519030593200073
17.583 17.653 17.610
0EX65002519030593200076
17.710 17.797 17.723
0EX650025190305932000A2
17.530 17.530 17.507
0EX650025190305932000CD
17.540 17.590 17.723
0EX65002519030593200166
17.543 17.647 17.547
0EX6500251903059320018F
17.683 17.560 17.560
0EX6500251903059320019A
17.537 17.647 17.553
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5190 MCS9 VHT BW-40 TX3 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.220 0.220 0.240 0.476
0EX65002519030592T00026
0.130 0.100 0.020 0.476
0EX6500251903059320006E
0.150 0.170 0.120 0.476
0EX65002519030593200073
0.260 0.190 0.150 0.476
0EX65002519030593200076
0.100 0.190 0.210 0.476
0EX650025190305932000A2
0.270 0.180 0.180 0.476
0EX650025190305932000CD
0.200 0.230 0.260 0.476
0EX65002519030593200166
0.090 0.200 0.250 0.476
0EX6500251903059320018F
0.140 0.470 0.400 0.476
0EX6500251903059320019A
0.050 0.070 0.070 0.476
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.21 0.220 17.29 17.41 17.53 0.240
17.7 0.100 17.6 17.59 17.61 0.020
17.63 0.170 17.52 17.56 17.64 0.120
17.97 0.190 17.71 17.84 17.86 0.150
17.9 0.190 17.95 17.74 17.86 0.210
17.59 0.180 17.64 17.58 17.76 0.180
17.79 0.230 17.55 17.69 17.43 0.260
17.73 0.200 17.68 17.9 17.65 0.250
17.76 0.470 17.64 17.36 17.76 0.400
17.75 0.070 17.88 17.87 17.81 0.070
17.644 0.202 Average = 17.664 0.190
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.000
17.800
Average
17.600
17.400
17.200
17.000
16.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.487 17.287 17.410
0EX65002519030592T00026
17.717 17.663 17.600
0EX6500251903059320006E
17.623 17.547 17.573
0EX65002519030593200073
17.813 17.853 17.803
0EX65002519030593200076
17.863 17.843 17.850
0EX650025190305932000A2
17.603 17.577 17.660
0EX650025190305932000CD
17.710 17.663 17.557
0EX65002519030593200166
17.747 17.730 17.743
0EX6500251903059320018F
17.657 17.550 17.587
0EX6500251903059320019A
17.743 17.723 17.853
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5190 MCS9 VHT BW-40 TX4 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.050 0.210 0.050 0.330
0EX65002519030592T00026
0.120 0.010 0.050 0.330
0EX6500251903059320006E
0.010 0.170 0.030 0.330
0EX65002519030593200073
0.220 0.050 0.260 0.330
0EX65002519030593200076
0.220 0.140 0.110 0.330
0EX650025190305932000A2
0.100 0.140 0.090 0.330
0EX650025190305932000CD
0.060 0.130 0.170 0.330
0EX65002519030593200166
0.060 0.120 0.190 0.330
0EX6500251903059320018F
0.090 0.180 0.100 0.330
0EX6500251903059320019A
0.230 0.170 0.310 0.330
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.53 0.210 17.48 17.5 17.53 0.050
17.83 0.010 17.89 17.85 17.9 0.050
17.71 0.170 17.93 17.9 17.9 0.030
17.64 0.050 17.8 17.54 17.65 0.260
17.84 0.140 17.87 17.98 17.98 0.110
17.92 0.140 17.89 17.82 17.8 0.090
17.81 0.130 17.82 17.99 17.85 0.170
17.69 0.120 17.67 17.86 17.81 0.190
17.58 0.180 17.75 17.66 17.76 0.100
17.73 0.170 17.69 17.89 17.58 0.310
17.749 0.132 Average = 17.785 0.136
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.000
17.900
Average
17.800
17.700
17.600
17.500
17.400
17.300
17.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.477 17.547 17.503
0EX65002519030592T00026
17.933 17.827 17.880
0EX6500251903059320006E
17.743 17.787 17.910
0EX65002519030593200073
17.640 17.643 17.663
0EX65002519030593200076
17.833 17.917 17.943
0EX650025190305932000A2
17.787 17.837 17.837
0EX650025190305932000CD
17.863 17.763 17.887
0EX65002519030593200166
17.827 17.757 17.780
0EX6500251903059320018F
17.683 17.650 17.723
0EX6500251903059320019A
17.740 17.767 17.720
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5795 MCS9 VHT BW-40 TX1 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.130 0.350 0.200 0.450
0EX65002519030592T00026
0.080 0.370 0.080 0.450
0EX6500251903059320006E
0.070 0.120 0.150 0.450
0EX65002519030593200073
0.330 0.200 0.130 0.450
0EX65002519030593200076
0.150 0.130 0.210 0.450
0EX650025190305932000A2
0.270 0.290 0.420 0.450
0EX650025190305932000CD
0.100 0.280 0.160 0.450
0EX65002519030593200166
0.120 0.140 0.130 0.450
0EX6500251903059320018F
0.190 0.010 0.020 0.450
0EX6500251903059320019A
0.020 0.180 0.200 0.450
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.46 0.350 17.59 17.72 17.52 0.200
18.72 0.370 18.41 18.49 18.49 0.080
17.54 0.120 17.8 17.72 17.87 0.150
17.78 0.200 18.02 18.02 17.89 0.130
18.17 0.130 18.31 18.45 18.24 0.210
17.88 0.290 18.08 17.66 17.75 0.420
18.21 0.280 18.25 18.09 18.14 0.160
17.88 0.140 17.86 17.73 17.73 0.130
17.66 0.010 17.63 17.65 17.65 0.020
17.77 0.180 17.52 17.58 17.72 0.200
17.905 0.207 Average = 17.919 0.170
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.800
18.600
Average
18.400
18.200
18.000
17.800
17.600
17.400
17.200
17.000
16.800
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.590 17.693 17.610
0EX65002519030592T00026
18.470 18.577 18.463
0EX6500251903059320006E
17.467 17.493 17.797
0EX65002519030593200073
17.880 17.867 17.977
0EX65002519030593200076
18.257 18.253 18.333
0EX650025190305932000A2
17.647 17.740 17.830
0EX650025190305932000CD
18.100 18.107 18.160
0EX65002519030593200166
17.877 17.957 17.773
0EX6500251903059320018F
17.540 17.657 17.643
0EX6500251903059320019A
17.643 17.703 17.607
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5795 MCS9 VHT BW-40 TX2 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.110 0.160 0.100 0.437
0EX65002519030592T00026
0.180 0.220 0.070 0.437
0EX6500251903059320006E
0.180 0.080 0.180 0.437
0EX65002519030593200073
0.210 0.200 0.100 0.437
0EX65002519030593200076
0.090 0.120 0.060 0.437
0EX650025190305932000A2
0.320 0.070 0.050 0.437
0EX650025190305932000CD
0.110 0.280 0.160 0.437
0EX65002519030593200166
0.160 0.270 0.420 0.437
0EX6500251903059320018F
0.160 0.130 0.200 0.437
0EX6500251903059320019A
0.190 0.090 0.410 0.437
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.43 0.160 17.41 17.31 17.37 0.100
17.62 0.220 17.74 17.81 17.76 0.070
17.57 0.080 17.5 17.39 17.57 0.180
17.41 0.200 17.73 17.73 17.63 0.100
17.55 0.120 17.67 17.67 17.73 0.060
17.62 0.070 17.46 17.44 17.41 0.050
17.73 0.280 17.74 17.58 17.6 0.160
17.74 0.270 17.88 17.65 17.46 0.420
17.68 0.130 17.44 17.64 17.46 0.200
17.53 0.090 17.4 17.81 17.49 0.410
17.596 0.162 Average = 17.583 0.175
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
17.900
17.800
Average
17.700
17.600
17.500
17.400
17.300
17.200
17.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.400 17.423 17.363
0EX65002519030592T00026
17.700 17.733 17.770
0EX6500251903059320006E
17.657 17.610 17.487
0EX65002519030593200073
17.590 17.537 17.697
0EX65002519030593200076
17.643 17.627 17.690
0EX650025190305932000A2
17.613 17.667 17.437
0EX650025190305932000CD
17.633 17.627 17.640
0EX65002519030593200166
17.553 17.613 17.663
0EX6500251903059320018F
17.593 17.657 17.513
0EX6500251903059320019A
17.463 17.470 17.567
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5795 MCS9 VHT BW-40 TX3 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.170 0.080 0.060 0.393
0EX65002519030592T00026
0.290 0.030 0.090 0.393
0EX6500251903059320006E
0.080 0.250 0.170 0.393
0EX65002519030593200073
0.190 0.210 0.160 0.393
0EX65002519030593200076
0.280 0.100 0.170 0.393
0EX650025190305932000A2
0.010 0.150 0.160 0.393
0EX650025190305932000CD
0.030 0.160 0.260 0.393
0EX65002519030593200166
0.080 0.140 0.070 0.393
0EX6500251903059320018F
0.220 0.280 0.080 0.393
0EX6500251903059320019A
0.110 0.260 0.230 0.393
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.75 0.080 17.69 17.72 17.66 0.060
18 0.030 17.93 17.91 17.84 0.090
17.91 0.250 17.79 17.76 17.62 0.170
17.96 0.210 17.99 17.98 17.83 0.160
18.04 0.100 17.91 17.98 18.08 0.170
17.77 0.150 17.69 17.85 17.77 0.160
17.84 0.160 17.92 17.84 18.1 0.260
17.78 0.140 17.9 17.93 17.97 0.070
17.66 0.280 17.83 17.91 17.87 0.080
18.05 0.260 17.8 18.03 18.02 0.230
17.855 0.166 Average = 17.871 0.145
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.200
18.100
Average
18.000
17.900
17.800
17.700
17.600
17.500
17.400
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.863 17.700 17.690
0EX65002519030592T00026
18.067 17.990 17.893
0EX6500251903059320006E
17.783 17.793 17.723
0EX65002519030593200073
17.977 17.847 17.933
0EX65002519030593200076
18.070 17.980 17.990
0EX650025190305932000A2
17.777 17.697 17.770
0EX650025190305932000CD
17.870 17.930 17.953
0EX65002519030593200166
17.897 17.870 17.933
0EX6500251903059320018F
17.903 17.840 17.870
0EX6500251903059320019A
17.980 17.900 17.950
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5795 MCS9 VHT BW-40 TX4 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.170 0.330 0.220 0.381
0EX65002519030592T00026
0.070 0.050 0.110 0.381
0EX6500251903059320006E
0.080 0.260 0.120 0.381
0EX65002519030593200073
0.250 0.090 0.100 0.381
0EX65002519030593200076
0.260 0.200 0.260 0.381
0EX650025190305932000A2
0.070 0.180 0.030 0.381
0EX650025190305932000CD
0.150 0.220 0.120 0.381
0EX65002519030593200166
0.120 0.250 0.170 0.381
0EX6500251903059320018F
0.080 0.110 0.090 0.381
0EX6500251903059320019A
0.140 0.020 0.110 0.381
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.42 0.330 17.29 17.31 17.51 0.220
17.78 0.050 17.67 17.68 17.78 0.110
17.64 0.260 17.48 17.46 17.58 0.120
17.51 0.090 17.38 17.48 17.47 0.100
17.58 0.200 17.76 17.5 17.59 0.260
17.33 0.180 17.56 17.57 17.59 0.030
17.59 0.220 17.62 17.55 17.67 0.120
17.4 0.250 17.42 17.4 17.57 0.170
17.62 0.110 17.44 17.53 17.44 0.090
17.45 0.020 17.53 17.48 17.59 0.110
17.551 0.171 Average = 17.530 0.133
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
17.800
17.700
Average
17.600
17.500
17.400
17.300
17.200
17.100
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.470 17.577 17.370
0EX65002519030592T00026
17.717 17.753 17.710
0EX6500251903059320006E
17.527 17.513 17.507
0EX65002519030593200073
17.460 17.460 17.443
0EX65002519030593200076
17.643 17.560 17.617
0EX650025190305932000A2
17.533 17.420 17.573
0EX650025190305932000CD
17.587 17.670 17.613
0EX65002519030593200166
17.530 17.537 17.463
0EX6500251903059320018F
17.423 17.560 17.470
0EX6500251903059320019A
17.457 17.457 17.533
control limit
9 10
Part Name: 613376 USL = 20
Dimension: 5610 MCS9 VHT BW-80 TX1 LSL = 16
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.220 0.120 0.100 0.445
0EX65002519030592T00026
0.220 0.300 0.200 0.445
0EX6500251903059320006E
0.010 0.100 0.290 0.445
0EX65002519030593200073
0.010 0.190 0.330 0.445
0EX65002519030593200076
0.200 0.280 0.190 0.445
0EX650025190305932000A2
0.180 0.220 0.120 0.445
0EX650025190305932000CD
0.180 0.080 0.090 0.445
0EX65002519030593200166
0.160 0.390 0.110 0.445
0EX6500251903059320018F
0.050 0.170 0.170 0.445
0EX6500251903059320019A
0.300 0.040 0.150 0.445
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
18.17 0.120 18.06 18.08 17.98 0.100
19.04 0.300 18.79 18.93 18.73 0.200
18.12 0.100 18.24 18.07 17.95 0.290
18.28 0.190 18.57 18.31 18.24 0.330
18.36 0.280 18.79 18.6 18.7 0.190
18.12 0.220 18.28 18.16 18.18 0.120
18.51 0.080 18.4 18.49 18.47 0.090
18.38 0.390 18.5 18.48 18.39 0.110
18.17 0.170 18.23 18.07 18.24 0.170
18.3 0.040 18.25 18.4 18.25 0.150
18.370 0.189 Average = 18.361 0.175
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
19.000
18.800
Average
18.600
18.400
18.200
18.000
17.800
17.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
18.123 18.130 18.040
0EX65002519030592T00026
18.823 18.877 18.817
0EX6500251903059320006E
18.093 18.127 18.087
0EX65002519030593200073
18.323 18.380 18.373
0EX65002519030593200076
18.617 18.497 18.697
0EX650025190305932000A2
18.203 18.250 18.207
0EX650025190305932000CD
18.633 18.463 18.453
0EX65002519030593200166
18.503 18.450 18.457
0EX6500251903059320018F
18.197 18.243 18.180
0EX6500251903059320019A
18.233 18.287 18.300
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5610 MCS9 VHT BW-80 TX2 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
Range
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.270 0.150 0.100 0.396
0EX65002519030592T00026
0.050 0.090 0.260 0.396
0EX6500251903059320006E
0.270 0.110 0.070 0.396
0EX65002519030593200073
0.240 0.190 0.020 0.396
0EX65002519030593200076
0.290 0.220 0.020 0.396
0EX650025190305932000A2
0.250 0.380 0.170 0.396
0EX650025190305932000CD
0.030 0.030 0.060 0.396
0EX65002519030593200166
0.300 0.190 0.160 0.396
0EX6500251903059320018F
0.130 0.070 0.070 0.396
0EX6500251903059320019A
0.050 0.240 0.130 0.396
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.59 0.150 17.58 17.64 17.68 0.100
18.08 0.090 18.19 17.93 17.97 0.260
17.89 0.110 17.98 17.92 17.91 0.070
17.82 0.190 17.86 17.84 17.85 0.020
18.02 0.220 18.09 18.1 18.11 0.020
17.61 0.380 17.67 17.83 17.66 0.170
17.97 0.030 18 17.96 18.02 0.060
17.98 0.190 17.97 18.02 18.13 0.160
17.86 0.070 17.74 17.76 17.69 0.070
17.57 0.240 17.78 17.66 17.65 0.130
17.873 0.167 Average = 17.873 0.106
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.200
18.100
Average
18.000
17.900
17.800
17.700
17.600
17.500
17.400
17.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.633 17.673 17.633
0EX65002519030592T00026
18.100 18.043 18.030
0EX6500251903059320006E
17.880 17.820 17.937
0EX65002519030593200073
17.877 17.810 17.850
0EX65002519030593200076
18.027 18.040 18.100
0EX650025190305932000A2
17.710 17.753 17.720
0EX650025190305932000CD
18.000 17.983 17.993
0EX65002519030593200166
17.900 18.010 18.040
0EX6500251903059320018F
17.717 17.893 17.730
0EX6500251903059320019A
17.740 17.700 17.697
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5610 MCS9 VHT BW-80 TX3 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.170 0.080 0.050 0.304
0EX65002519030592T00026
0.020 0.180 0.090 0.304
0EX6500251903059320006E
0.010 0.080 0.180 0.304
0EX65002519030593200073
0.220 0.140 0.110 0.304
0EX65002519030593200076
0.110 0.240 0.140 0.304
0EX650025190305932000A2
0.160 0.140 0.140 0.304
0EX650025190305932000CD
0.040 0.020 0.090 0.304
0EX65002519030593200166
0.080 0.050 0.140 0.304
0EX6500251903059320018F
0.250 0.040 0.240 0.304
0EX6500251903059320019A
0.150 0.030 0.150 0.304
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.61 0.080 17.6 17.58 17.63 0.050
17.66 0.180 17.76 17.75 17.67 0.090
17.64 0.080 17.5 17.59 17.68 0.180
17.68 0.140 17.7 17.81 17.73 0.110
17.9 0.240 17.79 17.7 17.65 0.140
17.52 0.140 17.67 17.53 17.58 0.140
17.65 0.020 17.62 17.55 17.64 0.090
17.65 0.050 17.59 17.72 17.73 0.140
17.61 0.040 17.44 17.64 17.4 0.240
17.7 0.030 17.57 17.72 17.62 0.150
17.666 0.100 Average = 17.639 0.133
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
17.900
17.800
Average
17.700
17.600
17.500
17.400
17.300
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.570 17.653 17.603
0EX65002519030592T00026
17.660 17.693 17.727
0EX6500251903059320006E
17.587 17.653 17.590
0EX65002519030593200073
17.830 17.750 17.747
0EX65002519030593200076
17.817 17.743 17.713
0EX650025190305932000A2
17.567 17.573 17.593
0EX650025190305932000CD
17.627 17.663 17.603
0EX65002519030593200166
17.763 17.617 17.680
0EX6500251903059320018F
17.537 17.627 17.493
0EX6500251903059320019A
17.543 17.687 17.637
control limit
9 10
Part Name: 613376 USL = 19.5
Dimension: 5610 MCS9 VHT BW-80 TX4 LSL = 15.5
Characteristic: #N/A 4
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.500
Range
0.400
0.300
0.200
0.100
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.080 0.500 0.170 0.353
0EX65002519030592T00026
0.150 0.160 0.100 0.353
0EX6500251903059320006E
0.070 0.120 0.200 0.353
0EX65002519030593200073
0.030 0.180 0.170 0.353
0EX65002519030593200076
0.170 0.170 0.130 0.353
0EX650025190305932000A2
0.030 0.070 0.030 0.353
0EX650025190305932000CD
0.150 0.060 0.250 0.353
0EX65002519030593200166
0.120 0.120 0.050 0.353
0EX6500251903059320018F
0.120 0.110 0.220 0.353
0EX6500251903059320019A
0.240 0.050 0.090 0.353
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
17.68 0.500 17.67 17.84 17.67 0.170 UCL Range Violation - B
18.25 0.160 18.35 18.28 18.25 0.100
18.32 0.120 18.14 18.34 18.15 0.200
17.86 0.180 17.97 18.13 17.96 0.170
18.27 0.170 18.42 18.55 18.52 0.130
18.16 0.070 18.1 18.07 18.07 0.030
18.37 0.060 18.44 18.43 18.19 0.250
18.29 0.120 18.25 18.28 18.3 0.050
17.97 0.110 18.05 17.97 17.83 0.220
18.07 0.050 18.09 18 18.02 0.090
18.151 0.154 Average = 18.144 0.141
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
18.600
18.400
Average
18.200
18.000
17.800
17.600
17.400
17.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
17.753 17.880 17.727
0EX65002519030592T00026
18.440 18.283 18.293
0EX6500251903059320006E
18.280 18.240 18.210
0EX65002519030593200073
18.037 17.973 18.020
0EX65002519030593200076
18.360 18.327 18.497
0EX650025190305932000A2
18.150 18.150 18.080
0EX650025190305932000CD
18.367 18.377 18.353
0EX65002519030593200166
18.133 18.220 18.277
0EX6500251903059320018F
17.987 17.980 17.950
0EX6500251903059320019A
18.023 18.080 18.037
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 2405 gn0 v240 LSL = 15
Characteristic: #N/A 6
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.350
0.300
0.250
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.150 0.010 0.470 0.183
0EX65002519030592T00026
0.010 0.010 0.200 0.183
0EX6500251903059320006E
0.090 0.000 0.010 0.183
0EX65002519030593200073
0.040 0.040 0.030 0.183
0EX65002519030593200076
0.130 0.160 0.010 0.183
0EX650025190305932000A2
0.050 0.240 0.190 0.183
0EX650025190305932000CD
0.070 0.020 0.010 0.183
0EX65002519030593200166
0.010 0.000 0.000 0.183
0EX6500251903059320018F
0.000 0.170 0.000 0.183
0EX6500251903059320019A
0.000 0.010 0.000 0.183
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.35 0.010 20.34 19.87 20.22 0.470 UCL Range Violation - C
20.24 0.010 20.05 20.24 20.04 0.200 UCL Range Violation - C
20.23 0.000 20.23 20.23 20.24 0.010
19.72 0.040 19.73 19.7 19.73 0.030
20.37 0.160 20.39 20.4 20.4 0.010
20.13 0.240 20.19 20.37 20.38 0.190 UCL Range Violation - B
20.09 0.020 20.08 20.09 20.08 0.010
20.21 0.000 20.2 20.2 20.2 0.000
20.4 0.170 20.4 20.4 20.4 0.000
20.09 0.010 20.09 20.09 20.09 0.000
20.195 0.066 Average = 20.169 0.092
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.600
20.400
Average
20.200
20.000
19.800
19.600
19.400
19.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.297 20.353 20.143
0EX65002519030592T00026
20.237 20.243 20.110
0EX6500251903059320006E
20.197 20.230 20.233
0EX65002519030593200073
19.797 19.703 19.720
0EX65002519030593200076
20.477 20.473 20.397
0EX650025190305932000A2
20.157 20.227 20.313
0EX650025190305932000CD
20.010 20.080 20.083
0EX65002519030593200166
20.193 20.210 20.200
0EX6500251903059320018F
20.400 20.343 20.400
0EX6500251903059320019A
20.080 20.083 20.090
control limit
9 10
Part Name: 613376 USL = 22
Dimension: 2440 gn0 v240 LSL = 16
Characteristic: #N/A 6
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.100 0.010 0.280 0.110
0EX65002519030592T00026
0.000 0.000 0.070 0.110
0EX6500251903059320006E
0.020 0.010 0.000 0.110
0EX65002519030593200073
0.040 0.110 0.070 0.110
0EX65002519030593200076
0.010 0.030 0.020 0.110
0EX650025190305932000A2
0.060 0.110 0.060 0.110
0EX650025190305932000CD
0.060 0.020 0.010 0.110
0EX65002519030593200166
0.010 0.010 0.000 0.110
0EX6500251903059320018F
0.010 0.150 0.000 0.110
0EX6500251903059320019A
0.000 0.010 0.000 0.110
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.78 0.010 20.77 20.49 20.61 0.280 UCL Range Violation - C
20.6 0.000 20.53 20.6 20.53 0.070
20.62 0.010 20.63 20.63 20.63 0.000
20.1 0.110 20.03 20.08 20.1 0.070
20.84 0.030 20.85 20.86 20.87 0.020
20.57 0.110 20.62 20.68 20.68 0.060
20.55 0.020 20.55 20.55 20.54 0.010
20.58 0.010 20.57 20.57 20.57 0.000
20.69 0.150 20.69 20.69 20.69 0.000 UCL Range Violation - B
20.38 0.010 20.38 20.38 20.38 0.000
20.568 0.046 Average = 20.558 0.051
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
21.000
20.800
Average
20.600
20.400
20.200
20.000
19.800
19.600
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.747 20.783 20.623
0EX65002519030592T00026
20.600 20.600 20.553
0EX6500251903059320006E
20.627 20.627 20.630
0EX65002519030593200073
20.157 20.057 20.070
0EX65002519030593200076
20.867 20.860 20.860
0EX650025190305932000A2
20.580 20.620 20.660
0EX650025190305932000CD
20.493 20.540 20.547
0EX65002519030593200166
20.563 20.573 20.570
0EX6500251903059320018F
20.693 20.640 20.690
0EX6500251903059320019A
20.370 20.377 20.380
control limit
9 10
Part Name: 613376 USL = 21
Dimension: 2480 gn0 v240 LSL = 15
Characteristic: #N/A 6
Results Key
0 to 10 Excellent EV and AV are based on 5.15sigma
10 to 20 Adequate 5.15sigma = (99% of the area under the normal distr
20 to 30 Marginal
> 30 Unacceptable Check = 30 Operators*Samples must
0.250
Range
0.200
0.150
0.100
0.050
0.000
1 2 3 4 5 6 7 8 9 10
Part
A B C
Part UCL
0EX65002519030592S00087
0.110 0.010 0.280 0.123
0EX65002519030592T00026
0.010 0.000 0.010 0.123
0EX6500251903059320006E
0.050 0.010 0.010 0.123
0EX65002519030593200073
0.120 0.190 0.160 0.123
0EX65002519030593200076
0.000 0.020 0.010 0.123
0EX650025190305932000A2
0.060 0.070 0.020 0.123
0EX650025190305932000CD
0.060 0.020 0.010 0.123
0EX65002519030593200166
0.010 0.010 0.000 0.123
0EX6500251903059320018F
0.000 0.160 0.000 0.123
0EX6500251903059320019A
0.010 0.010 0.000 0.123
FX-2 FX-3
Trial 3 Range Trial 1 Trial 2 Trial 3 Range
20.45 0.010 20.44 20.16 20.26 0.280 UCL Range Violation - C
20.35 0.000 20.34 20.35 20.34 0.010
20.27 0.010 20.27 20.27 20.28 0.010
19.85 0.190 19.7 19.83 19.86 0.160 UCL Range Violation - B
20.56 0.020 20.58 20.58 20.59 0.010
20.37 0.070 20.43 20.44 20.45 0.020
20.27 0.020 20.27 20.27 20.26 0.010
20.28 0.010 20.28 20.28 20.28 0.000
20.42 0.160 20.43 20.43 20.43 0.000 UCL Range Violation - B
20.1 0.010 20.11 20.11 20.11 0.000
20.284 0.050 Average = 20.281 0.050
Constants
a under the normal distribution curve) Trials D4 K1 K2
2 3.27 4.56 3.65
perators*Samples must be greater than 20 3 2.58 3.05 2.7
Average by Part
20.800
20.600
Average
20.400
20.200
20.000
19.800
19.600
19.400
19.200
9 10 1 2 3 4 5 6 7 8 9 10
Part
A B C
Part
0EX65002519030592S00087
20.410 20.453 20.287
0EX65002519030592T00026
20.347 20.350 20.343
0EX6500251903059320006E
20.287 20.273 20.273
0EX65002519030593200073
19.877 19.777 19.797
0EX65002519030593200076
20.580 20.570 20.583
0EX650025190305932000A2
20.390 20.410 20.440
0EX650025190305932000CD
20.207 20.260 20.267
0EX65002519030593200166
20.263 20.277 20.280
0EX6500251903059320018F
20.430 20.373 20.430
0EX6500251903059320019A
20.093 20.097 20.110
control limit
9 10